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SUMMARY
Haematology is the study o f one of the most vital systems, the blood, which is 
'a window1 to many other body systems often reflecting the abnormalities or 
pathological changes in diseased organs. The study o f this system has been and still is 
o f great interest to man. It is one o f the most intensely studied systems of animals and 
man. Haematology is a vast subject which includes the study of all the cells o f the 
blood, their formation and functions in normal and in pathological conditions. 
Haematological conditions are common and diverse, anaemia being one of the well 
recognised clinical conditions in animals and man. There is an increasing awareness 
amongst veterinarians regarding the implications o f anaemia in animals, resulting in an 
increasing number o f cases reported.
For a proper understanding of anaemia, it is necessary to know the details of 
the mechanisms of haemopoiesis which are reviewed in the first chapter. Pathological 
conditions affecting the erythropoietic system may be basically considered as 
hyperplasia, neoplasia or anaemia and these are discussed in the second chapter. For a 
systematic approach to diagnosing anaemia the clinical presentation o f the patient is 
essential with a history o f the subject. This information may provide a clue to the 
underlying mechanisms causing the anaemia and these matters are considered in the 
third chapter.
Once the diagnosis of anaemia has been established in a patient it is very 
important to classify the anaemia. There are various classifications of anaemia 
described for animals and man. A classification of anaemia in dogs has been proposed
13
on the basis of these classifications already described and this has been used 
throughout this study.
The retrospective study comprises of a survey of anaemic dogs presented at 
the University of Glasgow Veterinary School from 1st January to 31st December 
1994. There were in all 245 dogs presented with Packed Cell Volume (PCV) less than 
36.9% that were considered to be anaemic. From these dogs, 52 dogs (Group A) 
were examined post-mortem by the pathologists at the University of Glasgow 
Veterinary School. The haematological data of these 52 dogs was studied in more 
detail to co-relate the blood findings and the pathological observations for a better 
understanding of the underlying mechanisms causing the anaemia.
For the prospective part of this study, dogs presented as clinical cases to the 
veterinary school during the following year (1995), were selected. Knowing the 
pathological conditions observed in the retrospective study, dogs for the prospective 
study were chosen that were markedly anaemic. Only cases with significant anaemia 
as classified by the criteria adopted in the retrospective study and with some marked 
haematological findings were considered. These selected cases were grouped and 
studied in relation to the mechanism causing the anaemia.
This study has identified the commoner types of anaemia in the dogs 
investigated and classified the anaemias in the best possible way for veterinary use. 
Knowing the cause and the severity o f an anaemia enables a better assessment for the 
prognosis of a case to be made. Thus, it was concluded that a complete 
haematological investigation should be an essential part o f a diagnostic procedure for 
detecting the underlying causes of anaemia and for making a prognosis for the animal.
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CHAPTER 1
HAEMOPOIESIS
AND
ERYTHROPOIESIS
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1.1 BLOOD
The blood has always been and still is an organ of great interest to man and
his curiosity. The blood has always been regarded as a life-containing fluid, only
rarely is the blood considered as an organ. The blood is the most vital organ 
contained as a fluid matrix, circulating through vascular channels into every part of 
the body. It is the life of every tissue and cell o f the body, providing oxygen, 
hormones, nutrients and receiving the waste products o f metabolism from all the 
various organs for excretion and maintaining a homeostatic environment for the cells 
of the body. It consists of a number of different types of cells which are suspended in 
a fluid matrix called plasma. This fluid matrix is a complex mixture o f proteins 
controlling the pH and osmotic pressure. Many disease conditions can cause subtle 
changes in the blood most easily, making it the most important aid to a diagnosis o f a 
disease.
Knowledge and progress in haematology has increased in the past few 
decades with increasing technology and have resulted in greater success in diagnosing 
and treatment of many disease conditions of the blood including anaemia. To 
understand the development of anaemias it is essential to know, the processes
involved in the production of the blood cells and the factors involved in their
regulation.
1.2 HAEM OPOIESIS
Haemopoiesis is derived from Greek language, where haima means blood and 
poiesis means making. It is a complex process by which the cells that make up the 
blood are produced. Haemopoiesis during intrauterine life begins in the yolk sac,
19
successively it takes place in the liver and spleen of the embryo, to a lesser extent the 
kidney and adrenals (Valli and Parry, 1993). In dogs, splenic haemopoiesis may be 
found at birth with a gradual diminution over the next six months. In mice, the spleen 
retains this function throughout life and hence has been used as a model in 
understanding certain mechanisms (Jain, 1979). After birth, the sustainment and 
production o f haemopoietic cells takes place mainly in the shafts of long bones which 
contain the active red bone marrow the so-called myeloid tissue. After puberty, the 
flat bones of the sternum, pelvis, ribs, spine and proximal ends of long bones maintain 
haemopoiesis. The cavity of the long bones may be replaced by the fatty tissue called 
yellow marrow. Only in case of an increased demand for red blood cells will there be 
a haemopoietic conversion of the fat in the endosteal margins and in the cancellous 
bone areas (Valli and Parry, 1993). The red bone marrow is located centrally within 
the bone and is surrounded by the cortex of the bone. It has an arterial blood supply 
that delivers nutrients and also forms sinuses in the medullary bone. These sinuses are 
extravascular spaces within which haemopoietic cells grow and differentiate. The 
progenitor cells (discussed further), that grow and develop in these sinusoidal spaces 
are surrounded by the bone marrow stroma, which consists of endothelial cells, 
fibroblasts, adipocytes and macrophages. Cells from various cell lines grow in this 
bone marrow microenvironment until they are mature enough to be released into the 
venous circulation (Smith and Yee, 1992). The liver and spleen do have the potential 
to become active again and haemopoiesis may be re-established in case of increased 
demands. Formation o f blood outside the marrow cavities is called extramedullary 
haemopoiesis (EMH). In dogs, this may be observed in cases of an increased demand 
which may be seen in blood loss or haemolysis.
20
Blood cells have different life spans and new cells have to be produced 
continuously to maintain a balance of these cells. The different functions o f these cells 
makes their production very complex. Production, proliferation, maturation and 
release of the mature cells from the bone marrow is maintained in a steady state so 
that the production balances the loss. This is brought about by a number o f circulating 
haemopoietic growth factors which are glycoproteins, and factors derived from the T- 
lymphocytes, monocytes, and from the specialised stromal elements o f the bone 
marrow. These factors are the different colony stimulating factors (CSFs), 
interleukins (IL), interferons (IFN), thrombopoietin and erythropoietin (Epo) acting 
at different levels of the developmental process regulating the proliferation and 
differentiation of the haemopoietic stem cells, early and late progenitor cells (Metcalf, 
1989; Smith and Yee, 1992). Metcalf (1989), observed that in vitro the CSFs, not 
only regulate proliferation, but also enhance the survival of the precursors, maintain 
the functional integrity of the cells, cause irreversible induction o f commitment and 
differentiation, induce maturation of the cells and stimulate the activity of some 
mature cells. Development of the granulocytes, monocytes, platelets and lymphocytes 
are regulated by ILs and the CSFs, whereas erythropoiesis is mainly regulated by a 
hormone Epo produced by the kidneys.
Stem cells and early progenitor cells are morphologically unrecognisable and 
they were initially identified through cell culture colony forming assays. Hence, these 
cells are often referred to as colony forming units (CFU) or burst forming units 
(BFU). All the haemopoietic cells of the blood originate from a common pluripotent 
stem cell which is uncommitted and is able to differentiate into the various cell 
lineages, persisting throughout the life of the animal and capable of undergoing 
irreversible proliferation in a methodical process. The pluripotent stem cell is capable
21
of self-renewal and of differentiation into multipotential stem cells (these are cells 
producing progenitors of two or more cell lineages), which in turn differentiate into 
unipotential early precursor cells committed to a single lineage (Jain, 1993a; Metcalf, 
1989). These early precursors undergo a number o f cell divisions forming the late 
precursors which then reach a stage where they undergo maturation within the 
marrow. Only mature cells are released into the circulation. The presence of immature 
cells in the blood is associated with some haematological abnormality. Also, the 
production of the various cell types remains in proportionate numbers until this steady 
state is disturbed by some pathological condition.
The pluripotent stem cell gives rise to two types of multipotential stem cells 
which are the lymphopoietic and the haemopoietic (myeloid) stem cells and the 
subsequent development of these cell lineages in man is illustrated in Figure 1. These 
cells proliferate and form two pools, one for lymphopoiesis and one for myelopoiesis. 
They have a limited capacity for self renewal, and have the potential to become any 
progenitor cell termed multipotential cells (Smith and Yee, 1992). The myeloid 
progenitor cell (CFU-GEMM) derived from the myeloid stem cells is the cell from 
which the granulocytes, erythrocytes, monocytes and megakaryocytes are derived. 
The lymphopoietic stem cell is also derived from the same pluripotential stem cell but 
undergoes differentiation and maturation by different mechanisms than that o f the 
myeloid series. The lymphopoietic stem cell, regulated by growth factors, forms the 
precursors for the B and T cells. These then mature to form the B lymphocytes and 
the T lymphocytes in the primary lymphoid organs that is in the bone marrow and the 
thymus respectively. The CFU-GEMM under the influence of CSFs and ILs form the 
precursors for the granulocytic (CFU-G, CFU-Eo, CFU-Bas), monocytic (CFU-M) 
and megakaryocytic cell lineages (CFU-Meg), and burst forming unit for the
22
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erythroid cell lineage (BFU-E). The erythroid burst forming unit, gives rise to the 
colony forming unit erythroid (CFU-E), which undergoes cell divisions to finally 
produce the erythrocytes (Metcalf, 1989).
The differentiation, production, maturation and regulation of erythrocytes 
takes place under the influence of the hormone erythropoietin and other factors 
(Krantz, 1991). It is essential to understand the mechanism involved in the formation 
of the erythrocytes and the action of erythropoietin since anaemia is an abnormality of 
the erythrocytes.
1.3 ERYTHROPOIETIN
This hormone is the main regulatory factor of erythropoiesis. Pathological 
conditions affecting the regulation of erythropoietin (Epo) production cause 
abnormalities ranging from secondary polycythaemia due to the excessive production 
of Epo to the anaemia of chronic renal failure due diminished Epo production 
(Cowgill, 1992a). Erythropoietin is a unique glycoprotein hormone amongst the 
haemopoietic growth factors since it is produced primarily by the adult kidneys, 
transported via the blood stream and acts specifically on the erythroid precursors, 
having little effect on other cell lineages (Krantz, 1991). It is present in the plasma, 
urine and other body fluids. Although it is produced primarily by the kidneys, in foetal 
life and in special circumstances in the adults, the liver has also been described as a 
site for extra renal production (Adamson, 1994). During the first weeks of pregnancy 
in human beings the foetal liver is the main source of Epo that disappears after 2 
weeks and the kidney resumes the function (Cambi and David, 1994).
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In a series of experiments by Fried (1972), bilaterally nephrectomised and 
eviscerated rats had low plasma Epo titers. However, these levels were greater than 
the levels observed when the rodents were subjected to total nephrectomy and partial 
hepatectomy of 80 percent. When these rats were exposed to hypoxia for 8 hours, the 
plasma Epo levels of the rats with nephrectomy and 80 percent hepatectomy was 
undetectable, when compared with the nephrectomised rats in which there was a low 
level of Epo. This suggested some extra renal site of Epo production and was 
assumed to be the liver (Fried, 1972).
Erythropoietin selectively stimulates the proliferation and differentiation of the 
early erythroid precursor cells (BFU-E and CFU-E) into the pronormoblast,
(Figure 1), which is the first morphologically recognisable late precursor cell (Ikeda et 
al., 1990). The BFU-E is resistant to the action o f Epo. However, in the presence of a 
factor burst promoting activity (BPA), which is derived from T-lymphocytes and 
mononuclear cells, BFU-E becomes more sensitive and undergoes differentiation. In 
the first phase Epo stimulates mitosis and cellular growth, later its activity is directed 
towards the maintenance o f cell survival. The haematological response o f Epo 
depends on the number of circulating erythroid progenitors. At the cellular level, Epo 
increases RNA synthesis followed by haemoglobin synthesis and the action of Epo is 
increased at the CFU-E and pronormoblast stage (Cambi and David, 1994). At the 
CFU-E stage, the CFU-E is estimated to have 300 to 400 high affinity Epo receptors 
per cell and in healthy individuals is the cell with the highest number of receptors in 
the body (Adamson, 1994).
The normal levels of Epo have been measured in dogs. In a study of 25 dogs 
Ikeda et al., (1990), using mouse spleen cells and serum from dogs, found the normal 
Epo levels to be 38.5-135 mU/ml. There was no difference in Epo levels between the
25
sexes. However, older dogs had lower levels compared to the high levels observed in 
puppies. The high levels in puppies was thought to be due to a physiological increase 
in erythropoiesis. In another study by Cook and Lothrop (1994), Epo was measured by 
radio immunodiffusion assay and in normal dogs levels were found to be 7-37 mU/ml.
Tissue oxygenation depends on a number of factors and hypoxia is sensed by 
the kidneys with the release of Epo (Cambi and David, 1994). Hypoxia induces the 
kidneys to produce renal erythropoietic factor or erythrogenein which interacts with 
an a-2-globulin (erythropoietinogen) synthesised by the liver to form Epo (Jain, 
1979). As summarised by Woodman (1992), a variety o f hormones may also be 
involved in the release of Epo such as growth hormones, lactogenic hormones and 
vasopressin. The action of these hormones and vasopressin seem to facilitate Epo 
release rather than affecting its action. Calcium levels may also increase when Epo 
production is stimulated (Woodman, 1992). Sudden tissue hypoxia as in case o f 
severe haemorrhage, stimulates and increases the production of Epo which induces 
erythropoiesis to compensate for the developing anaemia. Whereas, hyperoxia 
reduces the amount of Epo and subsequently erythrocyte production (Krantz, 1991).
In dogs, advancing renal failure has been recognised to lead to a progressive 
non-regenerative anaemia due to the destruction o f the renal parenchyma and 
associated reduced Epo secretory function (Cowgill, 1992a). In dogs with renal 
failure the measurements of serum Epo concentration, revealed low to normal levels 
indicating either an absolute or a relative decrease of Epo and this suggests that any 
impairment to the kidneys may lead to a non-regenerative anaemia (King el al, 
1992). In cases of certain haemolytic and blood loss anaemias there is an increase in 
the levels of Epo, stimulating erythropoietic activity which results in reduction in the 
maturation time and early release of immature cells leading to reticulocytosis (Jain,
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1979). In a study by Cook (1994), it was observed by radioimmunoassay that in some 
dogs the levels of Epo increased in pure red cell aplasia. However, the bone marrow 
was unable to respond due to the aplastic conditions. Such animals probably would 
not benefit from Epo therapy.
With increasing knowledge, many haemopoietic growth factors have been 
studied and produced through cloning and recombinant DNA technology. Their 
biological applications and therapeutic role has raised keen interest in human beings 
and in animals (Ogilvie, 1993). These growth factors have the ability to increase the 
number of erythrocytes, granulocytes and platelets in clinical situations o f cytopenias 
when the stem cells are plentiful. Interleukins particularly, are likely to play an 
important role in treating cancer, infectious and immunodeficiency syndromes 
(Elmslie et al, 1991). Groopman et al, (1989), have well summarised their 
applications for human beings in certain clinical conditions. In veterinary medicine, 
there have been several reports and clinical trials in dogs and cats in studying the 
efficacy of these factors (Ogilvie et al., 1992, Ogilvie, 1993, Cowgill, 1992a). The 
highly purified recombinant human erythropoietin (rHuEpo) is now clinically available 
and has been used in human patients.
Erythropoietin has been of great help to human patients in correcting the 
anaemia associated with chronic renal failure although its uses have also been 
observed in other conditions (Eschbach et al., 1990). It has also been o f significant 
value in case of short term treatment of chronic renal failure in dogs and cats (Cowgill 
et al, 1990, Ogilvie, 1993; Bloomberg et al, 1992). Subcutaneous injections improve 
the quality of life as well as improving the severity of anaemia in these animals. The 
current formulation of rHuEpo is in human serum albumin which could promote both 
local as well as systemic reactions in dogs and cats. Cellulitis, fever, arthralgia and
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mucocutaneous ulcerations have been recognised in human beings, although an 
allergic basis could not be established, all these manifestations resolved when 
treatment was discontinued. It has also been observed that the use of rHuEpo has also 
resulted in the production of antibodies (Cowgill, 1992b). According to Bloomberg et 
al, (1992), when rHuEpo (Epogen, Amgen Incorporated, Thousand Oaks,California, 
USA), was administered to a cat with chronic renal failure, there was a progressive 
improvement in the packed cell volume (PCV) and in the general status of the cat. 
Nevertheless, after 178 days the cat died of seizures which the author thought may 
have been similar to the seizures observed in human beings. However, with caution, it 
may still be useful for a short term therapy. With increasing interest and research, 
growth factors have been produced by biotechnology. Their use in human medicine is 
increasing while for dogs some o f the factors have been cloned but are not yet 
commercially available for clinical use.
1.4 ERYTHROPOIESIS
Erythropoiesis is the systematic process in which the myeloid stem cells 
(CFU-GEMM) in the bone marrow differentiates to form the cells of the erythroid 
series, the erythrocytes (Figure 2). Differentiation of the myeloid stem cell (CFU- 
GEMM), to early committed erythroid progenitor cells called the burst forming unit 
erythroid (BFU-E), and then the development of the CFU-E results in the formation 
of morphologically recognisable erythroid precursors. The BFU-E is stimulated by 
Epo, various other cytokines (IL-3 and CSFs) and burst promoting activity (BPA) 
which is produced by various cells including macrophages and T-lymphocytes. 
Cytokines such as IL-3 and CSFs which are produced by T-Iymphocytes, promote
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survival, proliferation and development of the multipotential stem cells and 
differentiation of erythroid progenitor cells (Erickson and Quesenberry, 1992).
CFU-E is also sensitive to the actions of Epo which primarily stimulates proliferation 
and maturation of late erythroid precursors from the pronormoblasts onwards.
All the terminologies used to describe the late precursor cells are based on the 
appearance of the cell after staining. The process of blast transformation as seen with 
the Romanowsky stains takes place at the pronormoblast (proerythroblast) stage. It is 
the largest recognisable cell of the erythroid cell series, with a large central or 
eccentric nucleus, a large nuclear cytoplasmic ratio with one or more well-defined 
nucleoli. The cytoplasm stains deeply basophilic due to large amounts o f RNA. In 
subsequent stages, there is a progressive condensation of nuclear chromatin and 
cytoplasmic structures such as mitochondria, with a loss of RNA activity and an 
increase in haem synthesis. Each pronormoblast undergoes three to four divisions and 
forms 8 to 16 cells which then undergo further progressive maturation.
The early basophilic normoblast is the next recognisable cell in the series 
where the nucleus lacks the nucleolus and has a coarser chromatin pattern with a dark 
blue staining cytoplasm. Each early basophilic normoblast undergoes further mitotic 
cell division resulting in the formation of the intermediate polychromatophilic 
normoblast, with the nucleus being a heavily clumped chromatin. At this stage the 
cells are smaller, with a blue to reddish tinge to the cytoplasm due to 
haemoglobinisation. Each cell undergoes maturation resulting in the late 
orthochromatophilic normoblast. The late orthochromatophilic normoblast has a 
pyknotic dense nucleus and a small amount of reddish cytoplasm. It is one of the most 
commonly observed cells of the erythroid series in the bone marrow
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F igure 3A : Normal canine bone marrow cytology with different developmental stages 
of the myeloid and erythroid cell series and a background of mature erythrocytes. The 
cells are:
a: pronormoblast (proerythroblast)
b: basophilic normoblast (early)
c: orthochromatophilic normoblast (late)
d: metamyelocyte
e: mature neutrophil
f: myeloid cell in mitosis
Stained by May Grtinwald Giemsa, (x 400).
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Figure 3B: Normal canine bone marrow cytology showing erythroid and myeloid
precursors at various stages of development. The cells are :
a: pronormoblast
b: basophilic normoblast (early)
c: polychromatophilic normoblast (intermediate)
d: orthochromatophilic normoblast (late)
e: metamyelocyte
f: neutrophil
Stained by May Grunwald Giemsa, (x 1000).
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F igu re 3C: Normal canine bone marrow cytology showing different development
stages of the erythrocytes cell series. The cells are:
a: pronormoblast (proerythroblast)
b: basophilic normoblast (early)
c: polychromatophilic normoblast (intermediate)
d: orthochromatophilic normoblast (late)
Stained by May Griinwald Giemsa, (x 1000).
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showing progressive accumulation of haemoglobin (Beck, 1991; Aufderheide, 1981). 
These cells are illustrated in Figure 3 A, 3B and 3C.
Extrusion of the pyknotic nucleus leads to the formation of the immature 
erythrocyte, "the reticulocyte". This process requires four to seven days in a normal 
animal but may be accelerated to about two days under conditions causing erythroid 
stimulation (Weiser, 1995). Normally, nucleated erythrocyte precursors are not 
released into the circulation. However, when these cells are observed in excess they 
are indicative of increased bone marrow erythropoiesis or EMH.
1.5 THE RETICULOCYTE
According to the review by Houwen (1992), the history of the reticulocyte 
dates far back to the 19th century, when Erb described these cells which he observed 
were present in small amounts in healthy animals but increased in numbers when red 
cell regeneration took place. An overview of the history of the reticulocyte ever since 
its discovery has been given by Houwen (1992). Since then, there have been several 
investigations to elucidate their maturation and their role in regenerative anaemias. 
The reticulocyte is formed when the nucleus is lost from the orthochromatophilic 
normoblast during its passage through the marrow sinusoids. These cells are anuclear 
but still contain some ribosomes, Golgi bodies and mitochondria in their cytoplasm 
and undergo further maturation but no cell division. They are called reticulocytes 
because on a blood smear, after supravital staining with new methylene blue a method 
described by Schalm (1964), it produces a clumping of the above structures resulting 
in a granular blue stained reticulum (Figure 4A).
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F igure 4A: Peripheral blood smear from a dog showing aggregation of RNA i.e. 
reticulum formation in immature erythrocytes (a). Reticulum is demonstrated by the 
supravital stain new methylene blue, (x 1000).
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F igure 4B: Reticulocytes (a), have a bluish tint when the blood smear is stained with 
May-Grtinwald Giemsa stain and are referred to as polychromatic macrocytes or 
polychromasia of red cells, (x 1000).
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After staining with a standard Romanowsky stain such as Leishman or May - 
Griinwald Giemsa, they appear with a slight bluish tint which is called polychromasia 
and the mature erythrocytes appear eosinophilic due to their haemoglobin content 
(Figure 4B). In a blood smear the increased presence of polychromatic cells reflects 
increased erythropoiesis. The number of reticulocytes present in the blood can be 
counted manually and evaluation of reticulocytes has now become more accurate 
using flow cytometry methods by staining the cells with thiazole orange (Abbott and 
McGrath, 1991). Although there are drawbacks in this method, since Howell-Jolly 
bodies and small lymphocytes may be included in the counts, when compared to the 
manual method it has proven to be more precise.
Reticulocytes stay in the bone marrow for about two to three days where they 
undergo maturation before entering the circulation by diapedesis. Reticulocytes are 
sticky and lose their stickyness as they mature. As reticulocytes mature to form 
erythrocytes they undergo changes in addition to losing all its organelles (reticulum). 
They shrink in diameter and volume due to decrease in the water content, so that the 
haemoglobin is more concentrated along with a decrease in the total surface area. The 
amount of lipid present on the cell also decreases but the relative concentration of 
essential fatty acids and cholesterol increases resulting in the formation of a mature 
erythrocyte (Crosby, 1959). In the circulation or in the spleen they mature to 
erythrocytes within 24 to 48 hours but if the reticulocytes are produced under severe 
hypoxic conditions, they will have a greater amount of reticulum and tend to persist 
for a longer duration of three days (Laber et a/., 1974).
Normally, in the marrow reticulocytes contain more reticulum and are larger, 
less matured than those in the peripheral blood (Schalm et al, 1975b). They can also 
be distinguished from erythrocytes easily as they have not yet achieved their
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biconcave shape typical for canine erythrocytes. When observed in the circulation, 
they are larger in size than the mature cells. Hence, they are also referred to as 
“polychromatic macrocytes” . Due to the fact that reticulocytes have larger volume 
(MCV) and or relatively low haemoglobin concentration (MCH) the morphology of a 
regenerative anaemia with marked reticulocytosis will either be macrocytic and 
normochromic or hypochromic.
Dogs and cats may normally have a reticulocyte count of 0.5-1 percent in the 
peripheral circulation (Schalm et al, 1975b). Canine reticulocytes usually contain 
aggregates of RNA, while cats have aggregate as well as punctate forms of 
reticulocytes (Figure 4A). (Weiser, 1995).
Tissue anoxia due to anaemia after haemorrhage results in an immediate and 
premature release of reticulocytes into the circulation which is known as 
reticulocytosis. Accelerated release of reticulocytes is mediated by hypoxic conditions 
stimulating the release of Epo and consequently the stimulation of erythropoiesis in 
the bone marrow. Increased hypoxia may stress the marrow even further resulting in 
the release of some normoblasts. Thus, a reticulocyte count along with other 
parameters is an indicative tool in classifying and identifying the cause o f anaemia. 
According to Schalm et a/., (1975b) and many other researchers, in the dog the 
magnitude of the reticulocyte response in the peripheral blood circulation is directly 
related to the degree of erythropoietic activity. Marked increase in erythropoiesis is 
associated with a regenerative blood picture which is characterised by anisocytosis 
due to an exaggerated variation in cell size, polychromasia due to polychromatic 
macrocytes, an increased number of Howell-Jolly bodies and often by the presence of 
nucleated red cell precursors.
"Howell-Jolly" bodies are nuclear remnants containing DNA (Figure 5).
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F igure 5: Howell -Jolly body in the erythrocyte (a), is nuclear remnants containing 
DNA and appear as densely stained structures, 
b: neutrophil 
c: erythrocyte
Stained with May-Grunwald Giemsa stain,(xl000).
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They appear as dark staining structures in the reticulocytes and also in 
erythrocytes. These are frequently observed and may be present in high numbers 
when erythrocytes are being rapidly produced due to increased demand as in 
regenerative anaemia (Dacie and Lewis, 1991b). They may also be seen in the case of 
hyposplenism where there is an impaired splenic "pitting" function or due to 
corticosteroid therapy. This “pitting” function of the spleen is described later.
1.6 THE ERYTHROCYTE
The erythrocyte is formed after the reticulocyte loses all its organelles and 
undergoes certain changes. When blood is stained with a Romanowsky and examined 
under the microscope mature erythrocytes appear anuclear, reddish-brown in colour 
due to their haemoglobin content with a zone of central pallor. When a Romanowsky 
stained blood smear is examined, the normal feature is of a uniformity in all the cells 
(Figure 6A and 6B). A variation in this uniformity, which is the diameter o f the cells, 
is called cmisocytosis. At birth the erythrocytes of the neonate are large with a high 
mean corpuscular volume (MCV) and mean corpuscular haemoglobin (MCH) which 
decrease to the adult values by two to three months of age. By the first year the 
young dog attains all the values of an adult (Anderson and Gee, 1958).
Dogs have typical biconcave shaped cells and when observed with electron 
microscopy, the cells have a smooth surface. The life span of erythrocytes within the 
circulation is of 110-120 days and almost 0.9 to 1.3 percent are removed daily from 
the circulation (Weiser, 1995). The average size (diameter) of a canine erythrocyte is 
7pm, with a of volume of 60-72 fl, which is expressed as the MCV and the normal 
range of haemoglobin content (MCH) of 19.5-24.5 pg. In dogs the normal range of
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Figure 6A: Normal blood picture from a dog showing normocvtic and normochromic 
red cells with uniform size and shape, 
a: neutrophil 
b: lymphocyte
Stained by May-Grunwald Giemsa, (x 400).
F igure 6B: Normal blood smear from a dog with normocytic and normochromic 
erythrocytes. Slightly crenated erythrocytes may be artifacts, 
a: neutrophil 
b: lymphocyte
Stained by May Griinwald Giemsa, (x 1000).
42
circulating erythrocytes is 5.5-8.5 x 10 (Appendix A, Table Al). The cellular 
composition of the bone marrow is another important aspect which is a ratio of the 
myeloid and erythroid cells (M:E). The normal ratio in dogs is 0.75:2.5:1.0 which 
varies in different disease conditions (Schalm et al., 1975a).
Certain breeds have atypical red cell values which are not associated with 
anaemia but are normal features for that particular breed. When any of these breeds 
are encountered in practice these features should be considered in order to correctly 
interpret the haematological results. Red cells of Japanese Akita dogs have a low 
MCV of 55 to 65fl, whereas miniature and toy Poodles, both have high MCV ranging 
from 85 to 95fl. The cause of these features in Poodles according to Schalm et al., 
(1975a) and Schalm (1976), was unknown and may be physiological and not 
associated with any disease. Canfield and Watson (1989), investigated macrocytosis 
in detail in a Poodle and concluded that it may be similar to a congenital 
dyserythropoietic and megaloblastic disorder. Adult Greyhounds, German Shepherd 
Dogs and Poodles have higher than normal red cell counts, haemoglobin and pack cell 
volumes (PCV) (Squires, 1993, Schalm et al., 1975a; Doxey, 1966).
Anderson and Gee (1958), studied the normal red cell values o f 500 Beagle 
dogs and observed male dogs to have higher erythrocyte counts than females and the 
PCV and haemoglobin values were found to be higher in males. There are 
physiological adjustments too, in which the haemoglobin concentrations may fluctuate 
for example during oestrus, pregnancy and lactation in females. During gestation the 
PCV first decreases, then gradually starts to increase in the next few months. Later 
stages of pregnancy are associated with a pronounced decrease in erythrocytes called 
as "spurious anaemia" which is due to an increase in the plasma volume or iron 
deficiency, with a corresponding increase in leucocyte numbers (Wintrobe et al.,
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1974). During lactation the recovery is apparent but not complete till the litter is 
weaned (Anderson and Gee, 1958).
Erythrocytes are unique cells since they contain no cell organelles or nucleus 
and still survive. The primary function of erythrocytes is to transport oxygen via 
haemoglobin to various tissues of the body and to return carbon dioxide to the lungs. 
During their life span erythrocytes have to travel through a number o f vessels and 
come across different environments within the body. To achieve this special function 
they are made up o f a membrane consisting o f a lipid bilayer and a cytoskeleton. The 
lipid bilayer is composed of phospholipids and cholesterol. The cytoskeleton is made 
up of proteins spectrin alpha and p (a  and P), ankyrin, actin and protein 4 .1 which 
form a filamentous network in maintaining the cellular flexibility, biconcave shape and 
integrity of the cell (Smith, 1987).
For survival erythrocytes depend entirely on glycolysis by obtaining their 
energy mainly from glucose which is metabolised to lactate. This is by the anaerobic 
glycolytic Embden-Meyerhof (EM) pathway, the hexose monophosphate pathway 
(HMP) and the Rapaport-Luebering shunt (Figure 7). Through these pathways energy 
is generated in the form of reduced glutathione (GSH), reduced pyridine nucleotides 
(NADH, NADPH), 2,3-diphosphoglycerate (2,3-DPG) and adenosine triphosphate 
(ATP). Approximately 95 percent of the glucose is metabolised by the EM pathway, 
of which 30 percent is shunted via 2,3-diphosphoglycerate (2,3-DPG) and only 5 
percent goes by the HMP shunt (Kaneko, 1987). The ATP generated is essential for 
energy, maintaining the cell shape by controlling the movements of sodium into and 
potassium outside the cell. The reduced nicotinamide adenine dinucleotide phosphate 
(NADH) also formed in the EM pathway is utilised for the enzymatic reduction of 
methaemoglobin (iron in ferric form) to functional
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haemoglobin (iron in ferrous form) for oxygen transport. The reduced nicotinamide 
adenine dinucleotide phosphate (NADPH), formed in the pentose cycle is utilised for 
the conversion of oxidised glutathione (GSSG) to reduced glutathione (GSH) which 
is essential for the conversion of methaemoglobin to haemoglobin and for the binding 
of haemoglobin molecules to oxygen within the erythrocytes. It is also essential for 
the prevention o f oxidative damage to the erythrocyte membrane. Any deficiency may 
result in Heinz body formation and methaemoglobinaemias (Schalm et al., 1975b). A 
deficiency of any enzyme in the EM pathway leads to a decrease in ATP 
concentrations. The erythrocytes assume abnormal shape and or size and may be 
associated with haemolytic anaemias.
In dogs and cats, the sodium content within the cell is higher than the 
potassium because of a loss o f membrane sodium-potassium ATP during the late 
stages of erythrocyte maturation, unlike in human beings where a reverse condition is 
observed (Jain, 1993b). The Shiba is the smallest breed of dog, indigenous to Japan. 
It has been reported that in some of these Japanese Shiba dogs the potassium content 
is higher than the sodium content. These dogs also have high reduced glutathione 
levels (GSH), increase in the osmotic fragility and an increase in the MCV. This 
characteristic finding is described to be an autosomal mode of inheritance (Maede et 
a/., 1990). Some Akitas too, have high erythrocyte potassium which results in 
spontaneous in vitro haemolysis producing pseudohyperkalaemia (Degen, 1987).
46
1.7 HAEMOGLOBIN SYNTHESIS
The oxygen carrying capacity o f erythrocytes is associated with their 
haemoglobin content. With the help of its iron component, one haemoglobin molecule 
can combine with four molecules of oxygen. The compound 2,3 diphosphoglycerate 
which is formed in the Rapaport-Luebering shunt of anaerobic glycolysis is the 
potential regulator of energy and for the release o f oxygen from this haemoglobin 
molecule. An increase in the levels of 2,3-diphosphoglycerate which may be observed 
in anaemia, may be caused by a change in the intracellular pH of erythrocytes, that 
results in a decrease in the oxygen affinity (Erslev, 1990a). The oxygen affinity of 
haemoglobin is expressed as P50 which is, the oxygen tension at which haemoglobin 
is half saturated. Haemoglobin is a conjugated protein made up of two pairs of globin 
chains and each chain associated with an identical iron containing porphyrin, or haem 
group, with amino acid residues arranged in the form of an a-helix. Each globin chain 
has eight helical areas numbered A to H and haem occupies the position between the 
E and F helices of the chain (Jain, 1993a). There are three types of haemoglobin, 
embryonic, foetal and adult. The concentrations of foetal haemoglobin is highest at 
birth and gradually diminishes within a few months after birth and is replaced by adult 
haemoglobin. In dogs, these prenatal haemoglobins cannot be differentiated from the 
adult haemoglobin (Schalm et al., 1975b).
The synthesis of haemoglobin is under genetic control and occurs in the 
nucleated erythroid precursors and some amount takes place in the reticulocytes 
(Valli and Parry, 1993). Haem is synthesised in the mitochondria, by the combination 
of glycine and succinyl coenzyme A, leading to the formation delta amino levulinic 
acid (5-ALA) which is dependent on the presence of pyridoxal phosphate of
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pyridoxine (vitamin B-6) origin. The rate limiting enzyme is delta-amino levulinic acid 
(5-ALA) synthetase. Subsequently, this results in the formation of a protoporphyrin 
III ring with an ferrous iron atom in the centre which combines with a globin chain to 
form the haemoglobin molecule. Globin synthesis occurs in the cytoplasmic ribosomes 
of nucleated erythrocytes. It consists of two alpha and two non alpha (beta, delta or 
gamma) protein chains. Differences in the amino acid sequences in these globin chains 
account for species variance as well as differences within each species in the 
haemoglobin molecule (Jain, 1993b).
Certain haemoglobinopathies such as thalassaemias and sickle cell disorders 
are observed in human patients and have not been observed in dogs (Weiser, 1995; 
Squires, 1993). The thalassaemias are a heterogenous group of disorders which are 
characterised by various genetically determined defects of globin chain synthesis and 
are classified into a  and J3 types in whichever chain the defect is observed. Sickle cell 
disease is associated with the presence o f sickle cell S haemoglobin which is 
genetically determined. In anoxia erythrocytes assume a bizarre shape of a sickle 
hence the name (Cotran el a/., 1994a).
The incorporation of iron is a key component of erythropoiesis for 
haemoglobin synthesis. Iron is absorbed by the gut mucosa from the diet. The 
intestinal mucosal cells absorb ferrous iron more easily than the ferric iron. It is 
transported by the protein transferrin, to the receptors on the erythroid precursors 
(Adamson, 1994). Iron metabolism is discussed in the following section.
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1.8 ERYTHROCYTE DESTRUCTION
Erythrocytes have a limited life span and are removed from the circulation 
after 110 or 120 days as a physiological process balanced by a continuous renewal 
from the bone marrow (Schalm, 1975a). Senescence of erythrocytes is brought about 
by the exhausation o f their enzyme systems resulting in spherocyte formation and 
consequently removal from the circulation by the splenic macrophages. Shortening of 
the life span of erythrocytes may be due to abnormalities in the cell shape, defects and 
oxidation of the membranes, trauma, attachment of immunoglobulins as in auto­
immune haemolytic anaemia (AIHA), or excess loss in haemorrhagic conditions 
(Cotran et a/., 1994a). In haemolytic anaemias, erythrocytes are destroyed either 
intravascularly or extravascularly. Intravascularly, they lose their cell membranes and 
enzyme systems whereas extravascular destruction involves phagocytosis by the 
macrophages of the mononuclear phagocytic system (MNPS) mainly in the spleen, 
liver and bone marrow. Intravascular lysis involves the release of free haemoglobin 
into the plasma imparting a pink colour to it. The haem component of haemoglobin 
becomes bound to haptoglobin, a plasma protein, and it is then phagocytosed by cells 
of the MNPS. Excessive destruction of erythrocytes may result in surplus degradation 
of haemoglobin to dimers or monomers leading to saturation of haptoglobins and 
haemopexin leading in turn to the excretion of haemoglobin through kidneys, 
resulting in haemoglobinuria and in chronic conditions haemosiderinuria. Some part 
of haemoglobin may be oxidised to methaemoglobin, which dissociates and liberates 
haematin (Weiser, 1995, Jain, 1993b).
Extravascular haemolysis involves the process where the macrophages engulf 
the erythrocytes resulting in the release of free iron, as haemoglobin is degraded into 
its essential constituents. Free iron released from haem is carried as a ferric form in
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the plasma to the early erythroid precursors in the bone marrow. This process is 
achieved by a highly specialised beta globulin protein called transferrin, which is 
produced by the liver (Valli and Parry, 1993). Iron must exist in the ferric state to 
bind to transferrin. Ceruloplasmin a copper-containing globulin, facilitates iron 
transport and converts ferrous to ferric iron.
Iron is present in a variety of compounds and compartments within the body 
and is referred as iron pools. In the adult animal 75 percent of the iron is in 
haemoglobin and there are no sufficient reserves if the loss exceeds more than 30 
percent. The reticuloendothelial system stores some amount of iron as ferritin or 
haemosiderin. Ferritin is an iron-protein complex occuring in most cells and plasma, 
consisting of apoferritin protein subunits and iron. The serum ferritin levels are an 
accurate measure of body iron stores (Smith, 1992). Haemosiderin the other form of 
stored iron is most stable but least available. (Valli and Parry, 1993).
Bilirubin is produced in the phagocytic cells of the MNPS by degradation of 
haem pigment. The biliverdin that is first formed is converted to bilirubin which 
combines with albumin to be transported to the hepatic cells. Here a portion o f this 
bilirubin is conjugated with glucoronide and excreted to the bile. Most of it undergoes 
enterohepatic circulation while the remaining is stored as bile. Changes in the amount 
of bilirubin are proportional to the degree of haem degradation (Cotran et ah, 1994a). 
In severe haemolytic conditions bilirubin production may exceed the conjugating 
capacity of the liver. This may lead to the development o f jaundice. Haemolytic 
jaundice is associated with high levels of unconjugated (indirect) bilirubin in the 
plasma as opposed to the high levels of conjugated (direct) bilirubin found in 
posthepatic jaundice.
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1.9 THE FUNCTIONS OF THE SPLEEN AND ITS ROLE IN 
HAEMOPOIESIS
The spleen is the largest unit of the lymphoreticular mononuclear phagocytic 
system and is closely related to the haemopoietic system since it undergoes changes in 
a number blood diseases. It is a dumbbell-shaped flat organ, covered by a 
fibromuscular capsule, situated in the left anterior quadrant of the abdomen in a 
dorsoventral position in canines (Couto and Hammer, 1995). The architecture and 
position of the spleen makes it a multi-functional organ. It is positioned in the main 
circulation and performs a major role of a filter, entrapping pathogens present in the 
blood stream.
The spleen can also be viewed as a peripheral lymphoid organ because it has 
the presence of a white pulp, which consists of periarterial lymphatic sheaths 
contributing to lymphocyte production particularly after antigenic stimulation. The 
red pulp of the canine spleen has well developed venous sinusoids and has an effective 
"pitting" function as opposed to the spleen of cats which has poorly developed 
sinusoids and poor pitting functions. Thus, EMH is observed more often in dogs than 
in cats (Couto and Hammer, 1995).
The red pulp functions as a cleansing department of the erythrocytes by its 
"pitting" function. This pitting function is the ability o f the splenic macrophages to 
remove a solid particle from the cytoplasm of the erythrocyte without destroying the 
cell itself (Crosby, 1959). Erythrocytes are highly deformable and during their passage 
through the spleen erythrocytes traverse a network of sinusoids present in canines and 
which are absent in felines. Erythrocytes lose inclusion bodies during their passage 
from the splenic chords, into the splenic sinuses by squeezing through the spaces 
between the cytoplasmic processes of the endothelial cells that form the sinus wall
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(Crosby, 1977). The splenic macrophages remove abnormal structures such as the 
intraerythrocytic inclusions, the Howell-Jolly bodies and Heinz bodies, parasites and 
antibodies attached to the cell surface without damaging the morphology of rest of 
the erythrocyte (Crosby, 1959).
From a haematological point of view, the red pulp o f the spleen is most 
significant. It is the site where maturation of the reticulocytes occurs and the effect of 
the spleen on the red cell surface may influence the time when reticulocytes enter the 
circulation (Crosby, 1959). In pathological states, remodelling of the erythrocytes 
coated with immunoglobulins takes place by the splenic macrophages which either 
phagocytose the erythrocytes or remodel the erythrocyte membrane surface 
eventually resulting in the releasing of erythrocytes as spherocytes into the circulation 
(Couto and Hammer 1995; Crosby, 1959). In addition, the spleen retains its ability to 
initiate EMH in most adult animals especially in dogs (Couto and Hammer, 1995).
Platelets are also stored in the spleen and approximately 30 percent of the 
total platelet mass is in the spleen at any given time, where they circulate slowly. As a 
result of this feature, splenectomy in pathological conditions may result in an 
elevation of the platelet counts (Couto and Hammer, 1995). The spleen also regulates 
the kinetics of platelets and contributes to the development of anaemias caused by 
extravascular lysis. It is also involved in iron metabolism and immunological 
functions. The sinusoids are lined by splenic macrophages which have among others, 
receptors for both the Fc portion of immunoglobulins and C3b.
The erythropoietic bone marrow is most efficient in producing erythrocytes 
which are all similar in shape and size. However, sometimes it may produce mishapen 
cells which are removed by the “culling” function of the spleen. This function of the 
spleen enables it to scrutinise every cell before it enters the general circulation and the
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abnormal cells are removed (Crosby, 1959). The red pulp of the spleen is the 
"graveyard" of senescent erythrocytes which due to the exhaustion of their enzyme 
systems lose their biconcave shape and may become spheroid. This is more 
pronounced in human beings with hereditary spherocytosis. The red pulp also 
functions as a filter for not only the spherocytes but also every abnormally shaped 
erythrocyte such as acanthocytes which get entrapped by the sinusoids (Couto and 
Hammer, 1995).
In animals the spleen has a great capacity to store blood which can be released 
when required by splenic capsular contractions. The spleen of a sleeping dog can 
sequester a third of the red cells and when awake the spleen injects them all back into 
the circulation. The human spleen however, does not perform this function (Crosby, 
1977). Sometimes larger volumes of blood may suddenly be expelled into the 
circulation causing polycythaemia. Alternatively, splenomegaly which may be due to 
inflammatory, congestive and infiltrative causes, results in hypersplenism due to 
increase in the splenic red cell volume concentrating in the splenic red pulp which is 
usually associated with cytopenias. This is observed to a greater extent in animals 
than in human patients (Couto and Hammer, 1995; Crosby, 1959). When splenectomy 
is considered for patients with cytopenias the bone marrow should be always 
evaluated since the spleen may take on the function o f haemopoiesis as EMH.
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CHAPTER 2 
PATHOLOGICAL CONDITIONS
OF
THE ERYTHROPOIETIC SYSTEM
AND
THE CLASSIFICATION OF ANAEMIA
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2.1 INTRODUCTION
The function of the whole erythropoietic system is regulated and maintained in 
a steady physiological state. A number of pathological changes may disturb this 
steady state accompanied by physiological adjustments that eventually result in 
affecting the whole erythropoietic system at different rates and stages of 
development. Erythrocytes may be affected at their site of production which may 
result in either hyperplasia, neoplasia, hypoplasia or aplasia.
The number of erythrocytes can be affected by a variety of factors such as 
increased or decreased amounts or lack of Epo. Inherited defects in haemoglobin 
synthesis result in the haemoglobinopathies of human beings such as thalassaemias (a  
and B) and sickle cell anaemia. Enzymes are essential for the metabolism of 
erythrocytes and defects in these enzyme systems such as pyruvate kinase, glucose-6- 
phosphate dehydrogenase and phosphofructokinase deficiencies may occur, causing 
shortening of the life span of erythrocytes. There are also hereditary membrane 
defects of erythrocytes, such as hereditary elliptocytosis or spherocytosis or 
hereditary stomatocytosis which shorten their life span. Erythrocytes also require 
essential nutrients for their metabolism such as vitamin B-12 and folate, and 
deficiencies of both causing ineffective erythropoiesis have been recognised more in 
human patients.
The number of conditions affecting the erythrocytes are vast but eventually all 
result in either hyperplasia or neoplasia or anaemia. Anaemia is the consequence of a 
large number o f conditions causing a reduction in the number of erythrocytes and it is 
discussed further in detail (Section 2.5 of this chapter).
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2.2 HYPERPLASIA OF THE ERYTHROPOIETIC SYSTEM
An increase in the red cell mass occurs as a result of a primary increase in the 
production of the red cells or as a compensation for impaired delivery of oxygen to 
the tissues. This group of disorders is called “polycythaemia”; it is described as an 
increase in the red cell count, haemoglobin concentration and PCV (Chanarin, 1992). 
Polycythaemia has been classified as relative or absolute polycythaemia.
Relative polycythaemia develops secondary to disturbances which cause a 
decrease in the plasma volume, resulting in increase in the PCV and haemoglobin 
concentration whilst, the RBC mass (i.e. within the bone marrow) remains normal. 
This has been observed in animals usually as a result o f dehydration associated with 
vomiting, diarrhoea high fever or excessive burns (Peterson and Randolf, 1983). 
Absolute polycythaemia can be either primary or secondary. Primary polycythaemia 
or polycythaemia rubra vera is a chronic myeloproliferative disorder which has been 
reported in man, it is rare in dogs and cats (Chanarin, 1992, Peterson and Randolf, 
1983; Foster and Lothrop, 1988).
Secondary polycythaemia is the result of excessive production of Epo leading 
to increased erythropoiesis. This polycythaemia may be appropriate due to the Epo 
response to tissue hypoxia at high altitudes, cardiac disease, pulmonary disease or 
haemoglobinopathies. The inappropriate secondary polycythaemia is caused by 
excessive production of Epo without tissue hypoxia. In dogs there have been reports 
of this condition which exclusively is caused by renal neoplasms and renal cysts 
(Waters and Prueter, 1988).
The accurate diagnosis and differentiation of primary and secondary 
polycythaemia depends on the measurement of the levels of Epo in the serum and
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urine. The level of Epo is elevated in secondary polycythaemia unlike primary 
polycythaemia where the levels are undetectable (Peterson and Randolph, 1983). 
High oxygen affinity haemoglobins, familial polycythaemia and increased 
carboxyhaemoglobin levels are other causes of absolute secondary polycythaemias 
which have been described in human patients (Chanarin, 1992).
2.3 NEOPLASIA OF THE ERYTHROPOIETIC SYSTEM
Haemopoietic neoplasms are classified as myeloproliferative or 
lymphoproliferative disorders depending on the cell types involved. Leukaemia is 
defined as a neoplastic proliferation of haemopoietic cells affecting the bone marrow 
and the blood. The two main large groups of leukaemias are the myeloid and 
lymphoid leukaemias. Leukaemias can be further classified and identified on the basis 
of the maturity of cells and on the course of the disease as acute or chronic 
leukaemias. A variety o f diagnostic tools such as light and electron microscopy, 
cytochemical staining, immunophenotyping or molecular analysis are used in human 
medicine. However, standard methods of identifying cell morphology and 
cytochemical staining are used mainly in animals (Raskin, 1996; Cotran etal, 1994b).
In acute leukaemias the predominant cells are blasts or other immature cell 
forms, while in chronic leukaemias the cell types involved are mainly well- 
differentiated mature cells. Acute leukaemias usually have a short course o f disease 
and cause severe cytopenias. Chronic leukaemias have a more protracted course of 
disease and may or may not cause cytopenias. Myeloproliferative disorders originate 
from neoplastic haemopoietic (myeloid) stem cell clones which are capable of 
differentiating into erythroid, granulocytic, monocytic and megakaryocytic cell
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lineages. Myeloproliferative disorders result from the abnormal proliferation of one, 
several or all of the above cell lineages and include the acute myeloid leukaemia, the 
chronic myeloproliferative and dysplastic conditions (Raskin, 1996; Cotran et al, 
1994b; Moulton and Harvey, 1990).
According to the FAB (French, American, British) classification in human 
patients acute myeloid leukaemia comprises o f eight classes. This scheme of 
classification considers the degree of maturation (MO to M3) and the predominant 
line of differentiation of the leukaemic stem cells (M4 to M7) which are illustrated in 
Table 1 (Raskin, 1996; Cotran et al, 1994b). In the dog the causes o f these 
leukaemias still remain obscure. There has been a report by Jain (1993f), in which 24 
beagles were experimentally exposed to ^Co-y-irradiation and 5 o f these dogs 
developed erythroleukaemia. In cats, FeLV seems to be the cause of all haemopoietic 
neoplasms depending on the subgroup and the point o f integration of the viral 
genome (Jain, 1993f; Evans and Gorman, 1987; Grindem et al, 1985). In man, the 
causes of myeloproliferative disorders may range from chemicals to radiation. It has 
also been established that chromosomal translocations are involved (Cotran et al, 
1994b).
The erythropoietic system may undergo neoplastic changes resulting in 
erythroleukaemia which is according to the FAB classification (M6) a rare subgroup 
of the acute myeloid leukaemias. The FAB classification has been used in animals 
with certain modifications. A classification for acute myeloid leukaemias in dogs and 
cats, was proposed by Jain et al., (1991) using certain criteria’s from the FAB 
classification. In human patients, erythroleukaemia was first described by, and was 
named after DiGuglielmo in 1917 (Moulton and Harvey, 1990). Erythroleukaemia is 
rare in dogs, although there have been reports of affected cats (Jain, 1993f; Grindem 
et al, 1985).
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Table 1: Classification o f  Acute Myeloproliferative Disorders
Class ! Acute Myeloid vi 
• Leukaemia (AML)
f  Predominant Cell Type In the B o n p liH l  
Marrow
MO Minimally or poorly Blasts cells non-reactive for cytochemical
differentiated AML markers
Ml AML without maturation Blast cells >90% of NEC and PO or SB 
positive blast cells >3%
M2 AML with maturation Myeloblasts >30% to <90% of NEC, 
differentiated granulocytes >10%
M3 Promyelocytic leukaemia Blasts cells >30% of NEC, predominantly 
hypergranular, promyelocytes
M4 Myelomonocytic leukaemia Myeloblasts and differentiated granulocytes 
>20%, monocytic cells >20% of NEC
M5 Monocytic leukaemia Monocytic cells >80% of all NEC
M6 Erythroleukaemia Erythroid cells >50% of ANC, myeloblasts 
and monoblasts <30% of NEC
M6-Er Erythraemic myelosis Erythroid cells >50% of ANC, myeloblasts 
and monoblasts and proerythroblasts >30% 
of ANC
M7 Megakaryocytic leukaemia Megakaryoblasts >30% of NEC
(Adapted from Cotran et a l, 1994b and Jain et al., 1991). 
Abbreviations:
NEC=non-erythroid component ANC=all nucleated cells
SB=Sudan Black stain PO=Peroxidase stain
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Erythraemic myelosis (M6-Er), has been described by Jain et al, (1991), and in 
this condition erythroid precursors are more than 50 percent of all nucleated cells 
(ANC), myeloblasts are rare, and the total blast cell counts including proerythroblasts, 
is more than 30 percent of ANC. As this condition progresses, the red cell precursors 
become bizarre and multinucleated with increase in the number o f dysplastic blast 
cells and eventually it develops into erythroleukaemia which may terminate as 
myeloblastic leukaemia.
Erythroleukaemia (M6), is the abnormal proliferation of both the erythroid 
and granulocytic cell lineages. In erythroleukaemia, the erythroid component o f the 
bone marrow is more than 50 percent and the blast cells (myeloblasts and monoblasts) 
are less than 30 percent of all the nucleated cells (Table 1). It can also be 
characterised by the presence proerythroblasts o f more than 30 percent o f ANC. A 
designation of “M6-Er” may be used for the latter condition with predominance of 
proerythroblasts (Jain et al., 1991).
A myelodysplastic syndrome involving the erythroid component (MDS-Er) 
has also been described by Jain et al, (1991), characterised by more than 50 percent 
erythroid cells of ANC and less than 30 percent of blast cells including 
proerythroblasts of ANC.
Polycythaemia rubra vera is a subgroup of the chronic myeloproliferative 
disorder (Table 2). It is due to excessive proliferation at the stem cell levels of the 
cells of the myeloid series, with the predominance of the erythroid precursors 
resulting in excessive red cell production (Chanarin, 1992; Cotran et a l, 1994b). 
There is marked increase in the blood volume and viscosity in affected patients due to 
the high red cell numbers (Chanarin, 1992). On haematological examination, there is 
an increase in the haemoglobin and PCV values. The number of granulocytes and
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Table 2: Classification o f  Chronic Myeloproliferative Disorders
Chronic Myeloproliferative Predominant Cell Type in the
Disorders Blood
Chronic granulocytic leukaemia Mature neutrophils
Chronic eosinophilic leukaemia Mature eosinophils
Chronic basophilic leukaemia Mature basophils
Polycythaemia rubra vera Mature erythrocytes
Essential thrombocythaemia Platelets
Myelofibrosis Cells of extra medullary haemopoiesis
Myelodysplastic syndrome (MDS) Cytopenias
Myelodysplastic syndrome erythroid Cytopenias
(MDS-Er)
(Adapted from Cotran et al., 1994b, and Jain et al., 1991)
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platelets may also be increased reflecting the fact that this is a stem cell disorder. 
Bone marrow examination reveals a markedly cellular marrow showing erythroid 
hyperplasia and replacement of the fatty marrow. As the disease progresses myeloid 
metaplasia and myelofibrosis may develop in man (Cotran et al, 1994b).
2.4 ANAEMIA
Anaemia is defined as a reduction in the concentration of the erythrocyte 
number or the haemoglobin concentration or both (Wintrobe et al., 1974). It is an 
important and frequently encountered haematological abnormality in clinical practice. 
Anaemia is rarely a primary disease and is usually a result of a generalised disease 
process (Schalm et a l, 1975c; Weiser, 1981; Squires, 1993). All anaemias are caused 
either by abnormal loss or destruction o f erythrocytes and failure of normal 
erythropoiesis to compensate for it or by a decreased erythropoiesis which fails to 
replace the normal daily one percent loss of red blood cells.
On the basis of red cell mass, anaemia and polycythaemia can be described as 
relative or absolute (Erslev, 1990a). Relative anaemia is observed when the red cell 
mass is normal and it is usually not a haematological disorder but a disturbance in the 
regulation of the plasma volume or a physiological expansion of the plasma volume in 
neonates and in pregnancy (Erslev, 1990a; Jain, 1993c). Whereas an absolute anaemia 
is mainly a decrease in the amount of circulating red cell mass which is observed more 
often and is clinically more significant (Jain, 1993c). This type of anaemia has been 
studied in great detail by haematologists and there have been different approaches in 
identifying and classifying it. Human and veterinary literature seem to have similar
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ways of classifying anaemia, although there are some variations in the types o f 
anaemia observed in animals and in man.
The classification of anaemia is based either on the morphology o f the red 
cells or on the activity of the bone marrow or on the aetiology involved. However, an 
overall consideration o f all these classifications is essential in the evaluation of a 
particular case of anaemia.
2.5 CLASSIFICATION OF ANAEMIA
2.5.1 CLASSIFICATION BASED ON ERYTHROCYTE 
MORPHOLOGY
The mean cell volume (MCV), the mean cell haemoglobin (MCH) and the 
mean cell haemoglobin concentration (MCHC) have been referred to as "absolute" 
values. These values, calculated from the results of the red cell count, haemoglobin 
content and the packed cell volume (PCV), have been widely used in the classification 
of anaemia (Dacie and Lewis, 1991a).
In the dog, the normal range of the mean cell volume (MCV) is 60-77 fl, the 
mean cell haemoglobin concentration (MCHC) is 32-36 g/dl and the mean cell 
haemoglobin is 19.5-24.5 pg (Schalm et al., 1975a). In certain disease conditions 
there may be a disproportionate variation in these values resulting in a variety of 
morphological changes. The MCV may be within, above or below the normal range 
and accordingly an anaemia can be described as normocytic, macrocytic or 
microcytic. The haemoglobin content of the erythrocytes can be expressed as the 
mean cell haemoglobin concentration (MCHC), which is the average concentration of
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haemoglobin in red cells and is independent of cell size. This value measures the ratio 
of weight of the haemoglobin to the volume of red cells in grams per decilitre. It can 
also be expressed as the mean cell haemoglobin (MCH) which reflects the weight o f 
haemoglobin in picograms (pg) in a red cell and this value is dependent on the cell 
size (Dacie and Lewis, 1991a).
If the MCH and the MCHC are within the normal range the anaemia is 
normochromic, if they are below the normal range the anaemia is described as 
hypochromic. However, a low MCH may also indicate microcytosis. A high MCH is 
always associated with a high MCV reflecting the presence of macrocytosis (Dacie 
and Lewis, 1991a). A high MCHC is seen only if prominent spherocytosis is present 
which reflects the increased haemoglobin volume associated with decreased cell 
membrane and size (Feldman, 1983).
With the use of electronic cell counters a graphical representation o f the 
volumes of erythrocytes can be obtained. The red cell distribution width (RDW) 
which is a histogram of the distribution of the volumes of erythrocytes is a coefficient 
of the variation of erythrocytes and quantifies the degree of anisocytosis. High values 
would indicate a heterogeneous population and low values indicate a homogenous 
population. It also helps in quantifying the mixed population of cells that is the 
microcytes as well as the macrocytes. Therefore, it is essential to consider these 
features because if only the MCV is considered these mixed population o f cells may 
be overlooked (Stone and Freden, 1990). In a study by Weiser and O'Grady (1983), 
RDW was very useful in accurately diagnosing microcytic-hypochromic anaemias.
In 1934, Wintrobe classified anaemias morphologically based on the changes 
in the absolute values. These changes were described as associated with different 
pathological disturbances in human beings, which were found to be useful in
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identifying the cause and deciding the type of therapy. Also, according to Erslev 
(1990a), morphological classification enables the clinician to consider certain types of 
anaemias such as iron deficiency, vitamin B12 and folic acid deficiency anaemias in 
human patients. However, Jain (1993 c), has described this classification as non­
specific and is useful only when other ways of classifications are also considered 
because morphological changes are slow and often do not indicate an early bone 
marrow response to the anaemia. Feldman (1983), too describes this classification as 
inadequate particularly when a mixed population of red cells with poikilocytosis or a 
moderate degree of anisocytosis is present.
Morphology of erythrocytes
On the basis of the absolute normal values (Appendix A: Table A l), anaemias can be 
morphologically classified as follows and as summarised in Table 3.
Normocy tic-normochromic anaemia
This is the commonest type of anaemia found in man and animals. This 
morphology is observed immediately after an acute blood loss. It is also observed 
when erythropoiesis is suppressed which may be either due to chronic diseases such 
as malignancies, infections and CRF causing mild anaemias or due to bone marrow 
hypoplasia or aplasia causing more severe anaemias (King et al., 1992; Dacie and 
Lewis, 1991b; Madewell and Feldman, 1980, Cartwright, 1966)
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Normocytic-hypochromic anaemia
This is an occasional finding in chronic diseases such as chronic infections, 
cancers and arthritis. Fractures or soft tissue injuries too may cause such a 
morphology (Cartwright, 1966). Also, chronic blood loss by a bleeding tumour may 
result in this type of anaemia. Depending on the severity and duration of the blood 
loss, these conditions may progress to a microcytic-hypochromic anaemia (Madewell 
and Feldman, 1980).
Macrocytic-normochromic anaemia
This morphology is often seen in man associated with megaloblastic anaemias 
caused by Vitamin B12 or folic acid deficiency (Cotran et al, 1994a). It is also 
observed in regenerative anaemias.
Macrocytic-hypochromic anaemia
This type of anaemia is seen in remission from an acute blood loss and 
particularly in acute haemolytic anaemia with marked reticulocytosis which increases 
the MCV and decreases the MCHC. The degree of reticulocytosis depends on the 
severity of anaemia and the bone marrow response (Schalm et al, 1975c).
Microcytic-hypochromic anaemia
This type of morphology is seen in iron deficiency anaemia which may be 
nutritional or associated with chronic blood loss. Microcytic-hypochromic anaemia is 
frequently seen in dogs due to chronic blood loss caused by intestinal neoplasms, 
ulcerative colitis, intestinal parasitism, severe flea and lice infestations (Madewell and 
Feldman, 1980; Schalm et al, 1975c). Nutritional deficiency of vitamin B6 or copper
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Table 3: Classification o f  Anaemia Based on Erythrocyte Morphology.
Erythrocyte Morphology ... MCV (fl) MCHC (g/dl) !;V
:
Normocytic normochromic 60 - 70 fl 32 - 36 g/dl
Normocytic hypochromic 60 - 70 fl less than 32 g/dl
Macrocytic normochromic more than 60 fl 32 - 36 g/dl
Macrocytic hypochromic more than 60 fl less than 36 g/dl
Microcytic hypochromic less than 60 fl less than 32 g/dl
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Table 4 : Some Commonly Observed Morphological Variations in Canine 
Erythrocytes and Associated Disease (Adapted from Jain, 1993b; 
Wintrobe et al., 1974 )
Terminology Associated Disease Conditions
Acanthocytes Increase in cholesterol phospholipid ratio of
(Spur cells) the cell membrane, diffuse liver disease,
haemangiosarcoma, portocaval shunts and high
cholesterol diets
Codocyte Liver disease with cholestasis, iron deficiency
(Target cells) anaemia, postsplenectomy and portocaval
shunts
Dacrocytes Myeloproliferative disorders, hypersplenism
Echinocytes Artifactual, uraemia, glomerulonephritis and
(Burr cells or crenated cells) neoplasia
Macrocytes Increased erythropoiesis and megaloblastic
anaemia
Microcytes Iron deficiency anaemia, anaemia of chronic
disease and portosystemic shunts
Schistocytes Microangiopathic haemolytic anaemia, DIC,
(Helmet or fragmented cells) haemangiosarcoma, neoplasms, hypersplenism
and myelofibrosis
Spherocytes Immune-mediated haemolytic anaemia,
(Microspherocytes) post-transfusion and Heinz body anaemia
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may also produce this type of anaemia but this is not often seen in dogs (Cotran et al, 
1994a; Aufderheide, 1981). Because iron is mainly absorbed from the upper parts of 
small intestine, malabsorption of iron may occur in some intestinal disease; this is a 
rare cause in animals but it may require parenteral iron therapy.
In addition to the above changes in the absolute values affecting the 
erythrocyte morphology, certain disease conditions also affect the erythrocyte causing 
some typical morphological changes which are listed in Table 4.
2.5.2 CLASSIFICATION BASED ON BONE MARROW 
RESPONSE
Morphological classification is helpful but limited especially in the case o f a 
normocytic-normochromic anaemia, since the latter has been observed to be 
associated with a number of disease conditions. Furthermore, morphological 
classification is also limited when the degree of anaemia is only slight; alterations in 
the size and haemoglobin content may not be pronounced making it difficult to 
classify the anaemia (Wintrobe, 1934). Hence, the study of the pathophysiological and 
the bone marrow response to anaemia are better ways of classifying anaemia.
The erythroid marrow responds to changes in the levels of erythropoietin by 
altering the rate of formation of erythrocytes. The production and loss of erythrocytes 
in the circulation is maintained in an equilibrium and anaemia may result when there is 
an alteration in any of these factors. Wintrobe et al., (1974), have classified anaemias 
on the basis of erythrokinetics which can result in effective or insufficient 
erythropoiesis. Effective erythropoiesis is associated with reticulocytosis whereas, if 
the reticulocyte count is low, erythropoiesis is presumed to be impaired either due to
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insufficient or ineffective erythropoiesis. Insufficient erythropoiesis as a result o f lack 
of sufficient erythroid precursors can be caused either by infiltration by tumour cells 
or aplasia of the bone marrow. Ineffective erythropoiesis refers to the production of 
defective erythrocytes that are destroyed before leaving the marrow or shortly 
thereafter. Anaemias of this type are the thalassaemias, sideroblastic and 
megaloblastic anaemias that occur mainly in man.
Based on the bone marrow response anaemia has been classified as 
regenerative (responsive) or non-regenerative (non-responsive) by Jain (1993c), 
Squires (1993), and many other haematologists. The reticulocyte count is a simple 
and practical way to assess the marrow response to anaemia. In regenerative anaemias 
erythropoiesis is stimulated by an increase in Epo production. The greater the 
stimulation the greater is the reticulocytosis. Erythropoietin reduces the intermediate 
time for the developing normoblasts, increases the rate of haemoglobin synthesis per 
cell and produces an early release of reticulocytes from the bone marrow. The number 
of Howell-Jolly bodies may also increase. In non-regenerative (non-responsive) 
anaemias associated with renal diseases, there is a diminished Epo production 
resulting in an inadequate stimulus for erythroid precursors leading to anaemia. In 
other non-regenerative anaemias the pathogenesis is not Epo dependent.
2.5.3 CLASSIFICATION BASED ON AETIOLOGY
Classification of anaemias based on the aetiology involved seems to be the 
most satisfactory approach. According to Cotran et al., (1994a), Jain (1993c), and 
Wintrobe et al, (1974), this type of classification involves an understanding of the 
aetiology and pathogenesis of the disease process causing the anaemia. Human
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literature has a broad approach considering all the possible erythrocyte disorders 
(Erslev, 1990a). Megaloblastic anaemias due to Vitamin B-12 and folate deficiency, 
the haemoglobinopathies such as haemoglobin structural deformities (sickle cell 
disease) and globin chain synthesis (thalassaemias) and other extrinsic and intrinsic 
factors affecting the red cell survival are discussed in great details many of which are 
not applicable to domestic animals especially in dogs (Kaneko, 1987).
In this study, anaemia in dogs was classified on the basis of the aetiology. 
Accordingly, anaemia was considered to be caused either by abnormal loss of 
erythrocytes due to haemorrhage and haemolysis or by decreased production of 
erythrocytes. The other important factor, the bone marrow response, was also 
considered in order to classify an anaemia as regenerative or non-regenerative. For 
this purpose the presence or absence of reticulocytes is established either by the 
reticulocyte count or by the microscopic examination of the blood smear. An 
illustration of the aetiological classification of anaemia is presented in Figure 8.
2.5.3.1 ANAEMIA OF ABNORMAL RED CELL LOSS
Haemorrhagic anaemia
Haemorrhage can occur from a number o f diverse conditions depending on 
the cause, amount of blood loss and the tissues involved. Blood loss may be external 
in which blood is lost from the body or it may be internal in which the essential 
components of haemoglobin are available for re-utilisation (Valli and Parry, 1993). 
Haemorrhagic anaemia may occur either due to an acute or a chronic blood loss.
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(A) Acute blood loss anaemia
A balance of the total blood volume is maintained by the plasma volume and 
the circulating red cell mass. Severe blood loss can acutely decrease the blood volume 
to such an extent that it can result in cardiovascular collapse, irreversible shock and 
death. In this situation the loss of blood cells is not as important as the loss o f total 
blood volume causing a sudden hypovolemic shock (Hillman, 1990). To prevent this 
shock, there is rapid replacement of plasma fluid from the interstitial compartments 
and intracellular compartments to the intravascular compartments. The mechanisms 
involved for restoring plasma volume operate slowly. The initial evaluation of the 
PC V does not reflect the magnitude of blood lost until three days, although anaemia 
will be evident within 24 hours (Feldman, 1981).
Acute blood loss is known to be observed in conditions that may be either 
focal such as acute trauma which may be surgical, gastrointestinal, genitourinary, 
wounds, ruptured spleen, ruptured neoplasm or systemic involving a significant 
amount of blood loss (Crystal and Cotter, 1992). Certain acquired bleeding 
tendencies of dogs may be related to thrombocytopenia or thrombocytopathy caused 
by immune-mediated thrombocytopenia or Ehrlichia canis, all which may lead to 
acute blood loss anaemia by epistaxis, malaena or haematuria (Carr and Johnson, 
1994; Kuehn and Gaunt, 1985). Hereditary coagulopathies such as Factor VIII 
deficiency, von Willibrand's disease (vWD) may also result in blood loss. Certain 
poisons such as hydroxycoumarin (warfarin), indandione (pindone), and diphacinone 
can also cause severe bleeding (Feldman and Mount 1983; Crystal and Cotter 1992). 
Diphacinone is more potent than warfarin and poisoned dogs die of severe internal
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haemorrhages due to increased capillary permeability and decreased plasma 
coagulability in addition to tissue hypoxia.
Disseminated intravascular coagulation (DIC), also called consumptive 
coagulopathy or defibrination syndrome, is due to excess coagulation and fibrinolysis; 
it may result in a haemorrhagic diathesis (Bell, 1994).
Dogs with neoplasms, especially with haemangiosarcomas of the spleen, 
usually die suddenly either due to the intra-abdominal rupture of the primary tumour 
resulting in acute blood loss anaemia or by metastasis of the tumour to vital organs 
which may cause bleeding (Brown et a/., 1985).
Haematological observations
There are no reserve pools o f matured erythrocytes to replace the cells lost 
immediately after haemorrhage. The oxygen supply to the tissues is maintained by 
cardiovascular adjustments by arteriolar constriction in organs such as the skin and a 
decrease in vascular resistance to the vital organs such as the kidneys. Plasma levels 
of Epo increase within 6 hours after anaemia appears in a bled patient (Hillman, 
1990). But the magnitude of increase in Epo levels depends on the severity of 
anaemia. The red cell precursors must first proliferate and mature over a period of 
two to five days prior to release into the circulation. Therefore, there is a considerable 
time lag in the response to an acute anaemia (Hillman, 1990).
Acute blood loss is not immediately associated with a reticulocytosis, because 
o f the time that is required for Epo production and stimulation for an increase in the 
marrow proliferation. There is initially, a marked increase in the platelet number to 
shorten the coagulation time and hasten clot retraction. However, as fluid adjustments 
also take place, the PCV and haemoglobin levels start to fall within 12 to 24 hours, 
depending on the amount of blood lost. Erythrocytes are normocytic and
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normochromic, with normal MCV, MCH and MCHC. The next response to an acute 
blood loss is Epo-related shift of marrow reticulocytes into the circulation which is 
seen by the appearance of polychromatophilic, macrocytic erythrocytes (reticulocytes) 
and by the next few days marked erythroid hyperplasia o f the marrow is apparent 
(Hillman, 1990). Grossly, the marrow hyperplasia is evident by an expansion of the 
haemopoietic areas along the endosteal surfaces of the long bones and 
microscopically, by an increase in the proportion of haemopoietic cells to fat cells in 
the red marrow areas from the normal 50 percent to 100 percent (Valli and Parry, 
1993).
Although the reticulocyte count may appear to increase soon after anaemia, 
the reticulocyte production does not increase for three to five days (Hillman, 1990). 
Some leucocytosis may also occur within a few hours o f haemorrhage, due to 
redistribution of the leucocytes from the spleen, lungs and splanchnic vessels 
(marginal pool) and from the marrow reserves (Valli and Parry, 1993; Hillman, 1990). 
Thrombocytosis may also be present with larger platelets due to the mobilisation from 
the marginal pools (Hillman, 1990).
Subacute blood loss, that is after three days, may be associated with a slight 
polychromasia due to the presence of reticulocytes. After an increase in the number of 
reticulocytes, which indicates a release of young red cells from the bone marrow to 
compensate for the ongoing anaemia, a characteristic macrocytosis is observed 
(Cotran et al., 1994a; Valli and Parry, 1993). This results in a high MCV, the MCHC 
is normal, therefore the anaemia is macrocytic and normochromic.
If there is still a severe anaemia, then EMH may be established which is 
characterised by the presence of normoblasts and erythroblasts in the peripheral 
circulation. A reticulocytosis which persists for longer than one or two weeks is
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usually indicative of some ongoing blood loss which may progress into an anaemia of 
chronic blood loss (Valli and Parry, 1993).
(B) Chronic blood loss anaemia
Chronic haemorrhage is observed when the rate of blood loss exceeds the 
regenerative capacity o f the bone marrow. This may occur either by an external blood 
loss due to parasitism such as hookworms, heavy flea and lice infestations or 
internally due to endoparasites, gastrointestinal ulcerations or gastrointestinal 
adenocarcinomas and other neoplasms (Harvey et al, 1982; Cosenza, 1984; 
Madewell and Feldman, 1980; Curtis, 1977). In a study by Harvey et al., (1982), 
from 25 dogs studied, there were 19 dogs with chronic blood loss anaemia, mainly 
due to external or internal parasites and hookworms were found most frequently in 
these dogs. Curtis (1977), had reported a dog with seizures and severe anaemia due 
to chronic blood loss, from Aricylostomum canhmm and a flea infestation.
Hypoproteinaemia may occur in addition to chronic blood loss (Weiser and 
O’Grady 1983; Harvey et a!., 1982). In a study by Weiser and O’Grady (1983), there 
were four dogs of the 12 studied that developed hypoproteinaemia, as most other 
dogs were able to replace the lost plasma proteins. However, hypoproteinaemia may 
also occur due to secondary infections and may not be proportional to the amount of 
blood lost
Haematological observations
Non-haem iron is stored primarily as haemosiderin and ferritin in the cells of 
the mononuclear phagocytic system particularly in the bone marrow. When an 
external blood loss occurs for a very long duration, then this iron store may be 
depleted and iron is needed for supplementation (Stone and Freden, 1990). In chronic
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blood loss continuous loss of both blood and iron takes place, which at first is 
associated with polychromasia and anisocytosis of the red cells due to reticulocytosis 
(Adamson, 1980). The morphology is normocytic and normochromic at this stage.
If the blood loss persists for a longer time, then a few cells may become 
hypochromic as a result o f greater external loss than uptake of iron, and if it still 
continues, then the red cells become microcytic and hypochromic and this 
morphology is typical o f a chronic haemorrhagic anaemia (Meyer and Harvey, 1994; 
Stone and Freden, 1990). These features are illustrated in Figure 9. According to 
Griffiths et al., (1981), dogs with portosystemic shunts may be presented with 
microcytic erythrocytes based on the MCV alone and hypochromasia may or may not 
be present indicating that iron deficiency is relative in these cases.
Although this occurrence was poorly understood, it was confirmed by Meyer 
and Harvey (1994). In their study, there were 60 percent dogs with microcytosis 
when compared with 72 percent of the previous study and the serum iron levels were 
within the low normal. These findings suggested that a microcytic-hypochromic 
anaemia may be seen in portosystemic shunts. Although the mechanisms causing 
hypochromasia was still unclear it appeared to be different from the mechanisms 
described in chronic disease.
Because of an extra cell division and poor haemoglobinisation, microcytic and 
hypochromic cells are produced and these poorly formed erythrocytes may break 
easily resulting in the formation of poikilocytes giving an overall picture of 
anisocytosis (Rogers, 1995; Schalm et al., 1975c). In a study by Weiser and O'Grady 
(1983), schistocytes were present in most o f the dogs with severe microcytosis which 
may have been due to the severity of the anaemia. Another feature seen in iron
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Figure 9: Blood smear of a dog with blood loss anaemia showing reticulocytes, 
a: reticulocyte (polychromatic macrocyte) 
b: microcytic hypochromic red cell 
c: target cell 
d: large platelets
Stained by May-Griinwald Giemsa (x 1000).
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deficiency anaemia is the size of the reticulocytes. In their study, Weiser and O'Grady 
(1983), also observed that the size of the reticulocytes was smaller which may be a 
significant finding associated with iron deficiency anaemia.
In severe iron deficiency anaemia, as long as sufficient iron is not available, 
haemoglobin synthesis lags behind and the hypochromasia becomes more evident than 
the microcytosis and a non-regenerative anaemia may be seen in addition to a 
hypoproteinemia. In such cases, there may also be some amount of EMH present as 
the spleen is enlarged and has an increase in the sinus stroma (Valli and Parry, 1993).
2.5.3.2 ANAEMIAS OF INCREASED RED CELL 
DESTRUCTION
Haemolytic anaemia
In haemolytic anaemia, the red cells are destroyed prematurely and are not 
able to survive the normal 100-120 days. There are two main types of haemolytic 
anaemias which are distinct. In one, lysis of erythrocytes is the consequence of 
inherited intrinsic factors such as abnormalities of the cell membrane, deficiencies of 
the enzyme systems, abnormalities o f the haemoglobin structure and globin chain 
synthesis. In the other, haemolysis is due to various acquired extrinsic factors such as 
infections, fragmentation, exposure to toxic-oxidative substances and to anti-red cell 
antibodies.
The main features of all haemolytic anaemias are the reduction in red blood 
cell survival time and the re-utilisation of iron which is not lost as in haemorrhagic 
anaemias. The shortened red cell survival time can be determined by radioactive 
sodium chromate labelling techniques (Dacie and Lewis, 1991c).
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There are also a number of clinical and haematological findings which reflect, 
on one hand the increased rate of destruction and on the other, increased rate of 
production of red cells. Destruction of erythrocytes may be either intravascular which 
may lead to haemoglobinaemia and haemoglobinuria or extravascular where the red 
cells are phagocytosed mainly by the splenic macrophages, which may lead to 
splenomegaly (Cotran et al, 1994a). Destruction of erythrocytes may result in the 
development of jaundice, reduced haptoglobin levels and occasionally 
haemoglobinuria. Hyperplasia is exhibited by an elevated reticulocyte count and 
normoblastic hyperplasia of the bone marrow. It is only in exceptionally rare cases 
that a low reticulocyte count is seen in uncomplicated haemolytic disease but this has, 
in general a poor prognosis (Jones and Gruffydd-Jones, 1991).
Haemolytic anaemias have an increased Epo stimulation of the bone marrow 
resulting in a shortened transit time of red cell precursors and the number of mitotic 
divisions is reduced, resulting in the release of rather large normoblasts and 
reticulocytes. The latter raises the MCV and marked anisocytosis and polychromasia 
is observed. Depending on the severity of the disease, the anaemia may be 
normochromic and normocytic or macrocytic and in some cases, hypochromic and 
macrocytic (Valli and Parry, 1993; Cotter, 1992).
(A) Intrinsic factors causing lysis of erythrocytes
Membrane and enzyme defects of erythrocytes
Since erythrocytes mainly depend on the anaerobic glycolysis for ATP, any 
deficiency of the enzymes involved in glycolysis may have significant effects on the 
function and survival of these cells.
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Table 5: Intrinsic Conditions Associated with Haemolytic Anaemia in Dogs
Conditions Breed Affected Reference
Hereditary stomatocytosis
Hereditary elliptocytosis 
Pyruvate kinase deficiency
Phosphofructokinase
deficiency
Familial non-spherocytic 
anaemia
Alaskan Malamute, 
Miniature Schnauzer 
Cross-Bred dog 
Basenji, Beagle, West 
Highland White 
Terrier, Cairn Terrier
English Springer 
Spaniel
Standard Poodle
Brown et al., (1994); 
Pinkerton eta!., (1974) 
Smith et al., (1983)
Searcy eta/., (1971), Prasse 
et a!., (1975), Chapman and 
Giger (1990), Schaer et al., 
(1992).
Giger and Harvey (1987), 
Harvey and Smith (1994).
Randolph et al., (1986)
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The membrane and enzyme defects of erythrocytes are not commonly seen 
conditions in dogs and have been identified only in certain breed. These however, 
should be considered in the differential diagnosis of haemolytic anaemias. These 
conditions are similar to the ones seen in human beings. However, in animals due to 
the reduction in the breeding from the affected animals this type o f anaemia is less 
frequently seen. Only some of these conditions are discussed as a part of this study. A 
summary of some of these conditions is shown in Table 5.
H ereditary stomatocytosis
Stomatocytes are erythrocytes with rectangular or elongated pale areas across 
their centre. Conditions similar to human hereditary stomatocytosis have been 
reported in Miniature Schnauzer and Alaskan Malamute breeds of dogs (Brown et al., 
1994; Fletch and Pinkerton, 1972). An autosomal-recessive mode of inheritance has 
also been reported in Miniature Schnauzers without clinical signs o f the disease but 
with macrocytosis, high range of the PCV and slightly shortened erythrocyte osmotic 
fragility (Brown et al., 1994). The condition recognised with haemolytic anaemia has 
been observed in chondro-dysplastic dwarf pure bred young Alaskan Malamute dogs 
and is thought to be caused by membrane changes of erythrocytes due to a pleiotropic 
effect of the dwarfism gene called dan (Fletch and Pinkerton, 1972).
A newly recognised disease has been reported by Slappendel et a l, (1994), 
called as familial stomatocytosis-hypertrophic gastritis (FS-HG). It is associated with 
a haemolytic anaemia, hereditary stomatocytosis and hypertrophic gastritis which 
seems to resemble Menetrier’s disease in man. The erythrocytes also have an 
increased osmotic fragility and the condition may be as a result of an abnormal lipid 
metabolism.
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Haematological observations
Dogs usually have a mild anaemia with stomatocytes, macrocytosis, low 
MCHC and increased MCV. The haematological findings are typical of a haemolytic 
anaemia. Mechanical and osmotic fragility is increased indicating an intrinsic red cell 
membrane abnormality. There is also a shortened erythrocyte life span with 
reticulocytosis and marrow hyperplasia with an increase in the iron turnover and 
reduced gluthatione levels in these dogs (Pinkerton et aI, 1974). However, according 
to Brown et al, (1994), in the Miniature Schnauzer studied there was macrocytosis 
and a high PCV value with the absence of marked erythrocyte regeneration. These 
erythrocyte abnormalities were suggestive of defects in volume regulation rather than 
membrane defects which increases as the cells get older.
Hereditary elliptocytosis
This condition is an inherited autosomal recessive trait o f an erythrocyte 
membrane abnormality due to a protein band 4.1 deficiency resulting in altered 
erythrocyte morphology, elliptocytosis, membrane fragmentation and poikilocytosis 
(Smith et al., 1983). A cross bred dog was studied with this condition, although 
anaemia was not present, there was marked reticulocytosis and an increase in the 
osmotic fragility o f red cells, indicating that some haemolytic process was taking 
place including a good bone marrow response (Smith et al, 1983).
Pyruvate kinase deficiency
Pyruvate kinase enzyme is involved in the maintenance of the sodium pump 
and hence the cell size. This enzyme normally catalysis the conversion of 
phosphoenolpyruvate to pyruvate. When this reaction becomes rate limiting the
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conversion of glucose to lactate in the EM pathway is impaired resulting in a 
deficiency of ATP and an increase in the glycolytic intermediates in the anaerobic 
pathway (Searcy et al, 1979; Searcy et al., 1971). This enzyme deficiency was first 
described in a young Basenji dog by Searcy et al., (1971). Subsequently, it seemed to 
be a well recognised autosomal recessive inherited trait in very young Basenji, Beagle, 
West Highland White Terriers and quite recently, in Cairn Terriers (Searcy et al, 
1971; Prasse et al, 1975; Chapman and Giger, 1990; Schaer etal., 1992).
Deficiency of pyruvate kinase enzyme leads to an impaired metabolism of 
erythrocytes resulting in an decrease in the ATP formation and glucose utilisation 
leading to the formation of macrocytes. The deficiency of pyruvate kinase can be 
demonstrated by an increase in the M2 type isoenzyme and a decrease or absence of 
the R-type isoenzyme normally found in mature erythrocytes with a simultaneous 
increase in the 2,3-DPG and phosphoenolpyruvate (Chapman and Giger, 1990). 
Haematological observations
Affected dogs may or may not be anaemic but always have marked 
reticulocytosis. Reticulocytosis, anisocytosis, thrombocytopenia and erythroid 
hyperplasia were seen in affected dogs (Searcy et al, 1971; Schaer et al., 1992). 
Secondary myelofibrosis and osteosclerosis were also commonly seen in these dogs 
causing death before they were three years old. Much of the red cell destruction also 
takes place in the spleen and liver; splenomegaly may therefore be present in affected 
dogs (Chapman and Giger, 1990; Schaer et al., 1992). Splenomegaly was seen due to 
EMH, which resolved after splenctomy and the thrombocytopenia improved. 
According to Schaer et al, (1992), in the Cairn Terrier breed of dog, the 
haematological parameters remained stable after a splenectomy and the longevity of 
the dog with this enzyme deficiency may have been due to the absence of
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myelofibrosis (Schaer et al., 1992). However, the pathogenesis o f myelofibrosis and 
osteosclerosis in all affected dogs still remains to be elucidated. Many of the features 
of PK deficiency in dogs are similar to man. However, the fibrosis and sclerosis within 
the marrow cavities, a constant feature in dogs, has not been seen in man and the 
pathogenesis seems uncertain (Searcy et al., 1979)
Phosphofructokinase deficiency (PFK)
Erythrocytes lack mitochondria and obtain their energy mainly from anaerobic 
glycolysis. In the oxidative EM pathway, there is an alternative route via the 
Rapaport-Luebering shunt whereby, 2,3-DPG is formed which influences the 
haemoglobin oxygen affinity. In PFK deficiency there is a decrease in the 2,3-DPG 
concentrations resulting in an increase in the oxygen affinity to haemoglobin.
The deficiency of this enzyme has been reported in middle-aged English 
Springer Spaniels and was suggested to be due to an autosomal recessive mode of 
inheritance caused by compensated haemolytic disorder characterised by bilirubinuria 
and reticulocytosis despite normal PCV or mild anaemia. Sporadic intravascular 
haemolytic crisis may occur due to hyperventilation caused by stressful situations 
(Giger and Harvey, 1987). In such crisis, severe anaemia, haemoglobinuria and 
hyperkalaemia were also present. It has been shown that PFK deficient erythrocytes 
were more alkaline fragile than the normal cells which indicated a pH-dependent lysis. 
(Harvey and Smith, 1994).
Thus, phosphofructokinase deficiency should be suspected in English Springer 
Spaniels and Cocker Spaniels when presented with the above findings. Despite the 
severe haemolytic crisis, PFK deficient dogs have much better life expectancy than the
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dogs with pyruvate kinase deficiency because no myelofibrosis occurs (Giger and 
Harvey, 1987).
Non-spherocytic haemolytic anaemia in Poodles
In standard Poodles a familial non-spherocytic haemolytic anaemia has been 
observed by Randolph et al., (1986). It is usually seen in very young dogs and may be 
fatal as they attain three years of age. This disorder is characterised by a severe 
anaemia , with marked regeneration and hepatosplenomegaly. The dogs may be 
Coombs’ positive and the red cell survival time may be reduced. In the dogs studied 
by Randolph et al., (1986), all the dogs had pathological changes of haemosiderosis, 
myelofibrosis and osteosclerosis. According to the author, all the above changes in 
Poodles may be related to an intrinsic erythrocyte abnormality.
(B) Extrinsic factors causing lysis of erythrocytes 
Infectious haemolytic anaemia
In dogs infectious causes of haemolytic anaemia occur mainly due to the 
blood parasites Babesia and Haemobartonella. Haemolysis may also be seen in canine 
Leptospirosis particularly, in Leptospira icterrohaemorrhagicae infections with 
haemoglobinuria, icterus, and a moderate to marked anaemia (Jain, 1993d; Valli and 
Parry, 1993).
Babesia
This is a tick borne, protozoal parasite that can affect vertebrate erythrocytes 
and cause severe intravascular haemolysis. All domestic species are susceptible to it
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and young dogs are reported to be affected especially by Babesia canis. However, 
Babesia gibsoni infection in dogs is restricted more to the Asian countries and the 
parasitised red cells are removed by the spleen with no evidence of intravascular 
haemolysis (Valli and Parry, 1993). This intracellular erythrocytic piroplasm, once on 
the surface o f the erythrocyte membrane, enters the cell by the disintegration o f red 
cell membrane at the attached site eventually rupturing the erythrocytes and leading to 
haemoglobinuria.
Canine babesiosis can be subclinical, peracute, acute or chronic. Anorexia, 
depression, anaemia, pyrexia, splenomegaly and jaundice are some of the commonly 
observed clinical signs (Harvey et a l, 1988; Farwell et al., 1982). Mildly affected 
animals develop anaemia and fever but they fail to show jaundice or haemoglobinuria 
and recover within a few days. Petechial or ecchymotic haemorrhages are observed in 
severely affected dogs with DIC or thrombocytopenia (Breitschwerdt, 1984). 
Haematological observations
Haematological features may vary depending on the course of the disease. 
However, the anaemia is usually regenerative with anisocytosis, poikilocytes and 
spherocytes (Breitschwerdt, 1984). Haematological complications o f vascular stasis is 
a prominent finding in severe disease, which causes hypoxia and subsequent tissue 
damage. Sequestration of the erythrocytes is also contributory factor to the decrease 
in the PCV levels (Taboada and Merchant, 1991). Severe coagulation disturbances 
and DIC are also caused by virulent strains of Babesia canis which may further 
complicate the disease (Valli and Parry, 1993).
Presence of the organisms can be demonstrated by examination of a peripheral 
blood smear stained by May-Griinwald Giemsa and by serology. The anaemia is 
usually, regenerative, macrocytic-normochromic. Blood findings include anisocytosis,
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polychromasia, poikilocytosis, reticulocytosis, normoblastosis and lymphocytosis. 
Spherocytes may also be seen (Farwell et al, 1982). Thrombocytopenia may also be 
present and may or may not be associated with a DIC (Harvey et al, 1988). Dogs 
may also be Coombs' positive due to the anti-erythrocyte antibodies formed as a 
result of alterations induced in erythrocyte surface antigens by the parasite (Jain, 
1993d)
This parasitic infection is fairly uncommon in the United Kingdom and there 
have been reports of it being more prevalent in the tropical countries and the United 
States.
Haemobartonella
This is a rickettsial organism found in many domestic animals, which is highly 
pleomorphic and occurs in coccoid or rod forms arranged as chains or rings or small 
specks on the erythrocyte surface. Although it is observed world-wide, there have 
been very few reports of its occurance in dogs when compared to the number of cases 
reported in cats, especially in the United Kingdom (West, 1979).
Haeniobartotiellci canis is non-pathogenic and affected dogs are 
asymptomatic. The infection may become more pronounced in dogs which have 
undergone splenectomy resulting in severe haemolytic anaemia (West, 1979; Kuehn 
and Gaunt, 1986). Affected dogs have similar clinical signs to the ones seen in 
Babesia canis infections although, haemoglobinuria is not seen since no intravascular 
haemolysis takes place.
Haematological observations
On examination o f a blood smear stained by May-Griinwald Giemsa, these 
organisms can be identified. In anaemic dogs, the blood smear shows all the features
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of regeneration with normoblastosis, Howell-Jolly bodies and leucocytosis. The 
anaemia is caused by removal of the parasite infected cells by the spleen. In addition, 
an immune-mediated mechanism may also be involved (Middleton etal., 1982).
Toxic haemolytic anaemia 
Lead poisoning
Lead poisoning has been reported in young dogs and cats resulting in 
neurological and severe gastrointestinal disorders and Poodles and German Shepherds 
seem to be more frequently affected (Morgan et al, 1991). Chronic lead poisoning 
causes increased red cell fragility but it also interferes with haem synthesis resulting in 
anaemia which may be normocytic or microcytic and even hypochromic. Lead also 
affects other tissues and the major presenting signs are referable to the nervous 
system. The presence of nucleated red cells without low PCV and basophilic stippling 
o f erythrocytes are suggestive of lead poisoning. Basophilic stippling of the 
erythrocytes is caused by an unusual clumping of the ribosomes due to lead induced 
deficiency of pyrimidine-5'-nucleotidase (P5N) enzyme, thus inhibiting several other 
enzyme systems most importantly the 5-aminolevulinic acid dehydrase (Jain, 1993b). 
This condition must be differentiated from other causes such as an intense bone 
marrow response to anaemia which may also cause basophilic stippling to occur.
Oxidative or Heinz-body anaemia
Inherited enzyme deficiencies, e.g. G-6-PD, can lead to oxidative damage of 
the red cells. Powerful oxidative agents in drugs, chemicals and certain vegetables 
may also reduce the normal glutathione levels on the red cell surface. This may cause 
oxidation of haemoglobin to methaemoglobin. The oxidised and precipitated
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haemoglobin appears as Heinz inclusion body in the red cell. Heinz bodies attach to 
the cell membrane and their release into the circulation may lead to 
methaemoglobinaemia as seen in copper poisoning of sheep. Normally, sulphydryl (- 
SH) groups maintain the protein tertiary structure and when it gets irreversibly 
oxidised haemoglobin loses this tertiary structure and becomes denatured and 
precipitates to form morphologically recognisable Heinz bodies (Lees, 1980). Heinz- 
bodies are also called “erythrocyte refractile bodies” and appear as highly refractile 
small dense bodies protruding from the erythrocyte surface (Figure 10A and 10B).
In cats, haemoglobin is more easily oxidised than in the dog or man as more 
sulphydryl groups are present in feline haemoglobin. Heinz bodies may be normally 
seen in cats without anaemia or they may be associated with anaemia (Weiser, 1995; 
Christopher, 1989). Presence o f numerous Heinz-bodies in the red cells may lead to 
erroneously high haemoglobin estimation in blood samples. Heinz bodies may be 
pitted out by the splenic macrophages and so called “bite” cells may be seen in the 
blood. The severity of haemolysis depends on many factors including the dose and 
type of drug or vegetable such as onions responsible.
The mechanisms that cause lysis o f red cells is quite complex. Haemolysis is 
due to the following event, oxidation of the sulphydryl groups of haemoglobin in the 
red cells, formation of Heinz-bodies and attachment of the Heinz bodies to the cell 
membrane. Next is the removal (pitting out) o f Heinz-bodies and Heinz body- 
containing cells by the spleen, loss o f membrane, spherocyte formation, increased 
membrane permeability, the end result is intravascular and extravascular lysis of 
affected cells.
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F igu re 10A: Heinz bodies in the erythrocytes (a), appear as refractile protruding 
bodies when stained with May Griinwald Giemsa stain. These are feline red cells but 
Heinz bodies look similar in every species, (xlOOO)
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F igure 10B: Heinz bodies in the erythrocytes when stained with new methylene blue, 
appear blue in colour. These are feline red cells but Heinz bodies look similar in every 
species, (x 400).
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There are reports of Heinz body-induced anaemia in dogs due to a number of 
causes such as zinc toxicity, onion and drug-induced causes. Methylene blue is also 
known to cause severe Heinz body haemolytic anaemia (Fingeroth et al., 1988).
A case of a dog eating onions which resulted in a marked haemolytic anaemia 
with Heinz bodies present has even been reported (Spice, 1976). This dog also had 
haemoglobinuria, bilirubin and urobilinogen in the urine. For the first 96-120 hours 
after ingestion of onions, no bone marrow regeneration was seen. Later, increasing 
regenerative anaemia was noticed which resolved within a few days on supportive 
treatment. (Spice, 1976). Zinc toxicity has been also reported in a dog which resulted 
in a severe haemolytic anaemia with Heinz body formation (Luttgen et al., 1990). 
Another report of zinc toxicosis was ingestion of zinc nuts which resulted in acute 
non-spherocytic haemolytic anaemia (Torrance and Fulton, 1987). The above factors 
should be considered in the differential diagnosis of dogs presented in a severe 
haemolytic crisis.
Microangiopathic haemolytic anaemia (MAHA)
This condition includes a group of disorders characterised by fragmentation of 
the erythrocytes within the circulation mainly due to shearing forces, leading to 
intravascular haemolysis (Martinez, 1990). In microangiopathic haemolytic anaemia, 
also called fragmentation anaemia, fragmentation may occur due to the passage of 
erythrocytes through damaged arteriolar endothelium which may be associated with a 
number of causes. This condition has been less studied in animals than in man (Rebar 
et al., 1980). This type of anaemia may be due to primary causes such as thrombotic 
thrombocytopenic purpura and uraemic haemolytic syndrome seen mainly in man. 
Other secondary causes may be include malignancy, drugs, DIC, immune-mediated
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conditions and many others. According to Rebar et al, (1980), for MAHA to occur 
with neoplasms, the total neoplastic mass should be large enough and the blood flow 
through the neoplasm should be significant.
Hypertension, narrowing and hardening of the arterioles and endothelial cell 
swelling, probably are contributory factors to fragmentation of the erythrocytes 
(Martinez, 1990). However, fibrin deposition in the blood vessels is a known major 
factor causing MAHA. In dogs there are few reports but MAHA has been seen with 
congestive heart failure, glomerulonephritis, myelofibrosis and neoplasia, especially 
haemangiosarcoma of the spleen, heart and liver (Rebar et al, 1980). One o f the 
other important cause is DIC which may be due to infections or neoplasia (Bell, 
1994).
In heart worm disease caused by Dirofilaria immitis, there is obstruction of 
the normal blood flow and circulating erythrocyte may fragment easily due to 
mechanical forces resulting in intravascular haemolysis. In a study by Kitagawa et al, 
(1992), the half-life of erythrocytes in dogs affected with pulmonary heartworm 
disease was investigated. The erythrocytes of dogs that were mild to severely affected 
had shorter life span than the less severely affected dogs.
Erythrocytes are teared by strands of fibrin within the vessels and by the force 
of the blood flow are released as fragments. Some cells flow in the circulation as 
schistocytes which can be seen on the blood smear whereas, some fold and acquire 
different shapes (Martinez, 1990; Madewell and Feldman, 1980).
Haematological observations
Fragmented and irregularly distorted red cells which may assume a helmet 
shape are the most prominent findings in addition to reticulocytosis. Schistocytes are
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F igu re 11 A: Blood smear from a dog with microangiopathic haemolytic anaemia 
showing anisocytosis and poikilocytosis caused by increased number of schistocytes 
(a). Large platelets (b). Stained by May Griinwald Giemsa, (x 1000).
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F igure 11B: Another blood smear from a dog with microangiopathic haemolytic 
anaemia There is marked anisocytosis and poikilocytosis due to the many small 
schistocytes, normal red cells and large polychromatic cells. Stained by May 
Griinwald Giemsa, (x 1000).
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illustrated in Figure 11A and 1 IB. Neutrophilia and thrombocytopenia may also be 
present depending on the extent and cause of the lysis. There may be a marked 
erythroid and megakaryocytic hyperplasia in the bone marrow (Martinez, 1990). 
According to Rebar et al, (1980), elongated erythrocytes were a common finding in 
addition to other shapes in cases which had more than 50 percent of schistocytes. 
Features of haemolytic anaemia such as haemoglobinuria and haemosiderinuria may 
also be present. The presence of schistocytes may reflect DIC which can be confirmed 
by the presence of raised FDP’s, low fibrinogen and low platelet count.
Immune-mediated haemolytic disorders
The immune-mediated haemolytic disorders are of two types. The first group 
consists of conditions induced by allo-antibodies (iso-antibodies) which may occur 
naturally or develop after exposure to allo-antigens (iso-antigens), haemolytic disease 
o f the new born and incompatible transfusions are examples o f this type (Giger et al, 
1995; Jain, 1993e). However, these are rarely observed conditions in dogs.
The other group consists of diseases caused by auto-antibodies produced 
against self antigens at some time during the post-natal life o f the animal. This group 
includes auto-immune haemolytic anaemias (AIHA), auto-immune thrombocytopenia 
or thrombocytopenic purpura (AITP), auto-immune neutropenia, certain drug- 
induced haemolytic anaemias and leucopenias (Jain, 1993e; Slappendel, 1986; Dodds, 
1977).
Immune-mediated haematological disorders are observed more commonly in 
dogs than any other species and has been well documented (Jones and Gruffydd- 
Jones, 1991; Dodds, 1983; Bennett, 1984; Halliwell, 1978). The number of dogs
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affected with these conditions has increased two to three fold since 1979, but 
according to Dodds (1983), whether this increase is due to an increased awareness 
about the disorder or due to the true increase in the number of cases is still unclear. 
Approximately 60-70 percent of the cases have been classified as idiopathic the 
remaining 30-40 percent being secondary (Dodds, 1983). According to Bennett 
(1984), there are several theories regarding the cause involving several mechanisms. 
Well known predisposing factors that can induce an immune-mediated disease are 
viruses, bacteria, pregnancy and specific drugs. Less specific causes can be hormonal 
irregularities, genetic influences and stress (Dodds, 1983).
According to Dodds (1983), a modified live virus vaccine may also be an 
important cause for immune-mediated diseases. The viral antigen could trigger a 
hapten-type immune-mediated reaction in a susceptible host. In about 25 percent of 
the 223 cases presented at her laboratory, there had been a definite association with a 
recent exposure to vaccination. Although this does not indicate that all vaccines may 
cause haemolytic anaemia the possibility should be considered.
Auto-immune haemolytic anaemia (AIHA)
Auto-immune haemolytic anaemia is caused by auto-antibodies which are 
produced against the patient's own erythrocytes resulting in erythrocytes with a 
shortened life span in vivo. It is associated with an increase in the erythropoietic 
activity of the bone marrow. The presence of auto-antibodies and complement on the 
surface of the affected red cells can be diagnosed by the direct anti-globulin test 
(DAT) or direct Coombs test (DCT) using polyspecific antisera (Jain, 1993e; 
Halliwell, 1978, Dodds, 1977).
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In the DAT, the patient’s erythrocytes are suspended in saline to which a 
polyspecific antisera containing antibodies raised against canine IgG, IgM, and 
complement (C) and C3b are added. If red cells contain any of the above components 
singly or in combination they will be agglutinated and this can be visualised under the 
microscope.
This is the most commonly observed auto-immune disorder in dogs. The 
aetiology is either primary or idiopathic, or secondary. The latter may be associated 
with lymphoproliferative disorders, systemic lupus erythrematosus, viral, bacterial or 
parasitic infections or may be drug-induced (Dodds, 1983; Halliwell, 1978). Genetic 
influences play a significant role in the genesis of AIHA and in auto-immune disorders 
in general.
According to Jain (1993e), Jackson and Kruth (1985), there is no particular 
breed predilection. But Dodds (1983), suggested that Old English Sheepdogs and 
Miniature Dachshunds were commonly affected. There has been a higher incidence in 
Cocker Spaniels, Poodles, Collies, Whippets and Musterlanders (Bennett, 1984). 
Several studies showed that the disease occurs more frequently in females with an 
average age of 6.4 years (Jackson and Kruth, 1985; Halliwell, 1978) and according to 
Dodds (1983), females whether intact or spayed are affected more than males in a 
ratio of 2:1 with an average age o f 4-5 years affecting young adult dogs.
There are theories regarding the factors triggering this event. The first theory 
states that a change on the erythrocyte membrane forms a new antigen which 
stimulates a normal immune response and the antigen is now altered or foreign to the 
host. The second theory is that the immune system fails to recognise itself. These 
theories are mere speculations but adequate for explaining the mechanisms (Dodds 
1977).
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The auto-antibodies involved are mainly IgG and IgM. These auto-antibodies 
are classified as warm, optimally active at 37°C, and cold antibodies active between 
2°C to 10°C but with thermal activity upto 37°C (Table 6). Antibodies may be 
agglutinins and lysins. The differences between the ability of individual antibodies to 
cause erythrocytes to undergo agglutination or lysis by complement and phagocytosis 
by macrophages are related to the structure of the antibody. In particular, to the size 
of the molecule (for example, IgG or IgM), its valency, (that is, the number of Fab 
sites), and chemical differences (within its constant and hinge regions). Complement 
is activated by the classical pathway. To activate complement the antibody should be 
an IgM molecule or two IgG molecules closely adjacent on the red cell membrane. 
About 200-or more antibodies are required per cell for detection by splenic 
macrophages (Dacie, 1992b).
The auto-antibodies most commonly occurring in dogs, are IgG, IgM or IgA, 
the latter two being observed less often (Stockham et al., 1980; Dodds, 1977). These 
have been summarised by Slappendel (1986), as follows:
• Type I in which immunoglobulin alone, usually IgG, is present.
• Type II in which both immunoglobulins IgG and or IgM with complement are
present.
• Type III in which only complement are present and
• Type IV in which neither complement nor immunoglobulins can be detected.
A combination of the above may be observed causing various reactions.
Type I and Type II reactions, in which IgG antibodies are detected by the DAT, 
indicate overt or latent AIHA. Haemolysis is noticed to be severe or acute only in the 
Type II reactions. Type III reactions have a strongly positive anti-C type DAT, due to 
activation by IgM, this type is associated with severe intravascular haemolysis. IgM
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Table 6: A Summary o f  the Autoantibodies Causing AIHA
Thermal Range Type Pathogenesis
Warm (37°C)
IgM
IgG-high concentration
C3b
Cold (below 37°C) IgM
IgM In vivo agglutination (rarely
observed)
In vivo haemolysis (intravascular 
lysis)
May activate complement in vivo 
haemolysis
IgG-incomplete antibodies Coat erythrocytes, extravascular
lysis (phagocytosis) and 
spherocyte formation. Commonest 
type in dogs.
Coat erythrocytes (extravascular 
lysis)
In vivo haemolysis due to 
complement activation (rare)
IgM In vivo agglutination, cold 
haemagglutinin disease affecting 
extremities
type warm and cold antibodies either fix complement causing lysis or agglutinate red 
cells. Type IV reaction, that is a negative DAT usually represents a false negative 
result which may be due a number of factors.
There are however true negative cases too. The mechanisms of Coombs’ 
negative AIHA has been studied in detail and it has been shown that the patient’s 
erythrocytes are coated with too few antibodies for detection by antiglobulin sera.
The mechanism of AIHA involves intravascular or extravascular lysis of the 
red cells. In extravascular lysis, the erythrocytes are coated by IgG and/or C3b and 
are phagocytosed by the MNPS, especially by the spleen which is the primary organ 
involved. The splenic macrophages have surface receptors for the Fc portion of the 
IgG and the C3b portions of complement. Partial erythrophagocytosis causes 
reduction in the erythrocyte membrane and the formation of spherocytes which are 
released into the circulation. The presence of spherocytes is diagnostic in identifying 
this type of AIHA, in addition to a moderate to severe splenomegaly the latter being 
due to the fact that spherocytes are sequestered and removed by the spleen (Cotran et 
ai, 1994a; Dacie, 1992a; Halliwell and Gorman, 1989).
In case of intravascular haemolysis, which may be severe, there is 
haemoglobinaemia and haemoglobinuria which is due to vigorous complement 
fixation by IgG or more frequently by IgM antibodies, leading to the formation of a 
membrane attack complex which involves the attachment of C8 to C5,6,7 and of C9 
to C8.
Cold auto-antibodies can activate complement and cause intravascular lysis or 
agglutinate red cells. If agglutination is caused by IgM type auto-antibodies the 
condition is called “cold haemagglutinin disease”. Cold agglutinin disease may be 
evident by auto-agglutination of erythrocytes at room temperature or by exaggerating
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it at 4°C. Auto-agglutination may also occur in association with monoclonal 
gammopathies which will not disappear at 37°C (Greene et al., 1977; Cotran et al., 
1994a).
Rouleaux formation of red cells occurs when there is an increase in the plasma 
proteins causing the red cells to stick together. However, the head of a blood smear 
with normal protein levels may also contain rouleaux, but the tail o f the same smear 
would show more evenly spread cells (Figure 12A and 12B). Rouleau can be 
distinguished from true auto-agglutination by the addition of isotonic phosphate 
buffered saline to the blood. Aggregated erythrocytes with rouleaux will be dispersed, 
whereas true auto-agglutination will remain unaffected (Halliwell, 1978; Slappendel, 
1986). A blood smear from a dog with IgM type AIHA would appear as shown in 
Figure 13, wherein the red cells are aggregated towards the tail of the smear.
The clinical symptoms result either from in vivo agglutination of red cells or 
from fixation of complement when temperatures drop below 30°C especially at distal 
ends of the body. Affected dogs may show necrosis of their extremities, for example, 
the nose, tail and ears due to microcapillary stasis due to exposure to a cooler 
environment and continuous exposure may cause gangrene to develop (Greene et al., 
1977). When complement is activated, intravascular haemolysis may be 
macroscopically seen which is a rare occurrence in dogs.
The onset of these disorders can be acute (sudden) or chronic (gradual). 
Clinical signs will depend on the mechanism involved. In the rare non-agglutinating 
cold antibody disease there is a sudden onset of anaemia, with haemoglobinuria, 
icterus, increased serum bilirubin levels and weakness (Dodds 1983).
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F igu re 12A: Numerous rouleaux are present at the head of a smear made from a
sample with normal plasma protein levels.
a: Rouleau i.e. a roll of red cells resembling a pile of coins.
b: neutrophil
c: platelet aggregation
Stained by May Griinwald Giemsa, (x 400).
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F igu re 12B: Rouleaux and dispersion of erythrocytes at the tail of a smear made
from a sample with normal protein levels.
a: Rouleau
b: neutrophil
c: platelet
d: lymphocyte
Stained by May-Griinwald Giemsa, (x 400).
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F igure 13: The gross appearance of a blood smear from a dog with IgM type auto­
immune haemolytic anaemia demonstrating uneven distribution of cells, 
a: head of the smear (starting point of the smear) 
b: centre of the smear with sparsely distributed cells 
c: tail of the smear showing agglutination of red cells (end of the smear)
The blue tinge of the background is caused by the increased globulin content (b ). The 
smear is stained by May-Grunwald Giemsa.
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Haematological observations
There is a markedly increased bone marrow response to the anaemia reflected 
in the blood as marked anisocytosis, polychromasia, many Howell-Jolly bodies 
leptocytosis and normoblastosis. Spherocytosis and auto-agglutination of red cells are 
characteristic findings associated with AIHA. If the auto-agglutination is massive it is 
most likely to be caused by high thermal amplitude cold antibodies. Warm antibodies, 
however, can also produce auto-agglutination which may be IgG or IgM or both. 
There is a marked increase in the MCV due to the increased reticulocytosis. The 
MCH and MCHC are within normal ranges and may be increased in patients with 
increased spherocytosis (Dacie, 1992a). Normoblastosis is often present in patients 
with IgG type AIHA and may exceed the white cell count (Dacie, 1992a). Some of 
the features as seen in dogs are illustrated in Figures 14A, 14B, 14C.
As erythropoiesis is increased in AIHA, there is hypertrophy due to an 
increase in the erythropoiesis and the M:E ratio may exceed the normal (Dacie, 
1992a).
A leuco-erythroblastic reaction is often noticed in AIHA, that is a high WBC 
count or erythroblast count (Mandell et al., 1989). There is leucocytosis with 
neutrophilia showing a left shift and monocytosis. Very high WBC counts 
(leukaemoid reaction) are also often seen (Halliwell and Gorman, 1989). 
Erythrophagocytosis by the circulating monocytes can be observed. It is an important 
feature by which the erythrocytes coated with auto-antibodies and or complement can 
be eliminated from the circulation (Dacie, 1992a). Thrombocytopenia may also be 
present which may be caused either by a true immune-mediated thrombocytopenia 
with AIHA (Evan’s Syndrome) or it may be due to haemorrhages or DIC.(Cotter, 
1995; Valli and Parry 1993; Jackson and Kruth, 1985). In cases of IgM type AEHA,
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F igu re 14A: A blood smear from a dog with IgG type auto-immune haemolytic 
anaemia showing features of marked regeneration with normoblastosis and 
spherocytosis
a: reticulocytes (polychromatic macrocyte) 
b: spherocytes 
c: normoblast 
d: erythrocyte 
e: band neutrophil
Stained by May-Grunwald Giemsa, (x 400).
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F igu re 14B: A blood smear from a dog with IgG type auto-immune haemolytic 
anaemia showing regenerative features and spherocytosis, 
a: reticulocytes (polychromatic macrocyte) 
b: spherocytes
c: basophilic normoblast (early) 
d: late metamyelocyte
Stained by May-Griinwald Giemsa, (x 1000).
109
e
*
*#
F igu re 14C: A blood smear from a dog with IgG type auto-immune haemolytic 
anaemia, showing features of regeneration and spherocytosis 
a: reticulocytes (polychromatophilic macrocytes/leptocytes) 
b: spherocytes
c: erythrophagocytosis by a typical monocyte 
d: neutrophil
Stained by May-Griinwald Giemsa, (x 1000).
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F igure 15A: A  blood picture from a dog with IgM type auto-immune haemolytic 
anaemia showing auto-agglutination of red cells and regenerative features, 
a: reticulocyte (polychromatic macrocyte) 
b: auto-agglutinated red cells 
c: intermediate normoblast 
d: late normoblast 
e: lymphocyte 
f: neutrophil
Stained by May-Griinwald Giemsa, (x 400).
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F igure 15B: A blood smear from a dog with IgM type auto-immune haemolytic
anaemia showing various characteristic features.
a: reticulocytes (polychromatic macrocytes)
b: auto-agglutination of erythrocytes
c: normoblast
d: metamyelocyte
e: large platelet
f: monocyte
Stained by May Grunwald Giemsa, (x 400).
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similar features may be observed but auto-agglutination is more pronounced and is a 
diagnostic feature as illustrated in Figure 15A and 15B.
Reticulocytopenia has also been recognised as a complication reflecting an 
immune-mediated hypoplastic or aplastic condition (Jones and Gruffydd-Jones 1991; 
Holloway et al, 1990; Jonas et a l, 1987). Suppression o f various haemopoietic 
precursors have been observed implicating that an immune-mediated mechanism may 
be involved (Weiss, 1986). Affected dogs may require a blood transfusion or stronger 
use of immunosuppressive therapy and there have been reports of recovery in some 
cases (Cotter, 1992; Holloway et al., 1990).
2.5.3.3 ANAEMIAS OF DECREASED RED CELL 
FORMATION
Hypoproliferative anaemias are seen in a large number of diseases which affect 
erythropoiesis resulting a reduction in the number of red cells. These may broadly be 
classified as intramarrow and extramarrow conditions depending on the mechanisms 
involved. The extramarrow conditions include the decreased stimulation by 
erythropoietin due to renal damage, chronic metabolic diseases, chronic inflammatory 
diseases and lack o f essential nutrients such as iron. The intramarrow conditions 
include the direct damage to the bone marrow microenvironment, especially to the 
haemopoietic cells due to irradiation and toxic effects o f drugs and chemicals, 
infiltrative diseases such as leukaemias leading to myelophthisis and myelofibrosis.
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(A) Intramarrow conditions causing anaemia
Aplastic or hypoplastic anaemia
The terms aplastic and hypoplastic imply that the anaemia is due to acellular 
or hypocellular marrow. Aplastic anaemia or bone marrow aplasia is defined as 
multifactorial disease involving a primary failure of all haemic cell lines. It is 
associated with cytopenias in the blood and with a hypocellular or acellular bone 
marrow replaced by adipose tissue (Nissen, 1991; Weiss and Klausner, 1990). The 
term aplastic pancytopenia can also be used depending on the degree of involvement 
of the cell lines and the severity of the syndrome. Nissen (1991), suggested that 
aplastic anaemia initially has myelodysplastic traits and a differentiation is often 
difficult.
Aplastic anaemia may be the result of a number of conditions which may be 
congenital or acquired. In human beings congenital aplastic anaemia is recognised as 
Fanconi’s anaemia due to an autosomal recessive chromosome which have not yet 
been reported in animals (Feig, 1980). Acquired anaemias in man may be idiopathic, 
or caused by chemical agents, irradiation or drug-induced myelotoxicity (Cotran et 
al, 1994a). Acquired aplastic anaemia occurs in dogs often as a result o f toxic insult 
to the bone marrow, due to drugs such as oestrogens, phenylbutazone, trimethioprim- 
sulfadiazine, meclofenamic acid, fenbendazole and quinidine and chloramphenicol 
(Weiss and Klausner, 1990, Weiss and Adams, 1987). In dogs, marrow hypoplasia 
can also be caused by infections such as chronic Ehrlichiosis and Parvovirus infection 
(Kuehn and Gaunt 1985; Boosinger et al., 1982). Myelofibrosis and chemotherapy 
may also cause hypoplasia or aplasia.
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The mechanism which cause bone marrow aplasia seems to be the 
consequence of stem cell damage resulting in the production o f cells with poor 
proliferative and differentiative capacity. If the stem cell damage is permanent then an 
aplastic anaemia develops (Cotran et a l, 1994a). Cline and Golde, (1978) and Nissen, 
(1991) suggested that idiopathic aplasia is probably immune-mediated.
According to Nissen (1991), in the development of aplasia T-cells, 
interleukins and genetic factors may be involved. The author also proposes that as the 
condition is highly responsive to immunosuppressive therapy, the immune system may 
play a major role in the development of aplastic anaemia. If the immune response is 
vigorous, the altered stem cells are depleted and marrow aplasia occurs and if it is 
weak then myelodysplasia with a chronic pancytopenia occurs (Nissen, 1991). Toxic 
destruction of stem cells, altered bone marrow microenvironment or lack of 
haemopoietic growth factors may also be involved in the process (Weiss, 1992). 
Haematological observations
Pancytopenia is the hallmark of an aplastic anaemia (Feig, 1980). However, 
due to the different life span of blood cells, cells with shorter survival time, such as 
platelets and granulocytes will disappear first followed later by the erythrocytes. 
Therefore, acute aplastic anaemia is characterised by a normocytic-normochromic 
mild degree of anaemia with severe granulocytopenia and thrombocytopenia. Chronic 
aplastic anaemia is characterised by severe non-regenerative anaemia and variable 
degrees of leucopenia and thrombocytopenia (Weiss, 1992). In true aplasia nucleated 
red cells are not seen in the blood.
Granulocytopenia renders the patient susceptible to infections whereas severe 
thrombocytopenia may induce haemorrhagic tendencies and affected patients may 
bruise easily (Feig, 1980). Bone marrow core biopsy is essential for evaluating the
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marrow architecture and cellularity. In aplastic anaemia the haemic tissue occupies 
only 25 percent or less of the marrow and the remainder is replaced by adipose tissue 
(Weiss, 1992). In severe aplasia only small lymphocytes and adipose tissue are 
present. Some commonly occurring conditions causing hypoplasia or aplasia o f the 
marrow in dogs are discussed below.
Oestrogens
Oestrogen and its derivatives are often used in clinical practice for the 
treatment of urinary incontinence, prevention of conception following mismating and 
for treatment of some adenomas and prolonged anoestrus. Endogenous oestrogens 
due to testicular tumours such as Sertoli cell tumour may also cause aplasia. 
Oestrogen toxicity has been well documented in dogs resulting in pancytopenia (Hall, 
1992; Shelly, 1988; Legendre, 1976). Frequently, haemorrhagic problems are the first 
clinical signs. The exact mechanisms are unclear but it is a well established fact that 
oestrogens act at the stage of stem cell differentiation (Teske, 1986).
Haematological observations
Initially, there is a thrombocytopenia which develops approximately two weeks after 
the drug administration. In the following 16 to 20 days an enhanced granulopoiesis 
with a left shift and a normocytic-normochromic anaemia develop. After 22 to 25 
days, there is a decrease in granulopoiesis resulting in leucopenia (Teske, 1986).
Ehrlichiosis and parvovirus infections
Ehrlichia catiis, a rickettsial organism is known to cause canine tropical 
pancytopenia. It is transmitted by the tick Rhiphicephahts sanguineus and infects 
canine blood mononuclear cells as an intracellular parasite. There are two phases in
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which Ehrlichia affects dogs. The acute stage which causes severe thrombocytopenia 
with a hypercellular bone marrow, and the chronic phase which usually responds 
poorly to treatment, resulting in pancytopenia and marrow hypoplasia. The dogs 
usually die due to severe non-regenerative anaemia, haemorrhages (epistaxis), 
secondary infections and seizures (Meinkoth et al, 1989; Kuehn and Gaunt, 1985). 
Hepafozoon catiis, a protozoan parasite may causes moderate degrees of a non- 
regenerative anaemia, thrombocytopenia and leucopenia and may mimic Ehrlichiosis. 
(Elias and Homans, 1988;Zinkl, 1981).
Bone marrow necrosis has not been frequently reported in dogs but can 
produce severe anaemia due to the pancytopenia. In the dogs studied by Weiss et al, 
(1985a), necrosis was suspected to be caused by chronic Ehrlichiosis, septicaemia 
and oestrogen toxicity. Marked amount of necrotic debris and haemorrhage within 
the marrow was evident in all the dogs in addition to erythroid hypoplasia. In dogs 
bone marrow necrosis may also be caused by Pan>ovirus infection. Parvovirus affects 
the rapidly dividing cells, initially, the virus replicates in the lymphoid tissue and 
circulates in the plasma. After initial replication, the virus starts multiplying in the 
bone marrow and in the intestinal crypts and in neonates in the myocardium (Valli and 
Parry, 1993). The first report of the effects of Parvovirus on morphological 
alterations in canine bone marrow was by Boosinger et al, (1982). The presence of 
Parvovirus may be associated with red cell aplasia, however and the cause may be an 
immune-mediated inhibition of erythropoiesis (Weiss, 1986).
The effects on the bone marrow are degenerative changes o f the myeloid cells 
and in the peripheral blood there is a neutropenia rather than pancytopenia (Greene, 
1984). However, if the condition is aggravated by secondary infections causing
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septicaemia and endotoxaemia, neutropenia and some degree of anaemia are observed 
(Boosinger et al., 1982).
Erythroid hypoplasia and pure red cell aplasia (PRCA)
The diagnosis of erythroid hypoplasia in human patients is mainly based on the 
following observations made by Seaman and Kohler (1953),
a. Severe, chronic, normocytic-normochromic or macrocytic-normochromic 
non-regenerative anaemia.
b. A cellular bone marrow with active granulopoiesis and thrombopoiesis but marked 
hypoplasia of erythroid cells.
c. Normal total and differential leucocyte counts.
d. Normal platelet count, 
c. No evidence of EMH.
This condition must be differentiated from pure red cell aplasia (PRCA), in 
which there is a complete selective depletion (aplasia) o f the erythroid precursors in 
the bone marrow. Both conditions must be distinguished from an aplastic anaemia in 
which all the cell lines are affected.
Erythroid hypoplasia has been observed in animals, the aetiology remains 
unknown, although an immune-mediated cause may be present (Kaplan et al., 1985; 
Weiss et al, 1982). In human beings, pure red cell aplasia may be congenital 
(Diamond Blackfan anaemia) or may be acquired. Acquired PRCA may be primary, 
idiopathic or secondary due to thymoma, infections or neoplasia (Krantz, 1980). In 
man, primary PRCA seems to be immune-mediated and an IgG auto-antibody 
directed against the erythroid precursors in the bone marrow seems likely to be 
involved in its development (Cline and Golde, 1978). Secondary form of PRCA is
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most often seen in association with thymoma in man and thymectomy is known to 
improve this condition (Krantz, 1980). Red cell aplasia and hypoplasia have been seen 
in dogs which were either Coombs’ positive or negative (Stockham et al., 1980; 
Weiss et al., 1982). According to Weiss (1986), a serum IgG inhibitor directed 
against the precursors of CFU-E has been detected in vitro in such dogs. As these 
cases respond to immunosuppressive therapy an immune-mediated mechanism seems 
to be the most likely cause for acquired PRCA in dogs as well as in man (Gilmour et 
al, 1991; Weiss, 1986).
Haematological observations
A normocytic-normochromic, non-regenerative anaemia and normal 
granulocyte and platelet numbers are observed in-addition to a marked decrease or 
absence of erythroid cells in the bone marrow (Kaplan et al., 1985; Weiss et al., 
1982). There is also an increase in the serum iron concentration and in the percentage 
of transferrin saturation and the level of Epo is high (Krantz, 1980). A differentiating 
feature of PRCA from the anaemia of chronic disease, in addition to the low 
erythrocyte numbers and high levels of serum iron, is the PCV which is usually well 
below 20 percent in PRCA, and above 25 percent in anaemia of chronic disease 
(Gilmour et al, 1991). Bone marrow examination is essential in diagnosis and this 
which may reveal a lack or absence of erythroid precursors and the presence o f all 
other cell lines at different stages of development.
Myelophthisic anaemia
This anaemia is the result of replacement of the normal active bone marrow 
architecture by foreign cells which may be neoplastic or fibrotic affecting all the cells 
of the blood by causing various degrees of cytopenias. The commonest causes are the
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metastases of neoplasms and variants of the myeloproliferative and 
lymphoproliferative disorders. Myelofibrosis and myelodysplasia are included in the 
former group of disorders (Raskin, 1996).
Myelofibrosis
Myelofibrosis is characterised by fibroblastic proliferation and varying degrees 
of collagen deposition within the marrow cavity. Myelofibrosis can be primary 
(idiopathic) or secondary to the invasion of the marrow, it is frequently seen in 
chronic myeloproliferative diseases. It is associated with myeloid metaplasia o f the 
liver, spleen and lymph nodes, proliferation of fibroblasts and abnormal growth of 
haemopoietic cells in the marrow (Dunn et al, 1986). Haematological abnormalities 
include a normocytic or occasionally, macrocytic-normochromic anaemia. Peripheral 
blood smear examination reveals mis-shapen cells (ovalocytes or tear drop 
dacrocytes), anisocytosis, giant platelets and a leuco-erythroblastic blood picture 
reflecting increased activity of unaffected marrow and EMH (Dunn et al., 1986). 
Platelet and WBC counts are usually normal or slightly increased. Megakaryocytic 
hyperplasia is seen particularly in myeloproliferative disorders.
Myelofibrosis has been observed in dogs as a terminal event in oestrogen 
toxicosis and in chronic myeloproliferative disorders (Weiss et al., 1985b). It has also 
been recognised as a terminal event in Basenji’s and Beagles with erythrocyte 
pyruvate kinase deficiency (Chapman and Giger, 1990).
Myelodysplasia is a part of the myeloproliferative disorders and may also be 
associated with anaemia.
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Myelodysplastic syndromes
Myelodysplasia is the qualitative and quantitative disorders of myeloid cells 
which need not be neoplastic. A hypercellular bone marrow and peripheral blood 
cytopenias are the characteristic features of myelodysplasia (Valli and Parry 1995). 
Myelodysplasia is a rare disease but it has been reported in dogs and as a condition 
preceding the development of acute leukaemia (Weiss et al, 1985b; Shull, 1981). In 
the two dogs studied by Weiss et al, (1985b) dysplastic changes were seen in all the 
different haemopoietic cell lines causing pancytopenia with a hypercellular marrow. 
Myelodysplasia as a pre-leukaemic state may have features of both dyserythropoiesis 
and dysgranulopoiesis.
(B) Extramarrow conditions causing anaemia 
Nutritional deficiency anaemias
Nutritional deficiencies are rare in dogs except for iron deficiency. In man however, 
megaloblastic anaemias are well recognised diseases.
Megaloblastic anaemia is caused by impaired DNA synthesis, cell maturation 
and cell division, resulting in abnormal erythroid precursors (megaloblasts) showing 
abnormal nuclear features in the bone marrow, and large erythrocytes (macrocytes) in 
the blood. The cause for this anaemia is the absence or reduced amounts of vitamin 
B12 or folic acid which are coenzymes for the DNA synthesis. Reduction in the 
amounts may be due to inadequate dietary intake or impaired absorption from the 
gastrointestinal tract. The RNA and protein synthesis in the cytoplasm is unaffected 
hence there is an asynchrony in the cytoplasmic and nuclear maturation leading to 
immature large nuclei with open chromatin patterns. A large proportion o f
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megaloblasts are destroyed in the marrow resulting in severe anaemia (Cotran et al., 
1994a). All anaemias due to deficiency of vitamin B12 or folic acid have the common 
morphological features of megaloblastic erythropoiesis with characteristic abnormal 
appearance of all nucleated red cells. Vitamin B12 and folate deficiencies usually 
occur separately and folic acid deficiency is usually dietary.
Addisonian megaloblastic or pernicious anaemia is caused by vitamin B12 
deficiency and it is the commonest type of megaloblastic anaemia in man. It is due to 
the absence from the gastric juice the substance known as intrinsic factor which is 
essential for the absorption of vitamin B12. Approximately 50% of the patients have 
auto-antibodies against this intrinsic factor indicating an immune-mediated disorder. 
The anaemia is normochromic and macrocytic with a high MCV and MCH and 
normal MCHC. In the peripheral blood there is marked anisocytosis and 
poikilocytosis, due to the presence of macrocytes, microcytes and pear-shaped cells. 
Polychromasia is not a feature. Hypersegmented large neutrophils and often low 
granulocyte and platelet counts are also present reflecting impaired DNA synthesis. In 
the bone marrow erythroid hyperplasia is present with megaloblasts at all stages of 
development. Granulopoiesis is also affected and many giant metamyelocytes and 
band forms can be seen (Rogers, 1995; Thompson 1979; Schalm e ta l,  1975c).
There have been very few reports of these deficiencies in dogs either in the 
U.K, or other developed countries. The provision of a well-balanced commercially- 
prepared diet for dogs does not predispose them to any dietary deficiencies compared 
to human beings.
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Iron deficiency anaemia (IDA)
Iron deficiency anaemia may be either a consequence of increased utilisation 
of iron, such as during growth and pregnancy or decreased intestinal absorption or 
chronic blood loss (as discussed before) (Harvey et ah, 1982). Milk has low levels of 
iron and fast growing puppies of large breeds can develop IDA if their diet is not 
sufficiently supplemented (Evans et al., 1987; Mahaffey, 1986). Iron deficiency 
results in a non-regenerative, microcytic-hypochromic anaemia. The serum iron 
concentration is low, with a decrease in the serum ferritin levels. Serum ferritin levels 
are low in dietary iron deficiency and are elevated in ACD and has been of advantage 
in distinguishing both types of anaemias (Refer to Table 7) (Stone and Freden, 1990). 
The above deficiency states and some other conditions may be associated with 
dyserythropoiesis.
Dyserythropoiesis refers to a qualitative abnormal erythroid maturation in the 
bone marrow. This is characterised by morphological changes such as multiple 
nuclear fragmentation, megaloblastic nuclear morphology, very large nuclei, very 
small erythroblasts and bi-and multinucleated cells due to incomplete cell division. 
Mild or moderate degrees of dyserythropoiesis may be seen in a number of deficiency 
states, including vitamin B12, folic acid and iron (Weiss and Reidarson, 1989). 
Dyserythropoiesis may also be seen in cases of DiGulielmo’s syndrome, pre- 
leukaemic states or acute leukaemias (Evans et ah, 1987; Weiss, 1985b). In the latter 
conditions dyserythropoiesis is only a part of the basic disease process.
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Table 7: Haematological comparison o f  ACD and IDA
Parameters Iron Deficiency Chronic Disease
Red cell Microcytic-hypochromic Normocytic-
morphology normochromic or
hypochromic
Serum iron Decreased Decreased
Serum ferritin Decreased Increased or normal
Total iron binding Increased (in other species) Decreased or normal
capacity (TIBC)* or normal in dogs
Marrow iron stores Decreased or absent High or normal
*Total iron binding capacity = a measure of serum transferrin content based on iron 
stores. (Adapted from Stone and Freden, 1990).
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Anaemia of chronic renal failure (CRF)
The renal cortex is the primary site for the production of the glycoprotein 
hormone erythropoietin (Epo) which is essential for stimulating erythropoiesis 
(Krantz, 1991). The kidneys are susceptible to a number o f toxins and ischaemic 
injuries. The number of pathological conditions affecting the kidneys are in many 
forms which may or may not involve the entire kidney but ultimately may result in 
acute or chronic renal failure. Renal failure results in an irreversible damage to the 
nephrons and the prognosis of any case would depend on the extent to which the 
nephrons are damaged and the functional activity of the kidneys is impaired.
Anaemia is the most common sequel of chronic renal failure in humans beings 
as well as in dogs (Erslev and Caro, 1990; King et al., 1992). The aetiology of 
anaemia in chronic renal failure is multifactorial and the deficiency of Epo is of major 
importance. There are other factors such as haemolysis and toxins which 
synergistically may contribute to the anaemia.
(A) Haemolysis
The life span of the erythrocytes in patients with chronic renal disease may be 
shorter than normal (Erslev and Caro, 1990). If this is observed in affected human 
patients the haemolytic uraemic syndrome should be considered. The anaemia 
observed is regenerative hence different from the majority o f anaemias seen in CRF. 
This condition is caused by the deposition of fibrin and microthrombi in the 
glomerular capillaries and arterioles, the cause of which may be the result o f viral or 
bacterial infection. There is also renal cortical necrosis, swelling and fragmentation of 
the glomerular basement membrane, resulting in a severe MAHA with regenerative 
features and marked haemolysis (Hammond and Lieberman, 1970). This syndrome of
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man has been recently described in three dogs by Holloway et a l, (1993). Features in 
dogs were similar to those seen in man.
(B) Uraemic toxins
Originally, it had been though that several inhibitors o f erythropoiesis were 
present in case of uraemia. Although the mechanisms for the mild haemolysis still 
remains unclear in affected subjects, no uniform correlation between blood urea or 
creatinine levels and red cell survival has been established (Eschbach et a l, 1990; 
Eschbach, 1980).
Uraemic metabolites were thought to be responsible for causing erythrocyte 
changes such as abnormalities in glycolysis and membrane changes leading to burr cell 
or acanthocyte formation (discussed later) (Erslev and Caro, 1990). It has also been 
suggested that there is an abnormality of the pentose-phosphate shunt preventing the 
glutathione balance to move towards the reduced form resulting in an increase in the 
oxidising process and haemolysis (Cambi and David, 1994). However, haemolysis 
according to Eschbach and Adamson (1985) cannot be the major cause of anaemia 
since the erythroid marrow can compensate for a mild degree of haemolysis.
Previously it was also believed that there were inhibitors of erythropoiesis 
such as spermine, spermidine and parathyroid hormone which were contributing to 
the anaemia (Radtke et al, 1981; Petrites-Murphy et al, 1989). Spermine and 
spermidine, however, were shown to be not specific for erythropoiesis in vivo (Cambi 
and David, 1994). According to King et al., (1992), and Eschbach et al, (1990), in 
man and dogs, hyperparathyroidism perhaps may co-relate with the severity of 
anaemia which is proportional to the extent o f renal failure.
Another condition, osteitis fibrosa, a complication of hyperparathyroidism, 
may also be present which may reduce the marrow space. It resolves after
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parathyroidectomy (Boxer et al, 1977). If fibrosis becomes severe it can lead to 
pancytopenia and to EMH and associated splenomegaly (Cambi and David, 1994; 
Eschbach and Adamson, 1985).
Recently, Eschbach et al., (1990), King et a l, (1992), Eschbach and Adamson 
(1985), and many other researchers summarised the causes of anaemia associated 
with renal failure and have proposed that the anaemia is primarily due to the lack of 
Epo. According to Eschbach et al, (1990), there is sufficient evidence that uraemic 
toxins do not play any significant role as the anaemia improves in vivo after Epo 
therapy. However, a raised parathyroid hormone level may be significant (Cambi and 
David, 1994).
(C) Decreased Epo production
Erythropoietin is the primary regulator of erythropoiesis and is secreted by the 
peritubular capillary lining cells of the kidneys. The production of Epo is inversely 
related to the oxygen availability to the kidneys (Adamson, 1994). Most anaemic and 
uraemic patients do not have measurable amounts of Epo in CRF, in contrast to other 
anaemic conditions, which have detectable high amounts. With the recent 
development of rHuEpo and its role in the management of anaemia in human CRF, 
has increased the interest in its application in animals too (Giger, 1992; Bloomberg et 
al., 1992). Erythropoietin therapy is known to be effective in human patients and in 
animals in correcting the anaemia of CRF without affecting the renal function, 
although there is an associated side effect (Refer article 1.3) (Cowgill, 1992b; Giger, 
1992).
The levels of iron have also been known to decrease in renal failure. 
Approximately one half of the dogs and cats with anaemia of CRF have low serum 
iron concentration and a transferrin saturation below 15 percent (Cowgill, 1992b). It
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may occur due to continued repetitive losses of blood associated with uraemic 
gastritis in which iron loss may exceed the absorption from the diet. In such patients 
iron must be provided to avoid iron deficiency anaemia (Cambi and David, 1994; 
Eschbach and Adamson, 1985). In addition to iron deficiency, folate deficiency, 
malnutrition, blood loss and loss of amino acids during dialysis, aluminium toxicity 
and hypersplenism may be certain complications (Cambi and David 1994). 
Haematological observations
The anaemia of CRF is normocytic-normochromic and non-regenerative 
implicating impaired erythropoiesis. In a study be King et al., (1992), 71 percent of 
the dogs with CRF had a normocytic-normochromic anaemia. The anaemia was from 
a mild to moderate severity with the lowest PCV of 22 percent. Usually, the anaemia 
is more severe in younger animals than in older ones. Sometimes the anaemia may be 
masked by dehydration.
The leucocyte and platelet numbers are usually normal but may be affected by 
the increasing uraemia and in man by dialysis (Erslev and Caro, 1990). Acanthocytes 
may be present in uraemia which may be caused by the uraemic metabolites affecting 
the surface of the erythrocytes (Erslev and Caro, 1990). According to Erslev and 
Caro (1990), burr cell formation in uraemia may be due to artifacts because these type 
of cells are not always seen in the circulation. But according to Bell (1963), and 
Dacie and Lewis (1991b), burr cells (red cells with small spiny fragments) may be 
seen in uraemia.
Anaemia of chronic disease (ACD)
Anaemia of chronic disease (ACD) may be defined as the anaemia associated 
with chronic infections or inflammatory conditions, or neoplastic illnesses which are
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not due to bleeding or marrow replacement by the tumour. It is one of the most 
frequently encountered types of anaemia as well in man as in dogs (Stone and Freden, 
1990; Feldman and Kaneko, 1981; Cartwright, 1966). There are several mechanisms 
that are involved in the development of ACD which result in a slightly shortened red 
cell life-span, a moderate disturbance in the iron metabolism and impaired 
erythropoiesis (Erslev, 1990b; Cartwright, 1966).
The shortened red cell life span may be due to extracorpuscular factors, such 
as bacterial toxins. In most cases, however, the bone marrow fails to increase its cell 
production sufficiently and a mild anaemia ensues. The red cell production is inhibited 
for some unknown reasons (Cartwright, 1966).
In this type of anaemia there is a characteristic disturbance in the iron 
metabolism despite adequate iron stores (Feldman and Kaneko, 1981). Moderate 
amounts of iron are absorbed from the intestines in ACD. However, because there is a 
disturbance in the cellular mobilisation of iron from ferritin or haemosiderin to 
circulating transferrin, there is an increase in the ferritin levels within tissues and a 
reduction in the iron binding capacity which is the concentration of transferrin. This 
results in the reduction of the circulating iron pool for uptake by the erythroid 
precursors (Cartwright, 1966). During inflammation there is lactoferrin released by 
the neutrophils, which complexes with iron and is phagocytosed by macrophages 
which prevents erythroid precursors from obtaining iron. The ACD shows features of 
iron deficiency, but the degree of anaemia and the extent of hypochromasia or 
micoryctosis are rarely pronounced as it is in true iron deficiency anaemia (Erslev, 
1990b). It seems likely that the low serum iron levels in ACD is caused by impaired 
release of iron from the monocyte-macrophage system and impaired re-utilisation
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Recording to Means and Krantz (1992), the anaemia o f  chronic disease is a
0f cytokines”. The amount and release o f  Epo is not impaired in this condition
the moderate degree o f  anaemia observed may be due to factors having 
4 1
ppreSsive effects on the bone marrow. These factors may be a variety o f cytokines 
ach as IL'I’ TL-6, TNFa, ylFN, that may be released during inflammation and 
Sections causing inhibition o f  the erythropoiesis. 
imatological observations 
The anaemia is moderate and the haemoglobin concentration is usually within 
lormal range. The anaemia is usually non-regenerative, normocytic-normochromic, or 
may be normocytic-hypochromic and occasionally microcytic-hypochromic. The 
severity of the anaemia is mild and usually not very progressive (Cartwright, 1966). 
he bone marrow is cellular with a normal or increased level o f  iron stores (Feldman 
and Kaneko, 1981). In inflammatory conditions there may be leucocytosis and a left 
h ift may indicate a bacterial or fungal infection. But other causes o f inflammation 
hould not be ruled out (Kidd, 1991).
krmonal deficiency anaemia
The anaemia in hormonal dysfunction is rarely o f  any clinical significance 
WcePt to distinguish it from other causes o f  anaemia (Valli and Parry, 1995). 
n<*°crinopathies such as hypothyroidism and Addison’s disease are usually 
s°ciated with a mild normocytic-normochromic, non-regenerative anaemia 
^erheide, 1981).
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Anaemia of malignancy
The commonest complication associated with neoplasia is the development of 
anaemia which may involve a number of mechanisms that may be primarily due to the 
malignancy or to complications of the malignancy or it may be the result of 
chemotherapy. The following types of anaemias may occur:
(i) Hypoproliferative anaemias for example: anaemia of chronic disease,
myelophthisic anaemia.
(ii) Haemolytic anaemias: AIHA, MAHA.
(iii) Blood loss anaemias: acute and chronic.
The degree of the anaemia varies depending on the duration of the disease the 
mechanisms involved and on the type of malignancy. A mild anaemia of the chronic 
disease is frequently seen in cancer which may be overlooked and noticed only after 
the cancer is in a far advanced state (Zucker, 1985). In this type of anaemia, increased 
levels of IL-1, ylFN, TNF all seem to be involved indirectly in causing the 
suppression of erythropoiesis (Bick, 1995). Replacement of the bone marrow by 
leukaemic cells, myeloma cells or by metastatic tumour cells can also result in 
moderate or severe myelophthisic anaemia and other cytopenias (Cotran et al, 
1994a).
In man and also in dogs, neoplasia, myeloproliferative or lymphoproliferative 
disorders, especially chronic lymphocytic leukaemia, may trigger an immune-mediated 
haemolytic anaemia (Arbaje and Beltran, 1990; Evans and Gorman, 1987; Madewell 
and Feldman, 1980; Dodds, 1977). Microangiopathic haemolytic anaemia, due to 
widespread metastasis of carcinomas and particularly due to haemangiosarcomas may 
also occur (Rebar et al, 1980; Madewell and Feldman 1980). Thrombocytopenia and
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associated haemorrhagic anaemia has also been seen in neoplasia as a result of 
decreased production or increased consumption of platelets i.e. DIC, increased 
sequestration or immune-mediated destruction of platelets. In a study by Grindem et 
al., (1994) 61 percent of the dogs had thrombocytopenia related to neoplasia.
Anaemia is frequently caused by chronic blood loss associated with 
gastrointestinal and urogenital tumours. Acute blood loss may occur after rupture of a 
haemangioma or haemangiosarcoma (Brown et al., 1985).
Anti-cancer chemotherapy may suppress granulopoiesis and erythropoiesis as 
these drugs are meant to act on the rapidly dividing cells. The cells with shorter life 
span would decrease faster than the cells with longer life span such as the 
erythrocytes. These drugs may cause bone marrow hypoplasia resulting in 
agranulocytosis and subsequently in a non-regenerative anaemia (Zucker, 1985; 
Madewell and Feldman, 1980).
The haematological features may vary depending on the type o f anaemia and 
the mechanisms involved. The anaemia may be non-regenerative, normocytic- 
normochromic or microcytic-hypochromic in case of defective iron utilisation and 
chronic blood loss. Acute blood loss, haemolytic anaemia and myelophthisic anaemias 
are usually normocytic or macrocytic and normochromic. Specific features may also 
be present such as schistocytes in MAHA, spherocytes in AIHA, nucleated red cells 
in regenerative and myelophthisic anaemias (Madewell and Feldman, 1980).
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CHAPTER 3
A DIAGNOSTIC APPROACH TO, AND THE 
CLINICAL MANIFESTATIONS OF ANAEMIA
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3.1 DIAGNOSTIC APPROACH TO ANAEMIA
A systematic approach is essential to diagnose the cause of anaemia which 
includes obtaining all the information concerning the dog. Taking an accurate history, 
recording the age, breed and sex is the initial procedure. Identifying the overt clinical 
signs of anaemia by a thorough physical examination o f the animal and taking a blood 
sample for a complete haematological and biochemical evaluation are the subsequent 
essential procedures. Other special investigatory tests, such as ultrasonography, 
radiology may be required to investigate for any organomegaly, infiltrative fluids or 
effusions, or any other underlying causes. Bone marrow examination may even be 
necessary in certain cases to assess the cellularity of the bone marrow and the 
estimation of the myeloid : erythroid ratio. The erythropoietic response to anaemia is 
best demonstrated by a reticulocyte count. Special tests such as direct or indirect 
Coombs' tests, clotting profile tests, soluble fibrin monomer complex test (SFMC) 
and von Willebrands factor (vWF) test may also be required.
When an anaemic patient is approached there are certain parameters such as 
the environment that needs to be considered. Taking a blood sample from the animal 
should be done carefully to avoid any stress and excitement because splenic 
contractions will force the reserve pool of erythrocytes into the circulation, causing a 
false increase in the PCV and plasma proteins which will mask the anaemia. Severe 
pain may also produce similar effects on the spleen (Schalm, 1970). Consideration of 
all these parameters and the presenting clinical signs can help to identify the aetiology 
and the pathogenesis of the anaemia in question.
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3.1.1 History
The history of the animal is essential in any condition and can be very 
informative. Any history of travel should be considered significant. One of the causes 
o f infectious haemolytic anaemia are the different kinds of parasites such as Babesia 
can is or Babesia gibsoni, HaemobartoneUa can is. Babesia a protozoal organism, can 
be acquired from different countries like U.S.A., Australia, Asia and Africa and can 
result in severe haemolytic anaemia due to the change on the erythrocyte surface by 
the parasitic organism (Farwell et al, 1982). HaemobartoneUa canis, a rickettsial 
parasite, is geographically widespread but is of no pathogenic significance, although 
latent infections can be activated by splenectomy (Middleton et al., 1982). Parasites 
such as Dirofilaria immitis (heartworm) may be acquired from areas of high 
prevalence which may also cause anaemia in affected dogs.
All these conditions are seldom observed in the United Kingdom and are 
observed with a higher incidence in other countries. Parasitic infections have been 
reported to have higher incidence in splenectomised dogs therefore it is important to 
obtain information regarding any surgery (Middleton et al, 1982).
Any information whether the dog has had any access to poisons or 
medications is equally essential to be obtained from the owner. Drugs such as 
corticosteroids and non-steroidal anti-inflammatory drugs (NSAIDS), have been 
known to cause gastrointestinal blood loss due to ulcerations (Stanton and Bright,
1989). Oestrogen compounds are used frequently and have been known to cause 
adverse effects on the bone marrow resulting in pancytopenia, although in many cases 
thrombocytopenia and associated haemorrhagic problems will be the first presenting 
signs, which may progress to severe marrow aplasia (Hall, 1992). Phenylbutazone,
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trimethoprim-sulphadiazine and some other drugs have also been reported to cause 
severe aplastic anaemia (Weiss, 1992; Weiss and Adams, 1987).
In dogs, methylene blue has been used for identification of parathyroid gland 
and pancreatic islet-cell tumours in surgical procedures. It is essential to know 
whether any infusions of this dye has been carried out as it causes severe Heinz body 
haemolytic anaemia (Fingeroth et al, 1988). It is also necessary to know whether the 
dog has ingested any foreign objects. Ingestion of coins been reported to result in zinc 
intoxication, causing a regenerative Heinz body haemolytic anaemia (Luttgen et al,
1990). Onions may be fed by owners to their pets which may lead to adverse effects 
of a severe Heinz body haemolytic anaemia, due to the toxic factor n-propyl 
disulphide and presence of haemoglobin, urobilinogen and bilirubin may be observed 
in the urine (Spice, 1976).
Any recent exposure to vaccines may be of significance since, according to 
Dodds (1983), there is a possibility that modified live virus vaccines may be the cause 
of immune mediated haemolytic anaemia. Although this has not been substantiated the 
possibility should not be ruled out in the history of the dog. In man, an acute transient 
warm antibody autoimmune haemolytic anaemia can develop in some patients as a 
sequel to an acute viral infection (Dacie, 1992b). The owners should also be asked if 
they have observed any overt signs of haemorrhages such as epistaxis melaena, 
haematuria, which may help to identify the underlying cause. Dehydration associated 
with pyrexia, persistent vomiting or diarrhoea should be recorded and considered 
when interpreting laboratory results because dehydration may mask the presence or 
severity of anaemia.
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3.1.2 The Role of Age, Breed and Sex
According to Lee et al., (1976), there is a great amount of destruction of 
foetal erythrocytes during the first two weeks after birth which seems to result in a 
neonatal anaemia. The anaemia appears to be in all puppies under ordinary nursing 
conditions which eventually disappears as the pup grows. In their study, they 
observed that dogs between birth and one week of age, had a decrease in their blood 
volumes, whereas the plasma volume remained unchanged. However, from one week 
to 2-3 months of age, the total blood volume and plasma volumes did not change 
markedly. Chronic haemorrhage and an associated iron deficiency anaemia is more 
likely to be caused by tumours in older animals whereas in younger ones especially 
puppies, hookworm and flea infestations may be the primary cause (Harvey et al, 
1982).
Age, breed and sex seem to play an important role in the development of 
certain type of diseases. For example, the onset of immune-mediated anaemia is found 
to be between 4 to 5 years; in other words it occurs mainly in middle age dogs, 
although it has also been observed in puppies (Dodds, 1983). It is known that chronic 
renal failure and certain neoplasias have higher incidence in older dogs for example, 
Moulton and Harvey (1990), have observed lymphosarcomas more often between the 
ages 5 to 11 years indicating that age must be considered.
The incidence of haemangiosarcoma has been reported to be higher in German 
Shepherd dogs than in other breeds (Pearson and Head, 1976; Kleine et al, 1970; 
Waller and Rubarth, 1967). The number of German Shepherds affected with 
haemangiosarcomas are more than the number of Boxers, although the latter are 
known to be more prone to neoplasia (Moulton and Harvey, 1990; Kleine et al, 
1970; Waller and Rubarth, 1967). German Shepherd dogs are also known to have a
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higher incidence of Factor VIII (Haemophilia A) deficiency which causes severe 
bleeding episodes in affected animals which if uncontrolled may lead to anaemia 
(Littlewood, 1992). A rare inherited lethal disease, cyclic neutropenia has only been 
observed in very young Grey Collies (Lange et al, 1976). Thrombocytopenia and 
anaemia may complicate the neutropenic episodes in terminal cases. According to 
Bennett (1984) and Dodds (1983), immunological disorders such as immune- 
mediated anaemia occur more often in females, spayed or intact due to stress from 
pregnancy and hormonal imbalances may precipitate the conditions.
If a young dog is presented with a long history of bleeding episodes which 
have been difficult to control, inherited haemostatic disorders should be considered. 
There are a number of rare hereditary conditions which have been recognised in dogs 
some having similarity to their human counterparts. Inherited coagulopathies have 
been observed in dogs which can be recognised at an early age, during vaccinations or 
eruption o f teeth or minor surgical procedures. Von Willebrand's disease (vWF) an 
inherited bleeding disorder with an autosomal dominant pattern has been identified in 
a number of breeds (Littlewood, 1992). Haemophilia A (Factor VIII deficiency) a 
rare inherited bleeding disorder has been reported in many breeds of dogs. It has a 
sex-linked recessive pattern so only males are affected with abnormal bleeding 
tendency and heterozygote females are carriers and asymptomatic (Littlewood, 1992). 
A coagulation screening and if necessary specific tests, must be performed and if 
possible the parents and litter mates of affected dogs should also be checked in order 
to avoid breeding from the affected animals.
Rare enzyme deficiencies such as phosphofructokinase deficiency and 
pyruvate kinase deficiency have also been observed in young dogs which are similar 
to the conditions observed in humans (Giger and Harvey, 1987; Searcy et al., 1971).
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3.2 CLINICAL MANIFESTATIONS OF ANAEMIA
The clinical signs associated with anaemia are a result of the reduced oxygen 
carrying capacity o f the blood and physiological adjustments which are designed to 
increase the efficiency of the remaining erythron, to reduce the workload on the heart 
and direct the blood to the vital organs (Erslev, 1990a). The consequence of anaemia 
if sufficiently severe or acute in onset may lead to a marked decrease in tissue 
oxygenation resulting in a variety of clinical signs.
The development of clinical signs depends greatly on the rapidity of onset, 
degree, and cause o f anaemia (Evans et al., 1987). In dogs with an acute blood loss 
of 30 to 40 percent, which may be substantial and sudden in onset, there is a decrease 
in the circulating blood volume resulting in a state of hypovolemic shock (Feldman, 
1981). The loss of plasma and red cell mass is in proportionate volume. If the loss is 
more than 50 percent, muscular weakness, subnormal temperature, terminal 
respiratory distress, increase in the heart rate and stroke volume to reduce the time 
taken for circulation by red cells, coma and death may ensue (Rogers, 1995). The 
plasma volume expansion takes place slowly by mobilisation of the extravascular 
albumin pool producing a haemodilution resulting in anaemia. Due to this 
haemodynamic change, the skin and especially the extremities may become pale and 
cold as a result of peripheral capillary vasoconstriction in an attempt to direct blood 
to the vital organs to compensate for the ongoing anaemia (Hillman, 1990, Wintrobe 
et al., 1974).
In chronic blood loss anaemia or in other chronic type of anaemias, whatever 
the type and cause, signs apart from paleness may not be so evident because the
139
animal will gradually be able to adapt to the anaemia. Symptoms seem to be more 
prominent in acutely developing anaemias and in aged patients.
Initially, an increase in Epo production takes place due to tissue hypoxia 
except in chronic renal failure. This increase in Epo level results in increased 
erythropoiesis in an attempt to maintain normal numbers of erythrocytes. In human 
beings, this may be associated with tenderness of the bones and with sternal pain or 
aches although in animals it may be expressed differently (Erslev, 1990a). There is 
also a slight decrease in the urinary output as a result o f a decrease in the renal blood 
flow pressure. Even in severe anaemia with the renal blood flow reduced by 50 
percent, the renal plasma flow is only moderately curtailed (Erslev, 1990a). Within 
the next few days of a blood loss, the blood volume may be restored by an influx of 
electrolytes and proteins which result in an increase in the plasma volume.
While examining a dog, it is essential to identify the overt signs o f anaemia 
which may be helpful to approach a diagnosis. The most commonly recognised signs 
associated with anaemia are pallor, cardiac murmurs, respiratory symptoms, 
tachycardia, dizziness or weakness, fatigue, fainting episodes and occasionally 
jaundice. Seizures have also been observed in a dog due to a chronic blood loss 
anaemia caused by parasitism. (Curtis, 1977).
3.2.1 Pallor
Pallor has been known to be the most prominent and characteristic sign of 
anaemia. Pallor is the result of peripheral capillary constriction which is an attempt to 
direct blood to the vital organs (Wintrobe et al., 1974). Paleness may be mild, 
moderate or severe depending on the degree and onset of anaemia. Pallor in animals
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may be observed on the non pigmented areas of the body such as the mucous 
membranes, conjuctivae, tongue, gums, vulva, penis and underlying skin. In dogs the 
pigmentation of the skin may make the diagnosis difficult. On one hand, absence of 
pallor does not necessarily indicate that anaemia is not present, whereas on the other 
hand, pallor may be as a result of shock or factors affecting the general circulation 
(Evans el al., 1987). It is known that jaundice and cyanosis may mask the pallor 
associated with anaemia, hence it is essential to obtain accurate haematological values 
for the detection and quantification and characterisation of anaemia (Wintrobe et al., 
1974).
3.2.2 Cardiovascular and Respiratory Signs
When PCV is very low a soft systolic "haemic murmur" may be evident due to 
an increased velocity of blood flow and a decreased viscosity which is known to 
disappear when anaemia is corrected. In a study of 72 human patients with acute and 
chronic anaemias, murmurs were present in two thirds of the patients and these 
murmurs were increasing as haemoglobin levels decreased and correction of cardiac 
murmurs was achieved by reducing the anaemia (Dawson and Palmer, 1966). In cases 
of severe anaemia, the murmurs are stronger due to mitral and tricuspid insufficiency 
resulting from cardiac dilatation (Wintrobe et al, 1974). Muffled heart sounds or 
abdominal distension may indicate bleeding into the thoracic and or peritoneal cavities 
and one may consider the possibility of a bleeding tumour (Weiser, 1995).
When anaemia is sufficiently severe signs of dyspnoea, tachypnoea, 
tachycardia and exercise intolerance, lethargy and weakness due to insufficient
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oxygenation are observed (Valli and Parry, 1993). Cerebral hypoxia and marked 
tachycardia can cause signs of fainting and dizziness (Wintrobe et al., 1974).
3.2.3 Jaundice
It is understood that bilirubin produced by the catabolism of haemoglobin 
imparts a yellow colour to the plasma. Excess haemolysis may result in the 
accumulation of unconjugated bilirubin in the plasma causing yellow discoloration of 
the mucous membranes. According to Jones and Gruffydd-Jones (1991), clinical signs 
such as jaundice, haemoglobinuria and collapse together could be indicative of an 
acute haemolytic "crisis" but not all dogs may show these typical signs. It has been 
observed by Cotter (1995), that destruction o f four grams of haemoglobin in 24 hours 
may cause jaundice even in the presence of normal liver functions. The cause of 
jaundice must be identified because persisting jaundice may also be due to primary or 
secondary hepatobiliary disease.
3.2.4 Other Relevant Signs
Any evidence of overt haemorrhage such as haematemesis, melaena, 
haematuria, epistaxis, haemarthrosis or subcutaneous haemorrhage (petechiae and 
ecchymoses) must be identified. Examination of the occular fundus may reveal pallor 
o f the retinal vessels in severe anaemia and retinal haemorrhages may also be present 
(Evans el al., 1987). In human beings, retinal haemorrhages are frequently observed 
due to aplastic anaemia, pernicious anaemia as well as in anaemia due to leukaemia. 
Also in human beings, gastrointestinal signs of anorexia, abdominal discomfort, 
nausea, vomiting, constipation or diarrhoea may be observed in anaemic patients
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which however can probably be related to the underlying gastrointestinal disease 
condition causing the anaemia (Wintrobe et al, 1974).
In dogs these signs are also frequently observed, although dogs tend to get 
anorexic in many disease conditions without being anaemic. Fever may be present 
which is often associated with infectious, inflammatory or neoplastic diseases. 
Organomegaly, if present, may be associated with haemorrhage, neoplastic, 
infiltrative disease or may be due to extramedullary haemopoiesis in case of the spleen 
and the liver (Rogers, 1995). Skin lesions, lameness, joint swellings due to 
autoimmune polyarthritis may also be present in anaemic dogs (Evans et al., 1987). A 
dermatological examination is necessary for identifying the presence or absence of 
ectoparasites such as fleas, lice or ticks as they may cause chronic blood loss anaemia 
and some of them are also responsible for the transmission o f some erythrocytic 
parasites.
In chronic blood loss, the haemoglobin levels may decrease sufficiently 
without the animal exhibiting signs of hypoxia, unless exerted, making it difficult to 
diagnose. Regional and generalised lymphadenopathy should be investigated in order 
to identify the underlying reactive or neoplastic process such as lymphosarcoma or 
leukaemia. Anaemia in the latter may be the result of bone marrow infiltration by 
neoplastic cells (Squires, 1993).
Presence o f a uraemic breath, oral ulcers, polydipsia, polyuria, dehydration 
may indicate chronic renal disease and uraemia which may be associated with signs of 
anaemia due to renal failure. The severity of the above signs may vary between 
individual animals depending on a number of factors, the pathogenesis and the 
aetiology of anaemia.
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CHAPTER 4
RETROSPECTIVE STUDY OF ANAEMIA
IN DOGS 
DURING THE YEAR 1994
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4.1 INTRODUCTION
Anaemia is a clinical sign observed in many diseases and results from an 
increased rate of destruction of erythrocytes or from loss of erythrocytes or from a 
decreased rate of production o f erythrocytes. Anaemia can be primary or secondary 
and can cause serious clinical diseases. In addition, anaemia is one of the most 
frequently encountered laboratory abnormalities in veterinary medicine (Squires, 
1993). Once anaemia is detected in an animal its pathogenesis and cause should be 
thoroughly investigated to determine proper therapeutic management.
The purpose of this study was to investigate the causes of anaemia as 
represented by the dogs referred to the clinicians at the University of Glasgow 
Veterinary School during 1994.
These cases were investigated by analysing the clinical diagnosis, haematological 
findings, and post-mortem reports of the referred cases.
4.2 MATERIAL AND METHODS
4.2.1 Animals
During the period 1st January to 31st December in 1994, 830 dogs were 
referred to the Veterinary Medicine and Veterinary Surgery Departments o f the 
University of Glasgow Veterinary School. Every dog admitted was given a case 
number for reference which for the purpose of this thesis was designated by a dog 
number (DN). A history was obtained for each dog and a clinical examination was 
carried out by the clinicians responsible for the case. A diagnostic workup was done 
for most of the dogs which involved a thorough clinical examination along with the
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collection of blood samples for biochemistry, haematology, and other diagnostic tests 
when necessary. All the 830 dogs admitted to the Veterinary School had at least one 
blood sample taken. The samples from these 830 dogs were submitted to the 
Veterinary Haematology Laboratory of the Department of Veterinary Pathology for 
haematological examination.
Of these 830 dogs, 245 had PCV of less than 37% and were therefore 
considered to be anaemic. These 245 dogs formed the basis of this retrospective 
study. Of these 245 anaemic dogs with PCV of less than 37%, 52 dogs were studied 
in more detail since they had undergone a full post-mortem examination in the 
Department of Veterinary Pathology. The following data were obtained on the 52 
anaemic dogs that were examined post-mortem:- breed, age, sex, haematological 
findings, clinical findings and post-mortem findings. These are listed in Appendix B 
and Appendix C.
4.2.2 Database Studies
The hospital computing system was used for retrieving the data regarding the 
dogs admitted in 1994. Every dog admitted was assigned a case reference number 
which was entered into the computing system of the University of Glasgow 
Veterinary Hospital Database, with the details of the owner and details about the dog 
such as age, breed, species, sex. The address o f the referring veterinarian and the 
clinician to be in charge of the case were also entered. A letter from the referring 
veterinarian was very useful since it provided a brief summary of the previous 
ailments of the dog which was helpful in the clinical examination. Additional details 
regarding the dog were not entered on the database but were kept in files stored, in
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case reference number sequence, at the case reception where further details regarding 
the dog could be obtained.
A laboratory reference number was given by the Haematology Laboratory7 of 
the Department of Veterinary Pathology to every sample for each day then the data 
for every blood sample from the dogs was entered in the haematology laboratory 
database, called "Dataflex". Records of each dog were kept in this database which 
was accessed to obtain the haematological details o f the dogs in this study. The 
features of the haematology details of “Dataflex” are shown in Figure 16. The post­
mortem reports were obtained through the "Dataflex" a database of the Pathology 
Department. The “Dataflex” is a computer software designed individually for some of 
the departments.
4.2.3 Haematological Examination
All the blood samples followed the same procedure in the haematology 
laboratory. Every blood sample (2-3ml) was collected by the clinicians from the veins 
o f the dogs in a potassium ethylene diamine tetra-acetic acid (KE-EDTA) tube, 
(SARSTEDT, Germany) and details o f the name of the dog, date of birth, case 
reference number, date and time of sample collection were recorded on each tube. A 
haematological form accompanied each blood sample sent to the laboratory. The 
above details of the dog and a clinical summary were written on the form which were 
helpful in providing a diagnosis. Sometimes, this clinical summary was the final 
diagnosis but often only the clinical signs or a tentative diagnosis was written on the 
forms. After the blood tubes and forms were received in the laboratory they were 
given a separate laboratory reference number.
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Figure 16: The display on the screen o f the Haematology Laboratory Dataflex 
database is shown describing some o f the essential details of the animal that are 
entered into the database.
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The tubes were allowed to mix for about 10 minutes on a mixer so that the 
anticoagulant mixed well with the blood and aggregation of the blood cells was 
avoided. A blood smear was then made from every sample using a microcapillary tube 
of dimensions 75x 1.3-1.5 mm.(technique is described on page 292). On the smear the 
laboratory reference number, date and case reference number were written. The 
smears were air dried and then stained using the May Griinwald Giemsa staining 
procedures (Appendix A). From the remaining sample 25 pi of blood was aspirated 
for a complete blood count (CBC) profile, using the Roche ABX Minos Veterinary 
Automated Haematology Analyser. The haematological values and a graph of the 
platelet distribution width (PDW) for that particular case was produced by an 
attached printer. After the smears were stained and dried the differential white cell 
count of 200 cells count was carried out manually and entered into the computer 
which was connected to another printer. The results from the Roche ABX Minos 
Veterinary Automated Haematology Analyser were transferred onto the computer for 
the haematology database "Dataflex", thus producing a complete record of the 
results.
Morphological examination of every blood smear was also done as a routine 
procedure by the haematologist and any significant observations were recorded (listed 
in Appendix B). A reticulocyte count was done manually using a supravital stain of 
new methylene blue only if requested by the clinician or if it was thought to be 
necessary by the haematologist.
The following haematological parameters were obtained in the routine 
procedures:- red blood cells (RBCxlO^/i)? haemoglobin (Hbg/dl), packed cell 
volume (PCV%), mean corpuscular volume (MCVfl), mean corpuscular haemoglobin 
(MCHpg), mean corpuscular haemoglobin concentration (MCHCg/dl), platelets
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(PLTxlO^/l), mean platelet volume (MPVfl), platelet crit (PCT%), platelet 
distribution width (PDW), reticulocytes (Reticsx 10^/1), white blood cells 
(WBCx 10^/1), band neutrophils (BNxlO^/1), neutrophils (Neutrox 10^/1), lymphocytes 
(Lymphoxl 0^/1), monocytes (Monoxl0^/1), eosinophils (Eosx 10^/1), basophils 
(Basox 10^/1), normoblasts (x 10^/1) Nucleated red cells were included in the total 
white cell count. However, the platelet parameters (MPV, PCT and PDW) were not 
considered as a part o f this study.
For some dogs depending on their clinical presentation the following special 
tests were carried out with other tests when necessary:- Direct Coombs' test (ICN 
Biomedicals, California), detection o f soluble fibrinogen monomer complexes 
(SFMC) (Diagnostica Stago, France), estimation o f fibrin degradation products 
(FDP) (Boehringer Mannheim, United Kingdom),
4.2.4 Criteria for Selection and Classification of Cases
The normal range o f canine PCV was considered to be 37%-55%. A dog with 
a PCV less than 37% was considered to be anaemic. The following criteria were used 
to classify the severity o f anaemia : i) PCV o f 36.9%-30% was considered to indicate 
mild anaemia , ii) PCV of 29.9%-20% was considered to indicate moderate anaemia, 
iii) PCV o f 19.9% and less was considered to indicate severe anaemia.
In cases from which multiple samples were taken the lowest PCV value was 
used to classify the dogs according to these criteria. When the post-mortem findings 
were available, the main cause contributing to the anaemia was investigated in more 
detail.
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4.3 RESULTS
There were 830 dogs in 1994 from which blood samples had been taken 
between 1st January and 31st December. From these 830 dogs, 245 (29.5%) had 
PCV of less than 37% and were considered to be anaemic according to the criteria 
stated above. When these anaemic dogs were classified according to the criteria used 
to grade the severity of the anaemia, the following results were obtained. The results 
are illustrated in the Table 8. There were 155 (63.3%) which were mildly anaemic, 65 
(26.6%) which were moderately anaemic and 25 (10.1%) which were severely 
anaemic.
When the 245 anaemic dogs, which had been examined clinically in the 
University of Glasgow Veterinary School in 1994, were classified according to 
whether they had a regenerative or non-regenerative anaemia, based on the blood 
picture and other data available, the following results were obtained. There were 74 
(30.2%) dogs with a regenerative anaemia and 161 (65.7%) with a non-regenerative 
anaemia. No data was available to classify the anaemia in 10 (4.1%) dogs from the 
245. Of the 74 dogs with regenerative anaemia, 55 (22.4%) dogs were found to have 
haemorrhagic anaemia and 18 (7.3%) had haemolytic anaemia. In the major 
proportion (65.7%) of the 161 dogs which had a non-regenerative anaemia, the 
anaemia was due to a variety of chronic conditions and infections. However, 11 
(4.5%) of these dogs had a non-regenerative anaemia due to renal disease and these 
dogs were considered separately. These results have been tabulated in the Appendix B.
Fifty two anaemic dogs were studied in more detail since there had been a 
post-mortem examination result to confirm the diagnosis and to explain the 
underlying cause of the anaemia. This group of 52 anaemic dogs was designated as
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Table 8: Degree of Anaemia in 245 Dogs Studied in the University 
of Glasgow Veterinary' School in 1994
Anaemia Number of Dogs
'
Mild 155 (63 3%)
Moderate 65 (26.6%)
Severe 25 (10.1%)
Table 9 : Degree of Anaemia in the 52 Dogs Studied in Group A 
(Anaemic dogs necropsied)
Anaemia Number of Dogs
Mild 26(50.0%)
Moderate 17(32.7%)
Severe 9(17.3%)
152
Group A for further reference. These 52 anaemic dogs (Group A) were classified 
according to the severity of the anaemia by the criteria already stated and there were 
26 (50.0%) dogs which were mildly anaemic, 17 (32.7%) moderately anaemic, and 
there were 9 (17.3%) dogs which were severely anaemic. These results are illustrated 
in Table 9.
4.3.1 Breed
In Group A, anaemia was most commonly seen in the following breeds : 
Cocker Spaniels 9(17.3%), Golden Retrievers 8(15.3%), German Shepherd dogs 
8(15.38%), Bull Terriers 6(11.53%) and Rottweilers 5(9.61%), 16(30.7%) dogs were 
other breeds. These results are illustrated in Table 10. The other breeds were 
represented by one or two animals and these are all listed in the Tables 12, 13 and 14 
respectively.
4.3.2 Age
Anaemia of varying degrees is a clinical sign which can be observed at any age 
and the aetiology of anaemia is often different in different ages of dogs. Consequently, 
the dogs in Group A were categorised into three age groups, less than 1 to 5 years, 
young dogs (Group A l); 6 to 10 years, middle aged dogs (Group A2); and dogs of 
more than 10 years, old dogs (Group A3). This facilitated the study of the causes of 
anaemia at different stages of the dogs life.
There were 16 dogs (30.7%) which were anaemic between the ages less than 
1 to 5 years, 25 dogs (48.1%) which were anaemic between the ages of 6 to 10 years
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Table 10: Breeds of 52 Anaemic Dogs Studied in Group A (Anaemic 
dogs necropsied)
Breed Number of dog
Cocker Spaniels 9(17.3%)
Golden Retrievers 8(15.3%)
German Shepherd 8(15.38%)
dogs
Bull Terriers 6(11.5%)
Rottweilers 5(9.6%)
Others 16(30.7%)
Table 11: Ages of 52 Anaemic Dogs of Group A
Ages of anaemic dogs. Number of dogs
up to 5 years (Group Al) 
6 to 10 years (Group A2) 
Over 10 years (Group A3)
16(30.7%) 
25(48.1%) 
11(21.2%)
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and there were 11 dogs (21.2%) which were anaemic in the age group of more than 
10 years. These results are illustrated in Table 11.
4.3.3 Diseases Associated with Anaemia in Group A Dogs in 
Relation to their Age 
Group A1
In the young dogs comprising of Group A1 there were 16 animals, 30.7% of 
the dogs in Group A. Information on the age, sex and breed, degree of anaemia and 
the associated diseases found post-mortem in the dogs of Group A1 is listed in Table 
12. The average age of this group was 3.3 years. The number of males which were 
anaemic was 8(50%) and there were 8(50%) anaemic female dogs. When the severity 
of anaemia was assessed it was seen that there were 10(62.5%) dogs which were 
mildly anaemic, 4(25%) which were moderately anaemic and only 2(12.5%) dogs 
which were severely anaemic.
From the pathological reports it was observed that there were five dogs that 
had renal problems which were considered significant. Three of these dogs, DN13, 
DN24 and DN230 were Bull Terriers with familial nephropathy which is a condition 
that has been recognised in this breed. Congenital renal failure was observed in one 
dog DN206, and one dog, DN133, had pyelonephritis. None of these five dogs were 
severely anaemic, but inevitably they all died o f renal failure.
Two dogs, DN15 and DN142, had lymphosarcoma and of these one had a 
mild anaemia and the other dog was severely anaemic. There were two severely 
anaemic dogs, one dog, DN70, with a myeloid leukaemia and the other, DN141, with 
bone marrow hypoplasia. Cardiovascular disease was seen in two dogs, DN90 and
155
Table 12: Degree o f  Anaemia and Pathological Diagnosis in the 16 Group A Dogs
up to 5 Years o f  Age (Group A l)
Dog Age Sex Breed PCV(%) Pathological Diagnosis
No. (yrs) and Degree
(DN) of Anaemia
13 5.4 F Bull Terrier 30 MI Familial nephropathy
15 5.9 FS Bull Terrier 35.6 MI Multicentric 
lymphosarcoma, 
urolithiasis and pulmonary 
calcinosis
24 2 F Bull Terrier 31.3 MI Familial nephropathy
33 1 M Bull Terrier 32.3 MI Lethal acrodermatitis
54 2.9 M German Shepherd 
dog
30 Ml Small intestine volvulus
55 1.9 FS Cocker Spaniel 33.6 MI Sarcoptic mange, focal 
chronic pneumonia
70 3.5 M Highland Terrier 27 MO Myeloid leukaemia
81 5.3 F German Shepherd 
dog
33.9 MI Pancreatic hypoplasia
90 4 M Cocker Spaniel 32 MI Dilated cardiomyopathy, 
pulmonary and systemic 
thromboembolism
105 1.4 F Retriever 35.9 MI Portocaval shunt
133 4 M Cavalier King 
Charles Spaniel
22 1 MO Chronic pyelonephritis, 
uraemic gastritis
139 4 M Cocker Spaniel 23.7 MO AITP
141 5.2 FS Rottweiler 7.9 S Bone marrow hypoplasia
142 5.8 M Cross bred dog 19.1 S Multicentric lymphoblastic 
lymphosarcoma
206 0.75 M Springer Spaniel 28.7 MO Congenital renal failure
230 1 F Bull Terrier 30 MI Familial nephropathy
Abbreviations
M = Male F = Female F (S) = Female Spayed MI = Mild anaemia
MO = Moderate anaemia S = Severe anaemia DN = Dog number
AITP= autoimmune thrombocytopenia
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DN105, which were mildly anaemic. In this group, only one dog, DN139, was
observed to have anaemia due to autoimmune thrombocytopenia.
It was observed that there were two dogs with dermatological problems 
DN33 and DN55. One dog, DN54, had small intestinal volvulus and was only mildly 
anaemic due to the sudden trauma. Pancreatic hypoplasia was observed in a mildly 
anaemic dog, DN81.
Group A2
In the middle aged dogs of Group A2, there were 25 anaemic dogs, 48.1% of 
all the dogs of Group A. The details of these cases and the diseases found post­
mortem are given in Table 13. The average age for this group was 8.1 years. The 
number of male dogs were 13(52%) and there were 12(48%) female dogs. The dogs 
were further classified according to the severity of the anaemia. Nine dogs, that is 
36%, were mildly anaemic, 10(40%) moderately anaemic and 6(24%) had severe 
anaemia. The severity of the anaemia was not related to any specific disease 
condition. There were three dogs, DN6, DN128 and DN238, with renal disease. One 
of these dogs, DN6, had familial nephropathy and it was a Bull Terrier.
Many of the dogs, 13 in total, had anaemia related to neoplasia. Four dogs 
had haemangiosarcoma, two of which, DN58 and DN88, had severe anaemia, and 
two dogs, DN190 and DN235, were moderately anaemic. Lymphosarcoma was 
present in three dogs, one dog, DN41, was mildly anaemic and two dogs, DN59 and 
DN71, were moderately anaemic. Three dogs had adenocarcinomas, one dog, 
DN149, had a tumour of the pituitary gland and the other two dogs, DN25 and 
DN49, had tumours of the pancreas. Of the other two dogs with neoplasms, one dog 
DN56, had a mast cell tumour and the other dog, DN214, had an osteosarcoma.
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Table 13: Degree o f  Anaemia and Pathological Diagnosis in the 25 Group A
Dogs Aged 6 to 10 Years (Group A2)
Dog
No.
(DN)
Age
(yrs)
Sex Breed PCV(%) 
and 
Degree of 
Anaemia
Pathological Diagnosis
6 10.2 M Bull Terrier 32 MI Familial nephropathy
16 6.8 M Golden Retriever 14.2 S AIHA and DIC
25 7.8 M Rottweiler 35.3 MI Pancreatic adenocarcinoma
41 8.9 M Cocker Spaniel 24.7 MO Multicentric lymphosarcoma
45 8.7 FS German Shepherd dog 24.7 MO Endocarditis, chronic cystitis
48 7.1 M Bearded Collie 12.2 S Dyserythropoiesis, thymoma
49 8.6 M Cocker Spaniel 34.3 MI Pancreatic adenocarcinoma
56 8 FS German Shepherd dog 28 3 MO Mast cell tumour
58 8 FS German Shepherd dog 10.5 S Haemangiosarcoma
59 8 FS Rottweiler 28 MO Lymphosarcoma
71 7 F Collie o MI Multicentric lymphosarcoma, 
hypercalcaemic nephropathy
72 10 FS German Shepherd dog 30.6 MI Road traffic accident
88 9 M Afghan Flound 19.4 S Haemangiosarcoma
128 9 FS Airedale Terrier 27.7 MO Chronic glomerulonephritis
146 8 F Cocker Spaniel 28.7 MO Compressive myelopathy
149 8.1 FS Great Dane 34.3 MI Pituitary adenocarcinoma
157 8 M Cocker Spaniel 27.7 MO Pancreatic hyperplasia
170 9.5 MC Cocker Spaniel 8.9 S AITP
190 9 M German Shepherd dog 29.7 MO Haemangiosarcoma
199 6.6 FS Spinone 5.2 S AIHA
207 8 F Rottweiler 21.7 MO AITP
214 8.6 MC Rottweiler 34.3 MI Osteosarcoma
226 7 M Retriever 36.3 MI Spinal cord compression
235 6 MC German Shepherd dog 25.4 MO Haemangiosarcoma
238 9 FS Border Collie 32 MI Renal failure
A b brev ia tions
M = Male F = Female F (S) = Female Spayed MI = Mild anaemia
MO = Moderate anaemia S = Severe anaemia DN=Dog number
AIHA= autoimmune haemolytic anaemia AITP= autoimmune thrombocytopenia
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All of these dogs were mildly anaemic except DN56, with mast cell tumour which 
was moderately anaemic.
Dyserythropoiesis was seen in DN48, with severe anaemia which also had a 
thymoma. Immune-mediated disease was observed in four dogs in this age group with 
three of them having severe anaemia and one having a moderate anaemia. A PCV as 
low as 5.2% was observed in one case DN199, which was the consequence of 
erythroid hypoplasia.
Anaemia was also observed in a case of endocarditis, DN45, associated with 
septicaemia. One case was observed with each of the following disease conditions:- 
road traffic accident, DN72, compressive myelopathy in DN146, pancreatic 
hyperplasia and spinal cord compression in dogs DN157 and DN226, respectively.
Group A3
There were 11 older dogs in Group A3 which was 21.2% of all the anaemic 
dogs in Group A, and Table 14, contains detailed information about these dogs.
The average age of this group of dogs was 12.1 years. There were 5(45.4%) 
males and 6 (54.4%) females in this group. The dogs were further classified according 
to the severity of the anaemia and there were 7(63.6%) dogs which were mildly 
anaemic, 3(27.2%) dogs which were moderately anaemic and 1(9%) dog was severely 
anaemic. There were five dogs with anaemia associated with chronic renal diseases. 
One dog DN52, with a protein losing nephropathy was severely anaemic and had the 
second lowest PCV value of 6.2% in this series.
There was one dog, DN93, with mild anaemia due to glomerulonephritis and 
another dog, DN10, anaemic due to chronic nephropathy. Severe infection causing
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Table 14: Degree o f  Anaemia and Pathological Diagnosis in the 11
Group A Dogs Aged over 11 Years (Group A3)
Dog Age Sex Breed PCV(%) Pathological Diagnosis
No. (yrs) and
(DN) Degree of 
Anaemia
4 15.2 M Retriever 29.3 MO Lymphosarcoma
10 12 FS Retriever 35.6 Ml Chronic nephropathy, hepatic 
nodular hyperplasia
37 11.1 FS Boxer 32.6 MI Lymphosarcoma but died 
of gastric torsion
40 12.8 M Jack Russell 
Terrier
27.7 MO Chronic pyelonephritis, Sertoli 
cell tumour
52 1 1 FS Cross bred dog 6.2 S Protein losing nephropathy
93 1 1 F Cairn Terrier 30 MI Chronic glomerulonephritis, 
mural endocarditis, aortic 
thrombosis
124 12.3 M Retriever 33 MI Squamous cell carcinoma, 
endocarditis,chronic pyelonephritis, 
purulent cystitis
143 12 M Newfoundland 32.6 MI AITP
144 11 M Retriever 32 MI Acute cardiac failure
234 12 FS Cross bred dog 25.4 MO Hepatocutaenous syndrome
244 13 FS Retriever MI Pulmonary adenocarcinoma
Abbreviations
M = Male F = Female F (S) = Female Spayed MI = Mild anaemia
MO = Moderate anaemia S = Severe anaemia DN = Dog number
AITP=auto-immune thrombocytopenia
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pyelonephritis and cystitis was observed in DN40 and DN124. Lymphosarcoma was 
observed in two cases DN4 and DN37, although the latter, DN37, died o f gastric 
torsion. Other cases of anaemia associated with neoplasia were DN244 with a 
pulmonary adenocarcinoma and DN124 with a squamous cell carcinoma.
Only one dog, DN143, had anaemia due to autoimmune thrombocytopenia. In 
one dog, DN234, a moderate anaemia due to hepatocutaenous syndrome was 
observed.
4.4 DISCUSSION
Epidemiology is the study of the distribution and dynamics of a disease in an 
animal population, with the objectives of identifying the prevalence of the disease and 
providing information on which to base preventive measures. For any disease it is 
important to understand its pattern of occurrence, factors associated with any 
predisposition to acquire the disease and the aetiology of the disease. The 
composition of the population in which the disease occurs is an essential element of 
any study. The population in this study was very selective, and was not a random 
sample of the general canine population. The dogs studied were referred to the 
University of Glasgow Veterinary School by veterinarians and this procedure would 
have created a bias towards certain types of cases. However, the hospital population 
of referred cases will give some idea about the types of anaemia found in the general 
population but will not necessarily reflect accurately the prevalence of disease in the 
population of the whole of the United Kingdom.
In an attempt to obtain information about the prevalence of anaemia in the 
canine population, particularly in the United Kingdom, a database search on the
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"Silver Platter 3.0 and 3.11" VetCD (veterinary computer disc, © Silver Platter 
International N.V.), designed specifically for veterinary use was done. There were no 
reports of an overall review of the occurrence of anaemia in dogs in a large 
population. There were reports regarding the diagnosis of different types o f anaemia 
in dogs for example Squires, (1993), Jain, (1993b) and Weiser, (1995). However, no 
study on the relative occurrence of the different types of anaemia to be expected the 
United Kingdom was found. There was one report by Hinton and Jones (1977), 
recording the analysis of blood samples from 1063 dogs, in the United Kingdom over 
a period of two years. Of these 1063 dogs, 203 (19.1%) dogs had anaemia 
(haemoglobin value of less than 11.9g/dl), but no further investigation was done 
regarding the aetiology of the anaemia and the type of anaemia present. In the work 
reported in this thesis, 29.5% of 830 dogs were found to have anaemia which was a 
higher prevalence than that reported by Hinton and Jones (1977).
Anaemia is known to occur as a primary condition or in association with a 
wide variety of diseases. Characterisation of anaemia frequently leads to identifying 
the underlying disease (Weiser, 1981). The types of anaemia found in this study were 
observed to reflect the types of anaemia that have been described in dogs already and 
recorded in the standard texts on the subject (Weiser, 1995; Valli and Parry, 1993; 
Schalm et ciL, 1975c). In this study, certain commonly observed disease conditions 
were found to be associated with the anaemias usually seen in dogs, although, as was 
expected some conditions causing anaemia were not observed as they do not occur in 
the United Kingdom.
There was no case of a blood borne parasite such as babaesia or 
haemobartonella, causing haemolytic anaemia in any of the dogs studied. Although 
there have been cases of Haemobartonella felis affecting cats, very few cases of
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Haemobartofiella canis affecting dogs have been reported in the United Kingdom 
(Bobade, et al., 1988; West, 1979). These infectious causes of haemolytic anaemia 
are known to have a high prevalence in dogs in tropical countries or in U.S.A. where 
there is a high tick population for transmission of the parasites (Valli and Parry, 
1993).
Enzymopathies such as pyruvate kinase and phosphofructokinase deficiencies 
are conditions which result in haemolytic anaemia in young dogs of certain breeds and 
are not very commonly observed (Schaer et al., 1992; Harvey and Smith, 1994). In 
this study, there were no dogs with any of these conditions. There was also no dog 
with anaemia due to an inherited coagulopathy, possibly because these conditions 
have been identified and breeding from animals with the causal genes has been 
avoided leading to a reduction in the prevalence of these conditions.
Drug-induced toxicity may cause anaemia, and oestrogen toxicity, which 
results in a severe pancytopenia, is a particularly well recognised problem which has 
been well documented in dogs (Shelly, 1988). No dog with anaemia due to oestrogen 
toxicity was observed in this study. This may also be due to an increased awareness of 
these problems, resulting in better drug administration.
In the 52 dogs studied in Group A, renal disease conditions were the 
commonest cause of anaemia occurring in 13 of the 52 dogs. The dogs with renal 
diseases were distributed in all the age groups, however, there were more cases in the 
very young dogs (Group A l) and in the older dogs (Group A3). The young dogs had 
mainly renal diseases such as familial nephropathies whereas, the older dogs had other 
conditions affecting the kidneys such as chronic pyelonephritis and chronic 
glomerulonephritis.
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The next most common cause of anaemia were various neoplasms, which were 
observed more frequently in the middle aged dogs (Group A2), although all other 
ages were affected. Haemangiosarcomas and lymphosarcomas were the most 
common tumours found. Haemangiosarcomas were observed only in the middle aged 
dogs, 6 to 10 years old, which was consistent with the literature in which Pulley and 
Stannard (1990), have described the average age to be between 9 to 10 years. 
According to Moulton and Harvey (1990), dogs with lymphosarcoma are seldom 
observed at less than one year of age with a high incidence between 5 to 11 years and 
a decline with increasing age. Similar findings were observed in this study in which 
seven dogs were found to have lymphosarcoma, three of these were aged 6 to 10 
years, two dogs were over 10 years and two were in the younger age group. The 
prognosis of all these conditions is not very good although proper treatment at the 
right time may prolong the animal’s life. In addition, other neoplasms such as 
pancreatic adenocarcinomas, osteosarcomas and pituitary adenocarcinomas were seen 
in the middle aged dogs.
Immune-mediated disease conditions, namely auto-immune thrombocytopenia 
(AITP)and auto-immune haemolytic anaemia (AIHA), were found, but less frequently 
than renal disease or neoplasia. There were four dogs between the ages of 6 to 10 
years with these conditions of which DN170 and DN207 had auto-immune 
thrombocytopenia and one dog, DN199, had AIHA. Disseminated intravascular 
coagulation was observed in one dog, DN16, of this age group. One dog with auto­
immune thrombocytopenia was observed in Group Al and another in Group A2. In 
the general population of 245 dogs studied, it was observed that 11 dogs had anaemia 
due to auto-immune conditions of which six were examined post mortem. However, 
there was a larger number of dogs with auto-immune thrombocytopenia than with
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AIHA which were examined post mortem. This may have been due to the fact that 
many cases of AITP are non-responsive to treatment. The associated bleeding 
episodes and the amount of blood loss talcing place make the mortality rate high in 
these conditions.
There were several other interesting features observed in the cases examined 
post-mortem. Auto-immune haemolytic anaemia are usually associated with marked 
reticulocytosis, although sometimes, they may be non-regenerative due to hypoplastic 
or aplastic conditions (Jones and Gruffydd-Jones, 1991). Reticulocytopenia is not 
observed very often and takes place especially when the individual's bone marrow is 
not able to compensate for the ongoing haemolytic process usually due to immune 
destruction of erythroid precursors. There was one dog, DN199, (Group A2) with a 
very severe anaemia and a PCV of 5.2%. This dog had an AIHA which eventually 
terminated in erythroid hypoplasia, the granulocytic and megakaryocytic cell lineages 
were not affected. The cause of death in this dog was the severity of the anaemia and 
the hypoplastic marrow.
A case of chronic myeloid leukaemia was observed in DN70 (Group Al). The 
clinical and haematological findings with cytochemical stains for myeloid cells in the 
peripheral blood had confirmed the presence of a myeloid leukaemia. The dog also 
had a DIC confirmed by a positive test for the soluble fibrin monomer complexes 
(SFMC) and a low platelet count of Pit. 14x 109/l. According to Evans and Gorman
(1987), a myeloproliferative disorder may be associated with thrombocytopenia which 
may be due to an immune-mediated condition.
Another rarely seen case was DN141 (Group A l), which was severely 
anaemic with a PCV of 7.9%, due to erythroid hypoplasia of the bone marrow,
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however, the aetiology was idiopathic in this case. A severe non regenerative anaemia 
with a PCV of 12.2% was present in DN48 (Group A2), which also had a thymoma. 
Histological examination of the bone marrow, revealed a hypercellular marrow with 
increased number of erythroid precursors showing dyserythropoietic features. 
According to human literature, thymomas may be seen associated with erythroid 
hypoplasia (Cotran et al, 1994a). Although this dog had dyserythropoiesis the 
presence of a thymoma may have been significant.
In this study, it was observed that the cases examined had a variety of 
pathological conditions associated with anaemia. The severity of the anaemia, in the 
cases studied, ranged from mild anaemia in dogs with PCV's in the low 30's to dogs 
with severe anaemia and PCV's less than even 10%. Severe anaemia, PCV of less than 
20%, had a higher incidence in Group A2 and was observed in six out of 25 dogs. 
Whereas only two dogs in Group A l, and only one dog in Group A3 were found to 
have severe anaemia.
The major causes of severe anaemia in the dogs of Group A2 were auto­
immune disease conditions which were found in three of the dogs.
Haemangiosarcoma was observed in two dogs with severe anaemia and 
dyserythropoiesis in one other dog. Dog DN199 in Group A2, had a PCV level of 
5.2%, and this was the lowest PCV level in the entire population of 245 dogs in this 
study. In this dog, the cause was an AIHA which terminated in an erythroid 
hypoplasia. Disseminated intravascular coagulation due to an immune-mediated cause 
was observed in DN16 (Group A2) with a severe anaemia and a PCV 14.2%.
Haemangiosarcomas may be associated with a regenerative anaemia and 
complications of DIC may also occur (Hirsch et al., 1981). This was observed in 
DN58 (Group A2) of this study. Two dogs, DN58 and DN88, in this age group had
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haemangiosarcomas with severe anaemia mainly due to blood loss within the thoracic 
cavity. Although the blood findings indicated a regenerative anaemia the prognosis in 
these two dogs was poor due metastasis of the neoplasm to vital organs.
In the younger dogs of Group A l, there was one dog, DN141, with bone 
marrow hypoplasia and a very severe anaemia with a PCV of 7.9%. A young dog 
with lymphosarcoma, DN142, was observed to have severe anaemia although the 
PCV of 19.1% was not as low as that in DN141.
There was only one dog, DN52, with severe anaemia in the group of older 
dogs (Group A3). This dog had a PCV of 6.2% and this was the second lowest PCV 
recorded in the entire population studied. The animal had a protein losing enteropathy 
and eventually also developed an acute renal failure. The severe progressive anaemia 
was probably due to co-existing marked kidney damage causing increasing uraemia 
and reduced Epo production.
In all the dogs with severe anaemia, the anaemia was considered to be a 
significant factor contributing to the animals' death. The severe anaemia was due to 
factors either directly damaging the erythrocytes membrane surface or affecting the 
production and release of erythrocytes.
A significant number of dogs, 10 out of 25 dogs, were moderately anaemic in 
Group A2, while only 4 dogs in the Group A l, and three dogs in Group A3 had 
moderate anaemias. A variety of pathological conditions were observed causing 
moderate anaemia in these dogs. The conditions that were found causing moderate 
anaemia had also been found to be associated with severe anaemia, namely immune- 
mediated diseases, haemangiosarcomas and lymphosarcomas. Lymphosarcoma was 
observed in all the age groups which were associated with moderate and severe 
anaemia depending on the pathogenesis involved. According to Moulton and Harvey
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(1990), about two thirds o f  dogs with lymphosarcoma have anaemia which may be o f
a normocytic-normochromic type.
According to Eschbach and Adamson (1985), there are many factors 
producing the anaemia of renal dysfunction. In renal diseases, anaemia may be due to 
low Epo level and increased loss o f erythrocytes through bleeding. Renal problems 
mainly cause a non-regenerative, normocytic-normochromic anaemia and the severity 
of the anaemia depends on the amount of damage to the nephrons and on the amount 
of Epo produced. In all the dogs with renal diseases in this study the degree of 
anaemia found was not severe, presumably because the disease had not affected Epo 
production drastically and the erythropoietic process had been maintained.
The major proportion of the dogs in Group A were mildly anaemic, 26 out of 
52. There were 10 dogs in Group Al, nine dogs in Group A2 and seven dogs in 
Group A3. Many of the dogs in Group Al were mildly anaemic mainly due to familial 
nephropathy although a few others had skin lesions or cardiac conditions. Neoplasms 
which were a feature of dogs in Group A2 were associated usually with a mild 
normocytic-normochromic, non-regenerative anaemia. There was one dog, DN72, 
(Group A2) with a mild anaemia due to a road traffic accident. In the older dogs 
(Group A3), mild anaemia was mainly due to chronic infections or other chronic 
conditions such as neoplasms. This type of anaemia is described collectively as 
anaemia of chronic disease (ACD).
As expected, in this study, familial renal disease conditions occurred most 
often in young dogs and these dogs were likely to be mildly anaemic. Skin diseases 
and congenital cardiac conditions were also important features in the young dogs. 
Middle aged dogs were more likely to have anaemia due to conditions such as 
immune-mediated diseases or neoplasms particularly lymphosarcoma and
168
haemangiosarcoma or chronic inflammatory and infectious conditions. In middle aged 
dogs, the anaemia was more frequently severe. While the oldest dogs, above 11 years 
of age, also suffered from chronic diseases such as neoplasia and renal failure, the 
severity of the anaemia was variable depending on the pathogenesis and the extent to 
which erythropoiesis and erythropoietin production were affected.
It appears that in clinical practice the age of an anaemic patient and the 
severity of the anaemia may give some indication as to the disease process causing the 
anaemia and may aid in the clinical diagnosis. However, certain kinds of disease 
conditions causing anaemia can affect all ages and the anaemia may not be restricted 
only to a particular age group. The population investigated in this study was small and 
care has to be taken in extrapolating these observations to the general population. 
Nevertheless, these results are interesting and have provided useful information on the 
occurrence and pathogenesis of anaemia in different age groups of dogs in the United 
Kingdom.
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CHAPTER 5
A PROSPECTIVE STUDY OF SELECTED CASES 
OF ANAEMIA IN DOGS 
PRESENTED DURING THE YEAR 1995
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5.1 Introduction
During the year 1995 interesting haematological cases were selected for study 
from the dogs referred by local veterinarians to the University of Glasgow Veterinary 
School. The selection of cases was carried out to analyse in some detail the 
haematological abnormalities found in these dogs in order to compare the findings 
with the information in the literature relating to the pathogenesis of anaemia.
In the cases chosen, the dogs were considered to be anaemic if the 
haematocrit was less than 37 percent. There were 15 cases selected in order to study 
more easily and comprehensively the haematological features which may be observed 
in cases of anaemia. The dogs were grouped according to the classification followed 
in this thesis (see 4.2.4). Most of these dogs had a moderate to severe degree of 
anaemia. However, this does not indicate that cases with a lesser degree of anaemia 
were not referred to the Veterinary School. Most of those cases were associated with 
chronic diseases or renal diseases and they have been excluded as cases for this study.
Essential data of the dogs in this study such as age, breed, sex, owners name, 
referring veterinarian were entered into the database called "Dataflex" at the case 
reception. A case number was given to every dog; and for the purpose of this study, 
they were designated as prospective cases (PC). The dogs were assigned to the 
clinician in-charge who took a history of the case and then performed a thorough 
physical examination. After the clinical examination and history taking, blood samples 
were taken for haematology and biochemistry. When a diagnosis had been made 
essential procedures for the treatment were decided by the clinician. In addition, 
arrangements were made to monitor the progress of the dog by further clinical 
examinations and blood sampling as considered appropriate.
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As part of the diagnostic procedures, blood samples were collected from the 
dog by the clinician for haematology and biochemistry. The blood samples submitted 
to the haematology laboratory were accompanied by a clinical summary and details of 
the dog. The blood samples followed the standard procedures o f the haematology 
laboratory as described in Chapter 4. A special record of the haematology and of the 
clinical progress of the dogs was made for this study. The haematological 
interpretations were made by the haematologist and the final outcome of the case was 
summarised by the clinician. In cases where the dog had a poor prognosis it was 
euthanased and a post-mortem examination was performed in agreement with the 
owner. The post-mortem and histological examinations were carried out by the 
pathologist on duty for that week.
Haematological values of all the blood samples of the cases studied have been 
recorded in Appendix D. In addition, the biochemistry reports and a report of various 
clinical signs for each case have been presented in Appendix E and Appendix F, 
respectively. When multiple blood samples had been taken from a dog, the first blood 
sample at presentation and the last sample of the series during the follow-up period 
have been shown here with some representative intervening samples. The complete 
series of samples has been shown in the Appendix D and Appendix E. The laboratory 
parameters were compared with the normal reference ranges in Appendix A: 
haematology in Table Al and biochemistry in Table A2.
Fifteen cases o f dogs with anaemia were selected. There were four cases of 
haemorrhagic anaemia, four cases o f haemolytic anaemia, three cases of 
hypoproliferative anaemia and four cases of anaemia due to neoplasia.
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5.1.1 HAEMORRRHAGIC ANAEMIA-CASE DETAILS
There were four cases in this category Case PC. 1 to Case PC.4 and the details o f the 
animals were as follows:
Case PC.l
A Boxer, 8.5 years old, male neutered.
History
The dog had been collapsed and very anaemic according to the history of the referring 
veterinarian. The dog had made a recovery but was presented at the Glasgow 
Veterinary School, as being very lethargic, pale and with knuckling of the rear paws.
Clinical Signs on Presentation
The mucous membranes were pale. The dog also had some weight loss, slight 
anorexia, polydipsia and polyuria. A slight increase in the heart rate (140 
beats/minute) with muffled heart sounds was detected. The pulse was regular and 
there were no respiratory signs.
A neurological examination was done and the local reflexes were found to be very 
slow in the right hind limb, especially in the left paw.
Radiography
A large mass was present in the ventral abdomen. There was also evidence of some 
free fluid.
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Ultrasonography
An enlarged spleen with a very irregular architecture was detected. There were 
multiple hypoechoic patches within it and no normal splenic tissue could be visualised. 
Laboratory Tests
Biochemistry: These results were all within normal ranges.
Urinalysis: This gave the following results; protein ++, blood +++, ketones +, pH 7.0, 
specific gravity 1.025.
Haematological Findings and Diagnosis
The haematological findings are shown in Table 15.
A markedly regenerative blood picture with numerous target cells, normoblasts and 
some schistocytes were seen on the blood smear.
The findings indicated blood loss and the presence of schistocytes suggested 
microangiopathy possibly due to a haemangioma or haemangiosarcoma.
Outcome
The dog died a few hours after the ultrasonography was done.
Pathological Examination
The carcass was in good body condition but with marked pallor. The abdomen was 
distended with fresh blood. The site of the abdominal haemorrhage was a large 
flattened spherical mass (15x13x13cm in size) located in the cranial pole of the 
spleen. This mass was soft, fluid in consistency and had ruptured at one point. There 
were extensive omental adhesions to the mass but there was no metastasis. Liver and 
kidney were pale, consistent with severe acute haemorrhage, but were otherwise 
normal.
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Histopathological Diagnosis
The splenic mass revealed an outer rim of compressed collagenous tissue with the 
mass itself formed out of blood. There was marked EMH in the adjacent splenic 
tissue with no evidence of any tumour mass. The splenic mass was considered to be a 
haematoma.
Diagnosis
Splenic haematoma.
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Table 15: Haematology results o fP C .l
Sample 1
R.B.C.x1012/1 3.17
Hb.g/dl 8.20
PCV% 24.10
MCVfl 76.00
MCHpg 25.80
MCHCg/dl 34.00
Plt.xl 09/l 189.00
Retie. % Not done
W.B.C.x109/1 9.60
BNeutro.xl09/l 0
Neutro.xl09/1 6.43
Lympho.xl09/1 1.20
M ono.xl09/1 0.14
Eosino.xl09/1 0.58
Baso. x l0 9/l 0
Normoblasts 1.25
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Case PC.2
A Flat Coated Retriever, 8 years old, female.
History
The dog was presented with a history of anaemia and anorexia.
Clinical Signs on Presentation
On examination the dog had pale conjunctivae and mucous membranes with no 
evidence of petechiae or ecchymoses. On palpation the abdomen was “lumpy” .
Radiography
On radiography the liver was normal but the spleen was slightly enlarged but smooth 
in contour.
Laboratory Tests
Biochemistry: The total bilirubin concentrations were elevated on the two occasions 
when the blood sample were taken. The values were 16 (amol/1 and 33 pmol/l, 
respectively.
Haematological Findings and Diagnosis
Haematological findings are presented in Table 16.
Sample 1 (day 0)
Anaemia, thrombocytopenia and a slightly regenerative blood picture with occasional 
schistocytes, many target cells, and large platelets were present suggesting a blood 
loss. Possibly an internal blood loss which would explain the raised bilirubin. The 
direct Coombs' test was negative.
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Subsequent samples showed a slightly regenerative blood picture with some large 
platelets, occasional schistocytes and many target cells. It was suggested that the 
thrombocytopenia may have been caused by increased splenic sequestration or 
increased consumption of platelets.
Bone Marrow Aspirate
There was an erythroid hyperplasia due to increased red cell production. Red cell 
precursors were present at all stages of differentiation.
Spleen Biopsy Report
A splenectomy was done and sent for biopsy. In the red pulp of the spleen a massive 
histiocytic reaction was found. The histiocytes contained red cells and red cell 
fragments. Mitotic figures were noted in these cells and there was also marked 
erythropoiesis and focal thrombosis causing infarcts.
Diagnosis
Hypersplenism and splenic infarction. “Neoplasia should not be ruled out” .
Outcome
Although no obvious cause for haemolysis could be found clinically or historically on 
the basis of the raised bilirubin levels a provisional diagnosis of immune-mediated 
haemolytic anaemia was made by the clinicians. However, the Coombs' test was 
negative. Immunosuppressive therapy was carried out with blood transfusions, the 
dog did not respond and was worsening and therefore it was decided to euthanase the 
dog.
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Pathological Examination
At necropsy the carcase was pale. Liver, kidneys and heart were pale. There was 
excessive fluid in the abdomen and thorax. Lungs were congested and oedematous. 
Bone marrow was fleshy and red.
Histopathological Diagnosis
Microscopically, an active marrow with normal red cell maturation was found. There 
was oedema and haemorrhages in the lung with microthrombi and infarcts in the 
kidney. The cause of the increasing anaemia and thrombocytopenia could not be 
established and a diagnosis of DIC causing the anaemia was made.
Diagnosis
Disseminated intravascular coagulation causing anaemia.
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Table 16 : Haematology results o f  PC . 2
Sample * 
Days after 
Sample 1
1
0
3
3
(before splenectomy)
5
5
6
6
7
10
R.B.C.x1012/1 1.90 1.13 2.57 2.32 1.96
Hb.g/dl 4.40 2.80 6.00 5.30 4.50
PCV% 13.90 9.00 18.60 16.40 14.20
MCVfl 73.00 80.00 72.00 71.00 72.00
MCHpg 23.10 24.70 23.30 22.80 22.90
MCHCg/dl 31.60 31.10 32.20 32.30 31.60
Plt.xl09/1 8.00 6.00 53.00 49.00 14.00
Retie.% 0 0 0.02 0 0
W .B.C.xl09/l 5.90 9.30 12.70 11.50 7.70
BNeutro.xl09/l 0.15 0.28 0.19 0.11 0
Neutro.xl09/1 4.84 7.58 11.43 10.35 7.01
Lympho.xl09/1 0.47 0.32 0.13 0.11 0.27
M ono.xl09/1 0.35 0.98 0.95 0.92 0.19
Eosino.xl09/1 0 0 0 0 0
Baso. x l0 9/l 0 0 0 0 0
Normoblasts 0.09 0.14 0 0 0.23
intervening samples are shown in Appendix D.
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Case PC.3
A German Shepherd dog, 3.5 years old, male castrated.
History
The dog had chronic hip dysplasia and in the last 12 months had been on the drug 
Ibuprofen.
Clinical Signs on Presentation
There were weight loss, lethargy, dullness and reluctance to stand and polydipsia. The 
mucous membranes were very pale. After rectal examination occult blood was present 
on the gloves. The hair of the animal’s coat was out of condition. A nasal discharge 
was seen which was more marked from the left nostril than from the right. There was 
no evidence of any gross haemorrhages. The lymph nodes were slightly enlarged.
Laboratory Tests
Biochemistry: Findings were unremarkable.
Haematological Findings and Diagnosis
Haematological findings are in Table 17.
Examination of the blood samples revealed a microcytic hypochromic anaemia with a 
slightly regenerative blood picture, pale target cells and reactive thrombocytosis. 
These findings were consistent with a chronic blood loss.
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Outcome
A diagnosis of gastric ulceration due to the long term treatment with Ibuprofen 
(NSAID) leading to chronic blood loss and iron deficiency anaemia was made. The 
dog was sent home with medications o f cimetidine, iron tablets and sucralfate. 
Diagnosis
Drug-induced gastric ulceration leading to chronic blood loss and iron deficiency 
anaemia.
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Table 17 : Haematology results o f  PC.3
Sample * 1 2 3 4 5 6
Days after Sample 1 0 4 6 8 11 15
R.B.C.x1012/1 4.36 4.140 3.48 3.80 4.330 5.830
Hb.g/dl 6.00 5.30 4.20 5.00 6.30 9.20
PCV% 21.30 19.20 16.60 18.60 21.70 29.90
MCVfl 49.00 46.00 48.00 49.00 50.00 51.00
MCHpg 13.70 12.80 12.00 13.10 14.50 15.00
MCHCg/dl 28.10 27.60 25.30 26.80 29.00 30.00
Plt.xl09/1 360.00 620.00 579.00 593.00 585.00 639.00
W.B.C.xl09/l 25.60 8.90 10.90 11.40 5.50 7.50
BNeutro. 0.13 0 0 0.28 0 0
Neutro.xl09/1 22.53 5.83 8.72 9.46 3.22 4.61
Lympho.xl09/1 0.64 1.42 1.20 1.25 1.13 1.31
M ono.xl09/1 2.18 1.29 0.71 0.34 0.44 0.49
Eosino.xl09/1 0.13 0.36 0.27 0 0.72 1.09
Baso. x 109/l 0 0 0 0 0 0
intervening samples are shown in Appendix D.
183
Case PC.4
A Labrador cross, 11 years old, female spayed, weight 26.5 kgs.
History
The dog had been intermittently anorexic and had been very lethargic with a very 
slow gait. There were two haematology and one biochemistry tests done by the 
referring veterinarian. The two haematology test results were enclosed. The first test
showed the following results: PCV. 23.3%, Hb. 7.9g/dl, Pits. 73x10^/1, leucocytes
9
12.9x10 /l, and Reties. 0.3%. In the second blood sample the haematocrit decreased 
significantly (16.3%), however, the platelet numbers were within normal ranges
9
453x10 /I.The biochemistry reports showed a very high serum Alk.Phos.
concentration of 543 IU/1. The dog had been on some amount of steroid and vitamin 
B12 treatment, however, the anaemia and anorexia seemed to have got worse and it 
was thought advisable to refer the dog here to the Veterinary Hospital.
Clinical Signs on Presentation
The dog was dull and lethargic. The abdomen felt ascitic on balottement. The mucous 
membranes were pale.
Radiography
Significant findings were of a bulge of the caudoventral abdominal wall caused by soft 
tissue mass. The gastric axis was rotated caudally by a soft tissue density in the cranial 
abdomen protruding beyond the right costal arch.
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Radiography Diagnosis
Hepatomegaly.
Ultrasonography
Enlarged diffuse hepatomegaly, large gall bladder and an increase in the echogenicity 
around the bile duct.
Laboratory Tests
Biochemistry: The concentrations of the serum ALT were high 180 IU/1 and serum 
alkaline phosphatse was extremely high 6930 IU/1 which may have been due to the 
steroids. Bile acids pre-prandial was 0.1 mmol/1 and post-prandial was 44.4 mmol/1. 
The amylase test was 2534 IU (normals: 510-1589 IU) and lipase was 546 IU 
(normals: 0-1004).
Urine test: The results were: proteins ++, some haematuria and leucocytes in the 
urine, pH 7.5 and specific gravity of 1.025.
Haematological Findings and Diagnosis
Haematological findings are in Table 18.
Sample 1
A slightly regenerative blood picture was seen showing marked poikilocytosis and a 
few schistocytes. The size of the platelets was large and many of them formed 
aggregates. Blood findings suggested a blood loss and the presence of schistocytes 
was thought to be due to a neoplasm or thrombosis.
Sample 2 (day 2)
The fibrinogen content of the blood was normal, 370 mg/dl. The normal range is 150- 
400 mg/dl. Coagulation tests failed to reveal any abnormalities.
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Prothrombin time of the blood sample was 8 seconds when compared to the control 
sample of 12 seconds. This test measures the status of the extrinsic coagulation 
pathway and it is performed for monitoring patients with hepatic disease or DIC. 
Kaolin cephalin clotting time of the test blood sample was 21 seconds compared to a 
control of 22 seconds. This test is essential to detect any abnormalities in the intrinsic 
coagulation pathway.
The dog had positive (++) soluble fibrin monomer complexes and this confirmed the 
presence of a thrombotic condition.
Sample 3 (day 7)
The blood picture remained regenerative with poikilocytes, a few schistocytes and 
with an increase in platelet size. As the anaemia did not improve a blood transfusion 
was advised.
Sample 4 (day 8)
After the blood transfusion anaemia seemed to have improved but poikilocytes and 
schistocytes were still present.
The anaemia appeared to be due to a blood loss. However, no tumour mass could be 
found. The diagnosis o f hepatomegaly was made by the clinicians.
Diagnosis
Hepatomegaly unknown aetiology was diagnosed .
Outcome
As the dog seemed to have improved after the blood transfusion, it was sent home on 
medications and was advised by the clinician to be treated with multivitamin injections 
and a small dose of prednisolone. No further follow-up was possible.
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Table 18 : Haematology results o f  PC.4
Sample *
Days after Sample 1
1
0
2
7
3
8
(after blood transfusion)
R.B.C.xlO 12/1 2.53 2.59 4.47
Hbg/dl 7.20 7.90 10.10
PCV% 19.40 19.10 32.60
MCVfl 77.00 74.00 73.00
MCHpg 28.40 30.50 22.50
MCHCg/dl 37.10 41.30 30.90
Pit x l0 9/1 410.00 522.00 396.00
Reties. % 0.01 0.05 0.01
W.B.C. x l 0 9/I 19.50 22.90 19.00
BNeutro.xlO 9/l 0.49 0.00 0.57
Neutro.xlO 9/l 13.85 20.95 17.77
Lympho.xl09/1 3.80 1.37 0.57
Mono. xlO 9/l 0.88 0.34 0.10
Eosino. xlO 9/l 0.01 0.11 0.00
Baso. xlO 9/l 0.00 0.00 0.00
Normoblasts 0.01 0.11 0.00
Metamyelocytes 0.097 0.00 0.00
*Intervening samples are shown in Appendix D.
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5.1.2 HAEMORRHAGIC ANAEMIA-DISCUSSION
Four cases of haemorrhagic anaemia were presented during the course o f this 
study. Splenic haematoma was seen in PC.l, whereas, case PC.2, was unusual and the 
cause of the anaemia remains unclear. PC.4 was diagnosed of having hepatomegaly, 
however, no particular cause could be found. Of these three dogs with haemorrhagic 
anaemia two had a poor prognosis due to the aetiology and severity of the anaemia 
and one was sent home on medications.
Chronic haemorrhagic anaemia as a result of gastrointestinal ulceration was 
seen in one case, PC.3. It was drug-induced and the dog had a good prognosis. The 
conditions causing haemorrhagic anaemia in these dogs are discussed below.
Splenic haematoma
Splenomegaly may be due to a number of diseases which may be 
inflammatory, infiltrative, suppurative or neoplastic. In a study on splenomegaly, by 
Couto (1990), of the 42 dogs which were splenectomised, 36 percent had 
haematomas and according to the author it seemed to be one o f the commonest types 
of splenic masses. According to another study on splenomegaly by Wrigley et al., 
(1989), of the 89 dogs studied, 10 had splenic haematomas. The authors considered 
that the attention given to haemangiosarcomas resulted in haematomas being rarely 
diagnosed.
Splenic haematomas, which are large, are usually formed as a result of 
intermittent haemorrhages within the mass. This may cause anaemia of a varying 
severity depending on the extent of blood loss. In PC.l, there was a large abdominal
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mass diagnosed as a splenic haematoma on ultrasonography. A sudden rupture of the 
haematoma resulted in abdominal haemorrhage which was confirmed post-mortem. It 
is known that a sudden haemorrhage does not cause an immediate fall in the PCV as 
haemodilution takes time to develop. In this case, the blood loss was subclinical at 
first, but eventually increased after the rupture of the haematoma causing 
hypovolaemic shock.
The disease conditions affecting the spleen are known to greatly influence the 
haematological findings (Couto, 1990). In this case, the anaemia was haemorrhagic 
with all the features of blood loss. In addition, there was a decrease in the platelet 
numbers. However, no marked changes in the leucocyte parameters were seen. Blood 
passing through a splenic haematoma as well as fibrin deposits which could have been 
present may have caused the fragmentation of the erythrocytes resulting in 
schistocytes. Extramedullary haemopoiesis may be seen in the conditions affecting the 
spleen resulting in a leuco-erythroblastic blood picture (Neer, 1996). In PC.l only 
normoblasts were present in an increased number and a left shift o f neutrophils was 
not seen.
According to Couto (1990), clinical signs of polydipsia and polyuria are 
frequently seen in dogs with splenomegaly. He considered these to be probably 
psychogenic due to the abdominal distension or pain. These observations were also 
seen in this particular case (PC.l). Case PC.l did not have any marked changes in the 
serum biochemistry which is consistent with the observations of other researchers. 
The haematological findings in this case were similar to those described in dogs with 
splenic haematomas and the lesion was confirmed by post-mortem examination.
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Hypersplenism and DIC
In cases of haemolytic anaemia the clinical signs most frequently seen are 
haemolysed plasma, hepatosplenomegaly, jaundice and occasional haemoglobinuria. 
The haematological findings include a markedly regenerative blood picture with 
normoblastosis, and a marked leucocytosis; spherocytes may also be present. 
Inaddition, there is often a raised unconjugated bilirubin level (Jones and Gruffydd- 
Jones, 1991; Dodds, 1983). The above clinical and haematological findings were not 
present in case PC.2 except for a high total bilirubin level. The initial haematology 
reports prompted the consideration of an auto-immune haemolytic anaemia and a 
possible immune-mediated thrombocytopenia. However, the Coombs' test was 
negative and there were no spherocytes both of which are features of auto-immune 
haemolytic anaemia. There was also no response to the immunosuppressive therapy 
where a splenectomy was performed. Splenectomy can have a beneficial effect on 
dogs with immune-mediated haematological diseases and this had been examined in 
dogs in a study by Feldman et al., (1985). In their study, the dogs did survive longer 
after splenectomy although the underlying mechanism was not elucidated.
After splenectomy, in case PC.2 there was no improvement in the anaemia and 
thrombocytopenia, so the diagnosis of hypersplenism and associated splenic 
sequestration could not entirely explain the thrombocytopenia. To complicate this 
case further, the post-mortem findings of haemorrhages and microthrombi in the lungs 
and infarcts in the kidney were interpreted as the result o f an underlying DIC. The 
mechanism for a DIC to occur is a systemic intravascular activation of the blood 
coagulation mechanism together with activation of the fibrinolytic system, as the 
result of the exposure of blood to abnormal surfaces and the entry of thromboplastic
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material into the circulation (Slappendel, 1988; Legendre and Krehbiel, 1977). There 
are a number of factors which will cause DIC and amongst them sepsis, neoplasms, 
liver diseases, complications of gynaecology are the most important causes (Bell, 
1994). The major feature of an uncompensated DIC is haemorrhage which may be in 
the form of ecchymoses, petechial haemorrhages or frank bleeding from a variety of 
sites, in addition to shock and hypoxia (Bell 1994). In this complicated case of dog 
PC.2, no overt signs of haemorrhages were found to explain the anaemia. The dog 
was not tested for FDP’s but the presence of schistocytes reflected microangiopathy 
caused apparently by a compensated DIC which may have been induced by an 
underlying neoplastic process. In the biopsy report, histiocytes were present and a 
histiocytic neoplasm could be a possible cause of the hypersplenism. Taking this into 
account, the clinical and haematological findings could be best explained if the dog 
had a systemic malignant histiocytosis type condition which is associated with 
anaemia and thrombocytopenia caused by the phagocytic activity of the neoplastic 
histocytes. This condition has been reported in dogs (Madewell and Feldman, 1980).
Chronic haemorrhagic anaemia
Chronic haemorrhagic anaemia is a consequence of an ongoing blood loss 
which sometimes goes undiagnosed for a long time until other supporting clinical 
signs appear. There are a number of conditions which can cause chronic haemorrhagic 
anaemia and gastrointestinal ulceration due to drugs can be one of the commonest 
causes. Certain drugs are known for their deleterious effects on the gastrointestinal 
tract, most often resulting in gastroduodenal ulcerations (GDU). The most 
commonest causes of GDU as a result o f drug usage are non-steroidal anti-
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inflammatory drugs (NSAID) some of which have been cited by Cosenza (1984). 
These drugs are known to cause GDU by inhibition of prostaglandin synthesis which 
decreases the mucosal blood flow and alters mucus production (Stanton and Bright, 
1989).
In a study by Stanton and Bright (1989), of 43 dogs with non-neoplastic 
gastric or duodenal ulcerations 32 had anaemia. In this study, dog PC.3, had a history 
of hip dysplasia and had been prescribed the drug Ibuprofen, a NSAID. This case had 
similar clinical signs to those of the cases described by Cosenza (1984). These clinical 
signs were melaena, pallor, weight loss and polydipsia. According to Stanton and 
Bright (1989), haematemesis or melaena are strongly suggestive of gastric or 
duodenal mucosal erosion or ulcerative disease. The history and the haematological 
observations confirmed the aetiology of this case.
A non-regenerative anaemia was a common finding in the dogs with ulcers in 
the study by Stanton and Bright (1989), but a microcytic, hypochromic anaemia was 
seen in one fourth of the cases studied. Case PC.3 had a slightly regenerative anaemia 
with an increase in platelet numbers, and in the first sample, an increase in the 
leucocytes, especially band neutrophils, which may have been caused by myeloid 
hyperplasia which accompanies erythroid hyperplasia in an ongoing blood loss. In 
subsequent blood samples there was a decrease in the MCV and MCHC and a 
diagnosis of microcytic hypochromic anaemia was confirmed.
The anaemia in this particular case was a result of chronic blood loss causing 
loss of iron and the development of iron deficiency. Prophylaxis and supportive 
treatment with antacids for ulcers usually resolves the problem. Case PC.3 made a 
good recovery after this type of therapy had been started.
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Hepatomegaly
Hepatomegaly in dogs can result from passive congestion, infiltrative disorders, 
inflammatory disease, reticuloendothelial hyperplasia, neoplasia, extrahepatic bile duct 
occlusion and cystic liver disease. This may lead to a variety of changes in the 
haematology of dogs with hepatic disease. The liver is the main organ for the 
synthesis of the coagulation proteins (Green, 1981). Any disturbance in the normal 
functioning of the liver may lead to some degree of haemostatic abnormality. In dogs 
however, only a severe hepatic disease, such as cirrhosis would cause a haemorrhagic 
problem.
In this particular case, PC.4 the anaemia was always regenerative with a slight 
neutrophilia which may have been reactive or may been caused by an underlying 
infection. Small numbers of schistocytes and poikilocytes were also present 
suggesting a neoplastic or thrombotic condition, but no neoplasm was found in this 
case.
The platelet numbers were within the normal ranges, although on one occasion 
it was high possibly due to splenic contraction. Slightly increased fibrin monomer 
levels were found indicating some degree of fibrinolysis, possibly due to the 
thrombosis. They were not high enough to consider DIC as a cause of haemorrhage. 
The normal platelet counts and the normal coagulation tests also excluded DIC. 
Taking everything into consideration it would seem most appropriate to diagnose a 
haemorrhagic anaemia and thrombosis although the underlying cause remains unclear.
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5.1.3 HAEMOLYTIC ANAEMIA-CASE DETAILS
There were four cases in this category Case PC. 5 to Case PC. 8 and the details of the 
animals were as follows:
Case PC.5
A Jack Russell Terrier, 3 years old, female spayed, weight 7.3 kg.
History
Five days ago the dog had become dull, weak anorexic and recumbent. The owners 
noticed very dark coloured urine and that her eyes were slightly swollen.
Clinical Signs on Presentation
A strong bounding pulse was palpable and on auscultation a grade I and II heart 
murmur was heard on the right and left side of the chest. The mucous membranes 
were pale and slightly icteric. The dog was very weak when standing.
Laboratory Tests
Biochemistry: The results that were significant were an increase in the concentrations 
of urea 9.6 mmol/1, total bilirubin 32 pmol/1, and serum Alk.Phos. 417 IU/1. 
Haematological Findings and Diagnosis 
The haematological findings are shown in Table 19.
The direct Coombs’ test was weakly positive. A markedly regenerative blood picture 
was detected with normoblasts, spherocytes and auto-agglutination of red cells. The 
MCV was very high. Neutrophilia with a left shift was seen as well as a monocytosis
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and lymphopenia due to haemolysis and steroids. These findings were consistent with 
IgG type AIHA.
Outcome
This was a typical case of an acute auto-immune haemolytic anaemia. Since the dog 
was deteriorating in condition and the prognosis was not very good, it seemed better 
to the clinicians to euthanase the dog.
Pathological Examination
At necropsy the dog was in good bodily condition and the subcutaneous fat and 
mucous membranes appeared yellow in colour. The spleen was enlarged and fleshy 
red in texture whereas the gall bladder was distended with normal bile and the liver 
was apparently normal. Kidneys were normal too.
Histopathological Diagnosis
Microscopic examination of the spleen revealed extensive necrosis of the red pulp 
with macrophages showing marked erythrophagocytosis and containing haemosiderin. 
There was marked EMH also in the splenic tissues. Marked erythrophagocytosis was 
also present in the liver resulting in the formation of haemosiderin which was seen in 
increased amounts in the Kupffer cells. The pattern of the splenic necrosis together 
with the limited change in the liver and kidney would fit with the recent and sudden 
breakdown of the red cells.
Diagnosis
Auto-immune haemolytic anaemia IgG type.
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Table 19 : Haematology results o f  PC. 5
Sample 1
R.B.C.xlO 12/1 1.07
Hb.g/dl 2.80
PCV% 9.90
MCVfl 93.00
MCHpg 26.10
MCHCg/dl 28.20
Pit x 10 9/1 231.00
W.B.C. x l 0 9/l 62.10
BNeutro.xlO 9/1 2.48
Neutro.xlO 9/1 56.20
Lympho.xl09/1 0.93
Mono. xlO 9/l 1.24
Eosino. x 10 9/l 0
Baso. xlO 9/1 0
Normoblasts 0.31
Metamyelocytes 0.93
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Case PC.6
An Airedale Terrier, 8 years old, male.
History
About a year ago the dog had a history of lethargy, pyrexia, anaemia and was treated 
symptomatically. The dog was ill again with an enlarged spleen on palpation and with 
polydipsia, haemoglobinuria, lethargy and anorexia. Anaemia was also detected. The 
dog was treated again symptomatically, however there was another third relapse and 
at this time the dog was referred to the Veterinary Hospital with this history.
Clinical Signs on Presentation
The dog’s mucous membranes were very pale and the dog had a bounding femoral 
pulse. No haemic cardiac murmurs were evident. The dog did have some cervical pain 
and difficulty in walking. It was hyperpnoeic and tachypnoeic with very harsh lung 
sounds on auscultation. The dog was dysuric too. Abdominal palpation provided a 
tentative diagnosis of splenic enlargement.
Radiography
Lateral abdomen: The liver shadow extended well beyond the costal arch yet 
retained a sharp caudal border. The spleen was visible ventrally and although it was 
not enlarged it did have rounding of its margins. There was a very large mass in the 
caudal abdomen which was most likely the bladder and a second irregular smaller 
mass from the pelvic inlet. A diagnosis of hepatomegaly was made.
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Ultrasonography
Nothing significant was observed on ultrasound of the spleen and bladder, although 
the liver revealed an enlarged, diffuse, regular increase in echogenicity. The 
ultrasound diagnosis of a cellular infiltrate or a generalised fibrous tissue deposition in 
the liver was made.
Laboratory Tests
Biochemistry: This revealed a moderate increase in urea concentrations (21 mmol/1), 
along with an increase in liver enzyme serum ALT (289 IU/1).
Urine and faeces examination: Moderate amount of blood which may be 
haemoglobinuria due to haemolysis 
Haematological Findings and Diagnosis
The haematological findings are shown in Table 20.
Sample 1
Examination of the blood film showed marked a regenerative blood picture with 
marked poikilocytosis and normoblastosis. Neutrophilia with a left shift was also seen 
probably due to a reactive bone marrow. The Coombs' test was positive.
Sample 2 and subsequent samples
A moderately regenerative blood picture, pale target cells and many schistocytes were 
found. The differential count probably reflected steroid effect. The blood in the urine 
and faeces, the presence of schistocytes, pale target cells and the modest regeneration 
were consistent with blood loss due to neoplasia which may have been lymphoid and 
may have induced the AIHA too.
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Bone Marrow Aspirate
It was decided by the clinicians to examine the bone marrow. There were numerous 
red cell precursors at all stages of differentiation with adequate numbers o f 
megakaryocytes and granulocyte precursors. The sample had a poor cytology and it 
was also diluted with blood which showed regenerative feature and some 
schistocytes.
Outcome
The dog was sent home with treatment for the auto-immune haemolytic anaemia and 
haemorrhage with a guarded prognosis.
Diagnosis
Auto-immune haemolytic anaemia and blood loss due to an underlying unknown 
neoplasm was diagnosed.
199
Table 20 : Haematology results o f  PC.6
Sample 1 2 3 4
Days after Sample 1 0 16 22 79
R.B.C.x1012/1 2.40 2.26 1.93 5.89
Hb.g/dl 6.70 6.10 5.10 11.70
PCV% 22.00 20.40 16.80 39.90
MCVfl 92.00 90.00 87.00 68.00
MCHpg 28.00 26.60 26.40 19.80
MCHCg/dl 30.00 29.90 30.30 29.30
Plt.xlO9/! 0 292.00 219.00 420.00
Retie. % not done not done 0.04 not done
W.B.C.x109/1 18.20 27.60 8.90 12.20
BNeutro.xl09/l 12.00 0.83 0.22 0
Neutro.xl09/1 11.60 23.87 7.7 8.11
Lympho.xl09/1 6.00 0.41 0.67 3.11
M ono.xl09/1 0.40 2.35 0.27 0
Eosino.xl09/1 0.20 0 0.04 0.47
Baso. x l0 9/l 0 0 0 0.12
Normoblasts 0 0.14 0 0
Zero for platelet indicates platelet aggregates.
200
Case PC.7
A German Shepherd cross, 4 years old, male castrated.
History
During the last three days the dog had been very dull, lethargic, anorexic and had lost 
a lot of weight.
Clinical Signs on Presentation
The dog was weak and dull with pale mucous membranes. There were hyperpnoea, 
and tachycardia but no cardiac murmurs.
Radiography
There was slight hepatomegaly.
Laboratory Tests
Biochemistry: There was an increase in the urea 11.8 mmol/1, cholesterol 9.1mmol/l, 
total bilirubin 16 pmol/1, Alk.Phos. 431 IU/1, ALT 88 IU/1 and AST 111 IU/1 
concentrations.
Haematological Findings and Diagnosis
The haematological findings are shown in Table 21.
Sample 1
The direct Coombs' test was positive indicating IgG class auto-antibodies. The blood 
picture showed all the features typical of auto-immune haemolytic anaemia i.e. 
anisocytosis, polychromasia, spherocytosis and auto-agglutination. The latter 
indicated high antibody concentration.
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Fibrinogen was slightly increased, 512 mg/dl. The normal range is 150-400 mg/dl. 
Sample 2
The dog was still anaemic. The blood picture still showed regenerative features i.e. 
Howell-Jolly bodies and occasional normoblasts.
Outcome
The dog was treated here with prednisolone and azathioprine until the haemolytic 
anaemia resolved and sent home with amoxycillin antibiotics.
Diagnosis
Auto-immune haemolytic anaemia IgG type.
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Table 21: Haematology results o f  PC. 7
Sample 1 2 3
Days after Sample 1 0 8 22
R.B.C.xlO 12/1 1.39 2.87 5.43
Hbg/dl 4.00 8.00 13.50
PCV% 13.00 26.50 43.50
MCVfl 93.50 92.00 80.00
MCHpg 28.70 27.80 24.80
MCHCg/dl 30.80 30.10 31.00
Pit x l0 9/1 117.00 207.00 485.00
Retics.% not counted 20.50 not counted
W.B.C. x l 0 9/l 87.00 35.10 11.80
BNeutro.xlO 9/l 13.92 0.53 10.03
Neutro.xlO 9/l 57.85 28.78 0
Lympho.xl09/1 1.31 2.11 0.85
Mono. xlO 9/l 6.96 1.93 0.47
Eosino. xlO 9/l 0.44 0 0.47
Baso. xlO 9/l 0 0 0
Normoblasts 6.55 1.75 0
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Case PC.8
A Cross bred dog, 1.5 years old, female spayed, weight 14 kg.
History
The dog had a long history which started initially with a fracture of the left humerus 
which was stabilised by interosseous bone pining. Recovery was good but the dog 
seemed in more pain than expected and the pin was removed and replaced with a 
plate with screws, as the fracture healed. Subsequently the dog was presented at the 
Veterinary School with a history of pyrexia.
Clinical Signs on Presentation
The dog was very lethargic with anorexia. Mucous membranes were very pale and the 
dog had a temperature of 39.9°C. On abdominal palpation an enlarged spleen was 
felt.
Laboratory Tests
Biochemistry: There was a marked increase in the total bilirubin 21 pmol/1, Alk.Phos. 
889 IU/1, A L T. 217 IU/1 and A S T 216 IU/1 in the first samples. Subsequent serum 
samples also showed a marked increase in the Alk.Phos., ALT. and AST. levels. 
Values of subsequent samples are shown in the Appendix E.
Urine Test : proteins and blood were present.
Haematological Findings and Diagnosis
The haematological findings are shown in Table 22.
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Sample 1
The direct Coombs' test was positive. A regenerative blood picture was seen with 
spherocytosis, auto-agglutination of the spherocytes and normoblastosis. Reactive 
neutrophilia with a left shift was also present. These findings were indicative of an 
auto-immune haemolytic anaemia of the IgG type. Marked decrease in the platelet 
numbers was also seen.
Sample 2
There was a markedly regenerative blood picture with a marked increase in the 
spherocyte numbers. An increase in the MCV was also present due to the 
reticulocytosis. The platelet numbers were still decreased.
Subsequent samples showed spherocytosis indicating an ongoing auto-antibody 
activity which seemed to affect the platelet numbers too. A slightly regenerative blood 
picture was seen but with schistocytes and many target cells. The presence of 
schistocytes suggested a thrombotic condition and the target cells possibly reflected 
steroid effect on the liver.
A diagnosis of an auto-immune haemolytic anaemia and an immune-mediated 
thrombocytopenia was made.
Outcome
The dog was on a high dose of prednisolone and azathioprine. Unfortunately there 
was a very poor response. It was decided to give the dog a blood transfusion. 
Following the transfusion there was a gradual improvement in the anaemia and 
thrombocytopenia and the drug doses were gradually lowered. However, the dog also
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developed severe lameness of the left forelimb, and osteomyelitis. It was decided to 
euthanase the dog.
Pathological Examination
On post-mortem examination the carcase was in a good condition. On examination of 
the abdomen the jejunum was dark red in colour, swollen, turgid and the contents 
were blood stained. The mesentry was also dark red and haemorrhagic. The liver was 
pale and friable. The spleen was small and the splenic vein contained a well organised 
thrombus.
Histopathological Diagnosis
Microscopy revealed the liver to have some amount of centrilobular fatty change with 
superimposed marked necrosis. Necrosis was also seen in the kidney. The intestinal 
architecture was well preserved despite the haemorrhage and congestion. The splenic 
vein thrombus was well organised and the spleen was small with an acellular red pulp. 
No evidence of EMH was seen.
The reason for deterioration in the dog’s condition was circulatory collapse with 
pooling of blood in the jejunum. However, the underlying aetiology was unclear. The 
liver collapse, possibly related to the anaemia and or therapy. The splenic thrombosis 
has been present for some time.
Diagnosis
Auto-immune haemolytic anaemia and thrombocytopenia. Haemorrhagic enteropathy 
and shock.
206
Table 22 : Haematology results o f  PC. 8
Sample * 1 2 3 4 11 14
Days after Sample 1 0 1 5 7 54 72
R.B.C.xlO 12/1 0.83 0.51 1.19 1.44 4.69 4.73
Hbg/dl 3.30 2.60 4.10 4.40 13.00 13.00
PCV% 10.50 9.30 13.30 14.8 37.80 37.50
MCVfl 127.00 182.00 112.00 103.00 81.00 79.00
MCHpg 39.70 50.00 34.40 30.50 27.70 27.40
MCHCg/dl 31.40 27.90 30.80 29.70 34.30 34.60
Pit xlO 9/l 16.00 10.00 5.00 11.00 431.00 257.00
W.B.C. x 10 9/l 89.20 70.20 33.20 36.40 23.70 16.80
BNeutro.xlO /^1 8.47 2.80 2.98 1.82 0 0
Neutro.xlO 9/1 70.46 54.05 25.89 26.57 21.92 0.08
Lympho.x 10 /^1 0.89 0.70 0.66 0.73 0.12 15.29
Mono, x 10 9/l 1.78 4.56 1.66 5.46 1.66 0.84
Eosino. x 10 9/l 0 0 0 1.36 0 0.50
Baso. x 10 9/l 0 0 0 0 0 0.084
intervening samples are shown in Appendix D.
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5.1.4 HAEMOLYTIC ANAEMIA-DISCUSSION
The four cases presented in this study were all examples of auto-immune 
haemolytic anaemia (AIHA). Auto-immune haemolytic anaemia can be primary 
(idiopathic) or secondary when it is seen in association with a number o f disease 
conditions (Jain, 1993e; Dodds, 1983; Halliwell, 1978). The primary cases have been 
described as acute because of their sudden onset whilst the secondary causes are 
chronic because of the more insidious onset. A history of a sudden onset, was seen in 
PC.5 and PC.7 and this suggested an idiopathic cause. This was similar to the findings 
o f Halliwell (1978), who describes the dogs as being in an acute haemolytic "crisis" 
and this was known to have a poor prognosis. In PC.6 however the history was of a 
slow onset and a suspected neoplasm may have triggered this event. In PC.8 the 
anaemia seems to have been associated with the bone pinning and antibiotics.
The diagnosis of AIHA is mainly based on the positive direct Coombs’ test in 
addition to certain typical haematological findings. All the dogs in this study had 
features of a regenerative anaemia, such as polychromasia, anisocytosis, 
normoblastosis, Howell-Jolly bodies. Neutrophilia with a left shift and increased 
W.B.C count were also observed which are features of this type of anaemia (Dodds 
1983). Spherocytosis and auto-agglutination of red cells are also characteristic 
findings associated with auto-immune haemolytic anaemias. Warm antibodies can 
produce auto-agglutination which may be IgM, IgG and IgM or high amounts o f IgG 
alone. Alternatively, agglutination be caused by high amplitude cold antibodies which 
are always IgM class. Spherocytosis and auto-agglutination were seen in all the cases 
described here and all of them were direct Coombs’ test positive indicating that the 
AIHA was caused by IgG class auto-antibodies.
208
The commonest clinical signs in all these cases, were increased dullness and 
pallor, occasional icterus and haemoglobinuria. These observations were consistent 
with the clinical signs described in the literature (Dodds 1983; Halliwell, 1978). 
Distinct cardiac murmurs (Grade I and II) were present in PC.5 which was probably 
due to the severity of the anaemia resulting in a PCV. 9.9%. This dog (PC.5) was 
presented in an acute haemolytic “crisis” with a high bilirubin of 32mmol/l. Changes 
in the serum biochemistry of all these dogs included a significant increase in the 
bilirubin associated with increased erythrocyte destruction, and the marked increase in 
the serum alkaline phosphatase may have been due to the effect of steroids on the 
liver.
Schistocytes were present in two cases PC.6 and PC.8. Schistocytes are 
usually seen in MAHA and are caused by excess fibrin deposition in the 
microvasculature which may be systemic (DIC) or localised. In PC.6 a neoplasm was 
suspected. In PC.8, the schistocytes appearing in the subsequent samples were 
suggestive of a thrombotic condition and may have been associated with the 
developing osteomyelitis. It was noted that in PC.7 an increase in the fibrinogen 
content of the blood was present similar to the cases reported by Ward (1983).
The prognosis of affected dogs is usually difficult to assess and depends not 
only on the amount of erythrocyte destruction but also on the regenerative capacity of 
the bone marrow. Treatment of these cases is usually with high doses of steroids or 
immunosuppressive therapy such as using azathioprine or cyclophosphamide. 
Splenectomy can also be considered as a form of treatment (Cotter, 1995)
A post-mortem examination was performed on two dogs. In PC.5, evidence of 
splenic erythrophagocytosis and marked EMH was found. In the case of PC.8
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haemorrhage and circulatory collapse due to shock were the main cause of death, in 
addition to the haemolysis.
According to Jain (1993e), Jackson and Kruth (1985), there is no particular 
breed predilection for this condition and this was in accord with all these prospective 
cases. The average age of all the dogs affected was 4.1 years and was similar to the 
findings by Dodds (1983) and many other researchers. According to the literature 
females are affected more often than males (Dodds 1983; Halliwell, 1978). In this 
study there were equal numbers of males and females, however, the samples were too 
small to be statistically significant.
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5.1.5 HYPOPROLIFERATIVE ANAEMIA-CASE DETAILS
There were three cases in this category Case PC.9 to Case PC. 11 and the details of 
the animals were as follows:
Case PC.9
A Newfoundland, 4 years old, male.
History
The dog was referred with a history of eosinophilic gastroenteritis which had been 
previously been treated with azathioprine and prednisolone. The dog subsequently 
developed signs o f vestibular disease and was found to be thrombocytopenic and 
lymphopenic and was referred.
Clinical Signs on Presentation
The dog was thin with pale mucous membranes, tachypnoea and irregular heart beats. 
There was a large ulcer on the centre of the tongue and the front paw was swollen 
with a bruise especially obvious over the first two digits.
Radiography
This showed only a slight cardiomegaly.
Electrocardiography: Artial fibrillation was seen on ECG.
Laboratory Tests
Biochemistry: There was a very high serum Aik. Phos. 2141 IU/1 and high serum 
ALT 92 IU/1 was also seen.
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Haematological Findings and Diagnosis
The haematological findings are shown in Table 23.
A non-regenerative blood picture with severe neutropenia and thrombocytopenia was 
observed. The direct Coombs’ test was negative .
The fibrinogen was 576 mg/dl.
Prothrombin time of the test sample was 12 sec compared with a control of 10 sec. 
Kaolin cephalin clotting time of the test blood sample was 19 sec and the control was 
22 sec.
A diagnosis of pancytopenia was made.
Outcome
It seemed that the bone marrow was depressed secondary to chemotherapy. The 
serum alkaline phosphatase concentrations were elevated probably due to the steroid 
therapy. Monitoring of the platelet numbers was considered, however, the numbers 
did not increase. The following morning the dog became paraplegic and developed 
mild epistaxis. Blood transfusion was given, but because of the grave prognosis the 
dog was euthanased.
Pathological Examination
At necropsy the dog was in fair bodily condition but there was a marked degree of 
autolysis. The carcase was pale and the spleen was small and contracted. The bone 
marrow was fatty. The liver was slightly enlarged and pale. Several small ulcers were 
noted in the gastric mucosae at the pylorus. The heart was slightly enlarged with pale 
muscle.
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Histopathological Diagnosis
Microscopic examination confirmed that there were very few haemopoietic cells in 
the marrow and the spleen. No lesions were detected in the gastric mucosae to 
confirm the diagnosis of eosinophilic gastroenteritis.
Diagnosis
Bone marrow hypoplasia due to drug induced myelosuppression.
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Table 23 : Haematology results o f  PC. 9
Sample 1 2
Days after Sample 1 0 1
R.B.C.x1012/1 3.19 3.09
Hbg/dl 7.10 7.40
PCV% 22.00 21.30
MCVfl 69.00 69.00
MCHpg 22.20 23.90
MCHCg/dl 32.30 34.70
Plt.xl09/1 272.00 20.00
W .B.C.xl09/l 7.00 1.40
BNeutro.xl09/l 0.00 0.00
Neutro.xl09/1 5.88 0.95
Lympho.xl09/1 0.70 0.41
Mono.xlO9/! 0.28 0.04
Eosino.xl09/1 0.00 0
Baso. x 109/l 0.00 0
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Case PC.10
A German Shepherd Dog, 3.5 years old, female.
History
The dog had been presented for assessment of a possible vaginal stricture. She was 
prescribed oestradiol several times for misalliance. The animal was described as being 
dull, becoming tired fast and losing weight.
Clinical Signs on Presentation
The dog was very dull and quiet. She was pyrexic with a temperature (40°C)> had pale 
mucous membranes, melaena, a firm mass in the dorsal neck region and a soft 
swelling dorsal to the anus. A very soft cardiac murmur could be heard on 
auscultation. Rectal palpation was slightly painful.
Laboratory Tests
Biochemistry: These tests were unremarkable.
Cytology: The fine needle aspirate of the masses revealed only some erythrocytes and 
white blood cells suggesting that the lumps were haematomas.
Urine test: On examination trace proteins, pH6.0 and a specific gravity o f 1.037 were 
seen. Examination of the urine deposit detected epithelial cells, cell debris and some 
organisms.
Haematological Findings and Diagnosis
The haematological findings are shown in Table 24.
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Sample 1
A non-regenerative blood picture, marked pancytopenia and lymphopenia were 
present.
Sample 2
A non-regenerative blood picture was still present with marked cytopenias.
Samples 3-5 were the same. The dog was transfused with blood on the day the third 
sample was taken. A fibrinogen estimation was also carried out and the result was 
806 mg/dl which was considered high. A direct Coombs' test was negative.
Sample 6
Occasional reticulocytes and normoblasts were present, along with a slight increase 
in the platelet numbers. The latter may have been the first signs of marrow recovery 
or may be due to the transfusion.
Sample 7 and 10
Slightly regenerative blood picture was seen with a slight leucocytosis. A bi-morphic 
population of erythrocytes i.e. round (young) and poikilocytes (old) cells was also 
present. There were also some large immature platelets.
Diagnosis
A diagnosis of oestradiol-induced bone marrow hypoplasia was made.
Outcome
A diagnosis of oestrogen induced bone marrow suppression was made based on the 
history of oestradiol (injectable) administration and the above haematological 
observations. Supportive therapy was started with antibiotics. The dog improved 
although her neutrophil count was still severely low. The haematomas resolved on
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their own and the dog was sent home with medications. The dog was later presented 
for a routine check and appeared bright and was eating well.
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Table 24 : Haematology results o f  PC. 10
Sample *
Days after Sample 1
1
0
2
1
3
2
(transfusion)
6
10
7
14
10
39
R.B .C .xl012/l 4.64 4.78 3.87 4.26 4.66 6.64
Hbg/dl 11.10 11.50 9.20 9.90 11.40 15.70
PCV% 30.30 32.20 25.40 28.20 31.60 44.90
MCVfl 65.00 67.00 66.00 66.00 68.00 68.00
MCHpg 23.90 240 23.70 23.20 24.40 23.60
MCHCg/dl 36.60 35.70 36.20 35.10 36.00 34.90
Plt.xl09/1 9.00 7.00 9.00 16.00 18.00 158.00
W.B.C.xl09/l 1.20 1.80 1.60 4.20 4.40 6.30
BNeutro.xl09/l 0 0.11 0.06 0 0 0
Neutro.xl09/1 0.24 0.65 0.58 2.12 2.09 3.72
Lympho.xl09/1 0.91 1.05 0.94 1.85 2.02 2.08
M ono.xl09/1 0.05 0.03 0.03 0.23 0.18 0.13
Eosino.xl09/1 0 0 0 0.02 0 0.38
Baso. x 109/l 0 0 0 0 0 0
Normoblasts 0 0 0 0.02 0.11 0
^Intervening samples are shown in Appendix D.
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Case PC. 11
A Rottweiler, 5 years old, female spayed, weight 41.4 kgs.
History
The dog had been very lethargic and had been looking very pale. It had a slight 
temperature and recently had developed a mild cough.
Clinical Signs on Presentation
The oral mucous membranes were pale and the dog was very lethargic. It had a Grade II 
haemic cardiac murmur and a bounding pulse. Her appetite was normal and there was no 
weight loss. On abdominal palpation a cranial abdominal mass was felt which may have 
been splenomegaly or hepatomegaly.
Radiography
There was a suggestion of a cranial abdominal mass, however, it was not conclusive. 
Abdominal Ultrasound
Spleen and liver were normal with normal echogenicity, normal size and no evidence of a 
mass.
Laboratory Tests
No abnormal findings were present in the urine test, biochemistry or faecal examination.
Haematological Findings and Diagnosis
The haematological findings are shown in Table 25.
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Sample 1
A slightly regenerative blood picture with a marked macrocytosis was seen. The 
platelets were aggregated.
Sample 2
There was a slightly regenerative blood picture. Although the number of platelets was 
normal, very large platelets were seen and also some as aggregates. A small number 
of blast cells were also seen. The abnormally large platelets were suggestive of a 
myeloproliferative disorder e.g. myelodysplasia.
Sample 3
The direct Coombs' test was negative and it was thought advisable to check bone 
marrow at this stage. There were some blasts present but the result was inconclusive. 
An increase in the platelet size was still present. A blood transfusion was given.
Sample 5
Very large platelets, normoblasts and many atypical lymphoid cells and lymphoblasts 
were seen. The latter were suggestive of a lymphoid neoplasia. The blood picture was 
slightly more regenerative than that of the previous samples which may have been due 
to the previous blood transfusion. Another blood transfusion was advised.
Sample 6
A regenerative blood picture with marked anisocytosis and some schistocytes were 
seen. The platelet and neutrophil counts were normal.
As seen from the reports it became apparent that the anaemia was caused by abnormal 
erythropoiesis which may have been due to myelodysplasia. In spite of haematological 
evidence no lymphoid tumour was found.
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Bone Marrow Aspirate
This was attempted on two occasions and on both occasions only a fatty marrow was 
seen with a small number of erythroid precursors and granulocytes. The marrow did 
not seem to be hypercellular excluding myelophthisis. The erythrocytes that were 
present showed slight polychromasia, marked shistocytosis and poikilocytosis.
Diagnosis
Erythroid hypoplasia due to myelodysplasia.
Outcome
The dog was given a chemotherapy protocol which consisted of: vincristine, 
cyclophosphomide and prednisolone, assuming that erythroid hypoplasia may be 
caused by an underlying tumour. The dog was presented for the treatments necessary 
and was sent home on a maintenance dose. However, the prognosis of the dog was 
guarded.
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Table 25: Haematology results o f  PC. 11
Sample
Days after Sample 1
1
0
2
9
3
9
(transfusion)
4
12
5
16
(transfusion)
6
19
R.B.C.x1012/1 2.40 1.90 2.25 1.89 1.89 3.19
Hbg/dl 6.40 5.80 5.10 5.00 4.70 7.10
PCV% 21.00 17.00 17.4.0 15.10 14.80 22.00
MCVfl 89.00 88.00 77.00 80.00 78.00 69.00
MCHpg 27.00 30.00 22.60 26.40 24.80 22.20
MCHCg/dl 31.00 34.00 29.30 33.10 31.70 32.20
Plt.xl09/1 0 0 89.00 230.00 0 272.00
Retic%. 0.6 0.3 not done not done not done not done
W.B.C.x109/1 5.7 6.4 6.2 7.6 8.3 7
BNeutro.xl09/l 0.17 0 0.12 0.15 0.25 0
Neutro.xl09/1 0 3.81 4.978 4.90 5.90
Lympho.xl09/1 1.5 0 1.86 2.01 2.78 0.70
M ono.xl09/1 0.4 0 0.19 0.30 0.25 0.28
Eosino.xl09/1 0.2 0 0.15 0.08 0.12 0.07
Baso.xl09/1 0 0 0 0 0 0
Normoblasts 0 0 0.06 0.08 0 0.07
Zero for platelet indicates platelet aggregates.
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5.1.6 HYPOPROLIFERATIVE ANAEMIA-DISCUSSION
Hypoplasia and aplasia of the bone marrow is known to occur in dogs and may 
be the result of toxic injury to the bone marrow cells and their environment or it may 
be due to immune-mediated injury or it may be idiopathic (Weiss and Klausner, 1990; 
Cline and Golde, 1978). In dogs, marrow hypoplasia can also be caused by infections 
such as chronic Ehrlichiosis and parvovirus infection (Kuehn and Gaunt 1985; 
Boosinger et a/., 1982). Acquired aplastic anaemia occurs in dogs and often as a 
result of toxic insult to the bone marrow, due to drugs such as oestrogens, 
phenylbutazone, trimethioprim-sulfadiazine, meclofenamic acid, fenbendazole and 
quinidine and chloramphenicol (Weiss and Klausner, 1990, Weiss and Adams, 1987). 
Myelofibrosis and chemotherapy may also cause hypoplasia or aplasia.
In this study, there were three cases with marrow hypoplasia that were 
particularly interesting. The first one, PC.9, had pancytopenia which seemed to be due 
to the drug azathioprine resulting in severe myelosuppression. The second dog, 
PC. 10, had thrombocytopenia and anaemia caused by oestrogen induced 
myelotoxicity, and the third dog, PC.l 1, had erythroid hypoplasia which was thought 
to be caused by an underlying neoplasia.
In marrow hypoplasia or aplasia the blood picture is usually non-regenerative 
and cytopenias are always seen, which may vary reflecting the suppression of one or 
more cell lines (Shelly, 1988). Dogs with marrow hypoplasia or aplasia caused by 
chemotherapeutic drugs may develop severe neutropenia within 5-7 days of drug 
administration and thrombocytopenia may develop 7 to 10 days later and there may 
be haemorrhages due to the markedly decreased platelet number (Weiss, 1992). In 
Case PC.9, the dog had a non-regenerative anaemia, severe neutropenia and
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thrombocytopenia i.e. pancytopenia. The coagulation tests were within normal 
ranges. The dog developed epistaxis due to the low platelet numbers which decreased 
markedly to 20x10;/l. An increased alkaline phosphatase concentration was also seen
which may have been due to the treatment. On post-mortem examination no 
particular cause for the hypoplasia could be identified indicating that the cause may 
have been either drug-induced or idiopathic.
According to Teske (1986), there is no breed or sex predilection for oestrogen- 
induced bone marrow toxicity, but the condition seems more common in older dogs 
probably due to the less responsive bone marrow with increasing age. However, in 
this study, PC. 10, was a young dog and the accurate history and haematological 
observations confirmed that the pancytopenia was oestrogen-induced.
The clinical course of oestrogen toxicity usually, starts with petechiae and 
haemorrhages due to the lack of platelets followed by pallor, most patients eventually 
die as a consequence of haemorrhagic diathesis (Teske, 1986). Despite the severe 
thrombocytopenia in PC. 10, which had a platelet count less than 20 x 109/1, no signs 
of bleeding was observed. This situation was similar to the case presented by Hall 
(1992). Therapy in this case was aimed to prevent secondary infections while the 
animal was recovering normal bone marrow function.
In bone marrow hypoplasia or aplasia caused by oestrogens in addition to 
thrombocytopenia there may be initially a hyperplasia of the leucocytes followed by 
neutropenia due to myeloid suppression (Teske, 1986; Weiss and Klausner, 1990; 
Legendre, 1976). Dog PC. 10 was presented in a hypoplastic state with pancytopenia. 
The mild to moderate severity of the anaemia was similar to the descriptions of other 
investigators. There was a progressive recovery in this case after the blood
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transfusion and this was similar to the observations made by Weiss and Klausner 
(1990). In their study, three dogs were studied, two were euthanased and the one dog 
that survived had been given a blood transfusion. This was significant, suggesting that 
even prolonged bone marrow hypoplasia is potentially reversible with supportive 
therapy.
Erythroid hypoplasia is known to occur in animals but the aetiology is unclear 
although it is thought to be immune-mediated or caused by parvovirus infection 
(Kaplan etal., 1985; Weiss et al., 1982). Case PC.l 1, was presented with a history of 
anaemia. There was no particular cause that could have been identified for the initial 
moderate degree of anaemia seen in this case. Gradually, the severity of anaemia 
increased. In erythroid hypoplasia, the blood picture is non-regenerative. The anaemia 
is due to an inadequate production and release of erythrocytes from the bone marrow 
although the other cells are unaffected (Kaplan et al, 1985). The blood picture in 
P C .ll, was however, slightly regenerative, although the anaemia was normocytic- 
normochromic. Occasional normoblasts, schistocytes and atypical lymphoblasts were 
also present. The regenerative blood picture may have been due to the blood 
transfusions. The bone marrow aspirate was fatty and may be best described as 
hypocellular. Hence the diagnosis of pure red cell aplasia could not be confirmed.
However, based on the haematological observations a diagnosis of erythroid 
hypoplasia seemed to be most appropriate for PC. l l .  History and clinical evaluation 
of PC. l l  did not reveal any obvious cause for the development o f erythroid 
hypoplasia and an immune-mediated mechanism, although the dog was Coombs’ 
negative could not be ruled out. Alternatively, it may have been idiopathic.
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5.1.7 ANAEMIA DUE TO NEOPLASIA-CASE DETAILS
There were four cases in this category Case PC. 12 to Case PC. 15 and the details of 
the animals were as follows:
Case PC.12
A German Shepherd Dog, 11 years old, female spayed, weight 38 kg.
History
The dog had a history of back problems since 1989. The animal was presented with 
right hind limb lameness and hip pain but reduced proprioception in both hind legs. 
The dog had been on prednoleucotropin since 1989, but had increasing bouts of hind 
limb weakness and cramps which persisted for 10-15 minutes. She was presented in 
1995, with the same problem but was worsening.
Clinical Signs on Presentation
The dog was dull, slightly deteriorating in condition and lethargic, with a decreased 
appetite. There was diarrhoea with some melaena from the lower intestinal tract. A 
swaying gait consistent with her neurological problem was still present.
Radiography
Nothing abnormal was diagnosed.
Ultrasonography
There was some peritoneal effusion and a very mottled spleen with areas of decreased 
echodensity throughout the spleen. There were also some areas which were
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suggestive of haemorrhages. Ultrasound diagnosis of a bleeding splenic mass was 
made.
Laboratory Tests
Biochemistry: The test revealed only an increase in the concentrations of ALT.
Faecal Culture and Sensitivity: The only potential pathogen isolated was Clostridium 
perfringens Type A.
Haematological Findings and Diagnosis
Haematological findings are in Table 26.
There were no significant changes in the first blood sample except a reduction in the 
platelet numbers and the presence of some normoblasts.
In the subsequent blood sample, examination of the blood smear detected features of 
a regenerative anaemia and some schistocytes and normoblasts. A low platelet count 
and slight leucocytosis were also present.
Diagnosis of anaemia due to a blood loss was made. The presence of schistocytes 
suggested a haemangioma or a haemangiosarcoma.
Outcome
Given the findings of a bleeding splenic mass on ultrasound and the haematological 
profile, it seemed probable that the dog had a splenic neoplasm, most likely a splenic 
haemangiosarcoma. Taking into consideration the poor prognosis the dog was 
euthanased.
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Pathological Examination
There was a large amount of blood free in the abdominal cavity. On the ventral tip of 
the spleen there was a dark red irregularly shaped mass (approximately 6.0cm in 
diameter). There were in addition a number of secondary small masses on the liver.
The spinal cord was removed to be examined for chronic degenerative 
radiculomyelopathy.
Histopathological Diagnosis
Microscopic examination of the spleen confirmed the presence of haemangiosarcoma 
and the spinal chord examination confirmed the chronic degenerative 
radiculomyelopathy.
Diagnosis
Chronic Degenerative Radiculomyelopathy.
Haemangiosarcoma and associated haemorrhagic anaemia .
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Table 26: Haematology results o f  PC. 12
Sample 1 2
Days after Sample 1 0 29
R.B.C.xlOI2/l 6.03 4.18
Hb.g/dl 13.80 8.80
PCV% 40.20 28.70
MCVfl 67.00 69.00
MCHpg 22.80 21.00
MCHCg/dl 34.20 30.60
Plt.xl09/1 88.00 98.00
Retic.%. not done not done
W.B.C.x109/1 14.10 20.10
BNeutro.xl09/l 0 0.10
Neutro.xlO9/! 11.70 17.48
Lympho.xl09/1 1.06 1.20
M ono.xl09/1 1.13 0.80
Eosino.xl09/1 0.07 0.10
Baso. x 109/l 0 0
Normoblasts 0.14 0.40
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Case PC. 13
A Labrador, 10 years old, male castrated, weight 37.2 kg.
History
The dog had decreased appetite with weight loss over a four month period. He had 
also developed haematuria, diarrhoea and a cough in the past two weeks prior to 
referral to the University of Glasgow Veterinary School. Haematemesis had occurred 
on two occasions. The dog was on medication prescribed by the previous 
veterinarian.
Clinical Signs on Presentation
The dog was thin due to chronic weight loss and had a decreased appetite. No pallor 
of the mucous membranes was seen, although the dog tired very easily. Frequent 
vomiting, some blood-stained diarrhoea, and on tracheal palpation a productive cough 
were found. On examination of the mouth there were severe halitosis, tartar and an 
ulcer on the soft palate. Haematuria was also present.
Radiography
The thoracic radiograph revealed a globular heart shadow and some pulmonary 
miliary neoplasia which was probably metastatic.
Laboratory Tests
Biochemistry: Nothing remarkable was seen.
Urine Test: The following results were seen: protein ++ , blood +++, pH 7.5, specific 
gravity 1.024, urea 395 mmol/1.
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Haematological Findings and Diagnosis
Haematological findings are shown in Table 27.
A slightly regenerative blood picture was observed, with schistocytes and 
echinocytes. A reduction in the platelet numbers and many target cells were also 
found. Blood loss was considered as a possible explanation for the findings.
Outcome
The dog started deteriorating and it was thought advisable to euthanase it. 
Pathological Examination
On gross examination the carcase was thin in condition with some disseminated 
neoplasms in internal organs. The primary tumour mass was an irregularly nodular 
lesion (3x2x2 cm in size), firm reddish-cream in colour located in the wall of the right 
atrium. Smaller nodules of similar or more haemorrhagic tissues were present on the 
adjacent dorsal pericardium with a nodule on the left atrial wall (1cm) . The 
pericardial sac contained a slight excess of blood tinged fluid. Multiple dark red to 
black, rounded, firm nodules (l-2mm to 1cm), were scattered throughout the lung 
lobes Nodules present were composed of clotted blood and there was some 
subcapsular and pelvic haemorrhage.
Histopathological Diagnosis
Microscopy confirmed that the tumour deposits in the heart, the pericardial sac, the 
lungs and the kidneys to be a highly malignant haemangiosarcoma.
Diagnosis
Atrial haemangiosarcoma with multiple metastases and associated haemorrhagic 
anaemia.
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Table 27: Haematology results o f  PC. 13
Sample 1
Days after Sample 1 0
R.B.C .xl012/l 4.38
Hb.g/dl 10
PCV% 30.6
MCVfl 70
MCHpg 22.8
MCHCg/dl 32.6
Plt.xl09/1 93
Retie. %. not done
W .B.C.xl09/l 13.7
BNeutro.xl09/l 0
Neutro.xl09/1 11.44
Lympho.xl09/1 0.82
M ono.xl09/1 0.75
Eosino.xl09/1 0.55
Baso. x 109/l 0
Normoblasts 0.14
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Case PC.14
A Boxer, 6 years old, female spayed, weight 27kg 
History
The dog was diagnosed having multicentric lymphosarcoma a year ago and was 
referred with a history of feeling “unwell” and was coming out of remission. 
Persistent vomiting, dullness, anorexia and intermittent diarrhoea were seen and 
recently the dog became polydipsic. The owners also noticed a progressive weight 
loss. The dog had been on medication of prednisolone and cyclophosphamide.
Clinical Signs on Presentation
The lymph nodes were all enlarged, the popliteal lymph nodes were 3 to 4cm and the 
submandibular nodes was approximately 4 to 5cm large. The dog appeared to be dull 
and on examination the mucous membranes appeared to be pale in colour.
Laboratory Tests
Biochemistry: This test showed an increase in the serum Alk.Phos., serum ALT 
concentrations and serum AST in some samples. Increase in urea and creatinine 
concentrations were also seen.
Urine Test: It was positive for proteins, pH 6.5 , a few white blood cells and epithelial 
cells were present.
Haematological Findings and Diagnosis
The haematological findings are shown in Table 28
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Sample 1 (day 0)
A regenerative blood picture was observed and the anaemia was most likely to be due 
to the neoplasia.
Sample 2 (shown in the appendix)
This sample was also regenerative, in addition, there were quiet a few schistocytes 
and target cells. The thrombocytopenia and schistocytes may have been due to a 
blood loss or DIC.
Subsequent blood samples (as shown in Appendix D), showed a regenerative blood 
picture, target cells, some schistocytes and a few normoblasts. Occasional 
lymphoblasts were also seen which may have been be exfoliating extramedullary or 
bone marrow-derived tumour cells. It was thought advisable to check the bone 
marrow. The coagulation profile was also checked.
Fibrinogen was estimated to be 370 mg/1 which was within the normal ranges 
(normal=l 50-400mg/dl).
A diagnosis of haemorrhagic anaemia due to neoplasia was considered.
Bone Marrow Aspirate
The bone marrow aspirate was diluted with blood and only small numbers of 
erythroid and granulocytic precursors were seen in the sample. No megakaryocytes 
or significant number of blast cells were seen excluding lymphoid leukaemia. The 
sample was suggestive of a drug-induced myelosuppression.
Outcome
The dog was under medication for lymphosarcoma. The chemotherapy protocol 
consisted of vincristine, cyclophosphomide and prednisolone. In addition to these
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drugs the dog was also given cimetidine and metoclopropamide to treat the 
developing diarrhoea and vomiting.
After regular checks and routine haematology and biochemistry the dog was finally 
presented with a very painful thymic mass. Unfortunately, the dog was deteriorating 
in condition and it was advised in consultation with the owner to euthanase the dog. 
It was not possible to conduct a post-mortem examination to determine the location 
and spread of the tumour and the cause of the blood loss.
Diagnosis
Lymphosarcoma and associated haemorrhagic anaemia.
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Table 28 : Haematology results o f  PC. 14
Sample *
1 8 9 10 17 18 19
Days after Sample 1 0 53 60 68 116 123 130
R.B.C.x1012/1
4.96 3.71 3.76 3.96 5.07 5.05 5.16
Hb.g/dl
12.00 8.80 9.00 9.40 11.70 12.90 12.10
PCV% 36.90 26.30 27.20 29.40 35.00 34.80 35.30
MCVfl
74.00 71.00 72.00 74.00 69.00 69.00 68.00
MCHpg
24.10 23.70 23.90 23.70 23.00 25.50 23.40
MCHCg/dl
32.50 33.40 33.00 31.60 33.40 37.00 34.20
Plt.xlO9/!
102.00 66.00 82.00 91.00 284.00 263.00 248.00
Retie.%.
not done 0.09 0.10 not done 0.00 0.00 0.00
W.B.C.x109/1
6.70 6.00 3.30 4.70 7.10 3.60 8.40
BNeutro.xl09/l
0.00 0.09 0.05 0.00 0.07 0.00 0.04
Neutro.xl09/1
3.38 3.72 0.33 1.97 4.90 2.646 7.22
Lympho.xl09/1
2.65 1.02 1.15 1.13 1.42 0.76 1.01
Mono.xlO9/!
0.30 0.15 0.18 0.14 0.46 0.11 0.08
Eosino.xl09/1
0.00 0.03 0.02 0.00 0.07 0.04 0.04
Baso. x 109/l
0.00 0.00 0.00 0.00 0.18 0.05 0.00
Normoblasts
0.37 0.99 1.57 1.32 0.00 0.00 0.00
intervening samples are shown in Appendix D.
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Case PC.15
A Golden Retriever, 8 years old, male castrated, weight 35 kgs.
History
The dog was referred to the veterinary hospital at the Glasgow Veterinary School, 
with small lumps over the eyes, on the neck and on the head which were lately 
growing in size.
Clinical Signs on Presentation
On physical examination there were warts present all over the head, near the eyes and 
on the neck. According to the owner the dog was also lethargic and had lost a 
significant amount of weight and was weaker. The dog was also polydipsic and 
polyuric. Mucous membranes were normal in appearance.
Laboratory Tests 
Haematological Findings and Diagnosis
The haematological findings are shown in Table 29.
Sample 1:
The blood picture was initially non-regenerative and there was increased rouleaux 
formation of red cells which may have been caused by an increase in plasma proteins. 
However, no protein estimation and electrophoresis were done so the presence or 
absence of a gammopathy was not established.
Sample 2
The blood picture became regenerative with many megaplatelets which were 
suggestive of an anaemia due to blood loss.
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Sample 3
A non-regenerative blood picture and a number of target cells were seen. It was 
advised to check liver functions.
Sample 4
This sample was taken immediately after a meal and hence the Hb, MCH and MCHC 
values were invalid due to hyperlipidaemia. However, there were some plasmacytoid 
lymphocytes and occasional blast cells present suggesting a reactive and /or neoplastic 
process.
Sample 5
A regenerative blood picture was present.
It was concluded that the dog had a possible myeloma or lymphosarcoma.
Bone Marrow Aspirate
A bone marrow aspirate was taken the next day after the first blood sample. On 
examination the aspirate was hypercellular and large proportion of the cells were 
plasma cells. In addition, there were normal numbers of erythroid and myeloid 
precursors. Megakaryocyte numbers appeared normal too. The presence of numerous 
plasma cells in the marrow may have been the result of a developing myeloma or 
infection. However, no further investigations were done in order to clarify the 
situation.
Skin Biopsy Report
An ellipsoidal skin biopsy of 1cm long x 0.5 cm in diameter was taken. On 
microscopic examination the nodule was composed of sheets of large uniform round 
cells infiltrating through the dermis. The cells had rounded or slightly cleaved nuclei,
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small nucleoli, a very coarse chromatin pattern and frequent mitotic figures, some of 
which were bizarre. The cells also had small amounts of poorly defined slightly 
basophilic cytoplasm. The skin biopsy was indicative of a cutaneous lymphosarcoma.
Diagnosis
Cutaneous lymphosarcoma and haemorrhagic anaemia of unknown cause.
Outcome
The dog was sent home on regular medications with no response from the owners 
regarding further follow ups.
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Table 29 : Haematology results o f  PC. 15
Sample 1 2 3 4 5
Days after Sample 1 0 30 36 43 71
R.B.C.xlO12/! 4.99 3.32 3.96 3.98 4.80
Hbg/dl 11.10 7.90 9.00 0.00 11.30
PCV% 35.30 25.40 27.50 27.90 33.70
MCVfl 71.00 77.00 69.00 70.00 70.00
MCHpg 22.20 23.70 22.70 0.00 23.50
MCHCg/dl 31.40 31.10 32.70 0.00 33.50
Plt.xl09/1 221.00 588.00 695.00 646.00 391.00
Retic%. 0.00 0.04 not done 0.25 not done
W.B.C.x109/1 5.20 13.70 8.60 6.60 6.80
BNeutro.xl09/l 0.00 0.14 0.00 0.00 0.07
Neutro.xl09/1 3.51 12.33 7.10 4.88 4.93
Lympho.xl09/1 1.59 0.41 0.39 1.19 0.92
M ono.xl09/1 0.08 0.82 0.21 0.36 0.61
Eosino.xl09/1 0.03 0.00 0.00 0.16 0.07
Baso. x 109/l 0.00 0.00 0.00 0.00 0.00
Normoblasts 0.00 0.00 0.00 0.00 0.20
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5.1.8 ANAEMIA DUE TO NEOPLASIA-DISCUSSION
Haemangiosarcoma
Haemangiosarcoma, also called malignant haemangioendothelioma or 
angiosarcoma, is a malignant tumour of the endothelial cells. It is seen more 
frequently in dogs than in any other domestic animal (Pulley and Stannard, 1990, 
Waller and Rubarth, 1967). According to Brown et al (1985), in a retrospective 
study, 62% of the dogs with haemangiosarcoma had a primary splenic involvement. 
The heart and lung have also been identified as primary sites (Oksanen, 1978). The 
right atrium seems to be the primary site for cardiac haemangiosarcomas. In a study 
done by Kleine et al, (1970), 31 dogs had haemangiosarcoma of the heart. In man, 
haemangiosarcoma is the least commonly found cardiac tumour, unlike domestic 
animals were there has been an increase in the number of cases identified (Kleine et 
a!., 1970). In this study, there were two dogs with haemangiosarcoma which had 
haematological changes. Dog PC. 13 had haemangiosarcoma of the right atrium and 
dog PC. 12 had the tumour in the spleen. Other organ involvement such as the liver, 
subcutaneous tissues, the brain, the kidney and the urinary bladder have also been 
observed (Waller and Rubarth, 1967; Kleine et al., 1970). Bingel et al., (1974), have 
studied haemangiosarcomas in the bones, and found osseous haemangiosarcomas in 
21 dogs which is an unusual location. However, since this is a tumour of endothelial 
origin, the primary tumour could theoretically arise in any organ (Pulley and 
Stannard, 1990). It is usually difficult to estimate the size of these tumours due to the 
extensive intralesional haemorrhages which also causes difficulty in identifying the 
primary site (Bingel et al., 1974).
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The malignancy of these tumours seems to be extremely high as it may 
become disseminated. It has a very rapid, effective and high rate of metastasis 
especially by the haematogenous route to various organs making the primary site 
difficult to identify (Waller and Rubarth, 1967, Brown et al., 1985). Metastasis to the 
lungs, liver, spleen, kidneys and brain has been reported to be frequent in cardiac 
haemangiosarcomas (Kleine et al., 1970). This was similar to case PC. 13 in which the 
dog in addition to the primary tumour of the heart had multiple metastasis to the vital 
organs such as the pericardial sac, lungs and kidneys. Whereas, according to Waters 
et al (1988), the metastatic pattern in dogs with splenic haemangiosarcomas was 
mainly to the liver, omentum, mesentery, kidneys, adrenals and lymph nodes, and to a 
lesser extent to the diaphragm, myocardium and brain. Dog PC. 12 had metastasis 
only to the liver which could explain the increase in the serum ALT levels.
The German Shepherd dog is the breed most frequently reported to be 
susceptible to this tumour (Hirsch et al., 1981; Kleine et al., 1970; Waller and 
Rubarth 1967). Haemangiosarcomas have also been observed in Boxers although this 
breed has been reported to be more liable to develop carcinomas than any other breed 
recorded (Waller and Rubarth 1967; Bingel et al., 1974). Case PC. 12 was a German 
Shepherd dog, and was a female. According to the literature male dogs are affected 
more frequently than female dogs and the other dog in this study was a male Labrador 
(Keline et al., 1970; Waller and Rubarth, 1967). The ages of PC. 13 and PC. 12 were 
11 and 10 years respectively, which corresponds with the findings of Pulley and 
Stannard (1990), who described the average age to be usually 9-10 years.
The commonest clinical sign observed is a marked anaemia, weakness, 
abdominal distension or sudden collapse. Indistinct signs may be cardiac insufficiency, 
cough, dyspnoea, polydipsia and apathy. Haemoperitoneum is also an important
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finding associated with haemangiosarcomas. (Oksanen, 1978, Kleine et al, 1970). 
The common signs in cases PC. 12 and PC. 13 were anorexia and lethargy. Blood­
stained diarrhoea was also seen in both these dogs which may have been due to the 
blood loss along the intestinal tracts. Marked haematuria was present in dog PC. 13 as 
a result of acute blood loss probably due to the multiple metastasis.
Several factors may contribute to the development of anaemia in a dog with 
haemangiosarcoma. Blood loss, either from rupture o f the tumour into the body 
cavities or lungs or haemorrhage within the tumour mass, may result in a mild to 
severe anaemia. This mainly depends on the extent of blood loss and the 
compensatory erythroid hyperplasia of the bone marrow. According to Kleine et al., 
(1970), dogs with haemangiosarcoma have active haemopoiesis unlike the anaemia 
associated with other types of neoplasia.
Haematological findings associated with haemangiosarcoma are of a wide 
variety. Haemangiosarcoma results in haemorrhagic anaemia which may be 
complicated with haemostatic abnormalities. The anaemia is usually regenerative and 
normocytic and normochromic. Anisocytosis, poikilocytosis, reticulocytosis, 
normoblastosis, increase in the number of target cells, Howell-Jolly bodies and 
neutrophilia with a left shift have been some commonly made observations (Hirsch et 
al., 1981; Ng and Mills, 1985; Kleine et al., 1970). The leucocytosis with neutrophilia 
present may be due to the erythroid hyperplasia affecting the myeloid elements but the 
degenerative tumour changes may also have an effect.
Schistocytosis and acanthocytosis have also been typical findings associated 
with haemangiosarcomas (Hirsch et al, 1981, Rebar et al, 1980). Microangiopathic 
haemolytic anaemia (MAHA), may also be observed in haemangiosarcomas, resulting 
in the formation of schistocytes. Schistocytes are formed due to the mechanical
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damage caused by the passage of the erythrocytes through the fibrin deposits within 
the neoplastic vasculature. However, in some cases if the lesion is too small, 
schistocytes may not be present in the peripheral blood (Rebar et al, 1980). 
Schistocytosis was most prevalent in dogs with haemangiosarcomas of the liver and 
heart (Rebar et a/., 1980). Interestingly, some spherocytes were seen in dog PC. 12 
which according to Kleine et al., (1970), and Rebar et al., (1980), have been 
observed in dogs which haemangiosarcoma.
In dogs PC. 13 and PC. 12, features of a regenerative blood picture together 
with schistocytes and normoblasts were seen. There was also a reduction in the 
platelet numbers and there was a slight leucocytosis in both dogs. These observations 
were consistent with the findings reported in the literature.
According to Hirsch et al, (1981), there is a definite association between 
acanthocytes and haemangiosarcomas. Acanthocytes are often seen in hepatic 
diseases due to known membrane changes, but their occurrence in 
haemangiosarcomas is unexplained. In case PC. 12 some acanthocytes were observed 
which may have been as a result of the hepatic metastases of the tumour which was 
diagnosed post-mortem.
Thrombocytopenia may also be present in cases of haemangiosarcoma 
suggesting an increased consumption of platelets in association with MAHA or due to 
blood loss. An increased number of large platelets along with an increase in 
erythrocyte production reflects a sequestration or haemorrhage into the tumour 
sinuses or body cavities (Ng and Mills, 1985). According to Hammer et al, (1991), 
haemangiosarcomas may also be associated with haemostatic abnormalities especially 
due to DIC. The evaluation of the coagulation profiles of 24 dogs in their study, 
revealed that 12 (50%) of the dogs had DIC.
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Dogs with haemangiosarcoma usually have a poor prognosis irrespective of 
the location of the tumour. The duration of signs before diagnosis is short and dogs 
may die suddenly from the rupture of the primary or metastatic tumour (Brown et al., 
1985).
In the two cases studied, the findings were typical and were consistent with 
the findings reported in the literature. Due to the poor prognosis both dogs were 
euthanased.
Lymphosarcoma
Canine lymphosarcoma is one of the commonest lymphoid neoplasm observed 
in dogs. The incidence in the general dog population is reported to be as high as 24 
per 100,000 dogs (Dorn et al, 1967). Classification of lymphosarcomas can be either 
based on a combination of the cytology, pattern of growth i.e. diffuse or follicular, 
immunomorphological or anatomical presentation. In animals the classification is 
commonly based on the anatomical form such as multicentric, thymic, alimentary, 
cutaneous and others. The multicentric form seems to be most commonly 
encountered in dogs (Dobson and Gorman, 1993).
Lymphosarcoma has no breed predilection, however, Boxers and pure bred 
dogs have been reported to be at a relatively higher risk (Dorn et al, 1967). In a 
survey by Dorn et al., (1967), of the 83 dogs with lymphosarcoma the average age 
was calculated as 8-10 years. Lymphosarcoma seldom occurs in dogs less than 1 year 
old although a few cases have been reported in pups as young as 4 months of age. 
Dogs 1-4 years old make up about 10% of the cases, and the incidence rises steeply at 
5-11 years (80% cases) (Moulton and Harvey, 1990). In this study two dogs were
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selected with lymphosarcoma, a Boxer, PC. 14, with a multicentric form and a Golden 
Retriever, PC. 15, presented with a cutaneous form of lymphosarcoma.
The ages of both these dogs were similar to the ages cited in literature for 
lymphosarcoma to develop.
Lymphosarcoma can be diagnosed by cytological or by histopathological 
examination. The skin biopsy taken from PC. 15, confirmed the growing skin lesions 
to be a cutaneous form.
According to Moulton and Harvey (1990), about two thirds of the dogs with 
lymphosarcoma have anaemia usually with a normocytic-normochromic erythrocyte 
morphology. However, the type of anaemia observed in lymphosarcoma can vary. 
The anaemia due to neoplasia can vary from being markedly haemorrhagic to a non- 
regenerative anaemia of chronic disease. A haemolytic anaemia may also be seen 
(Arbaje and Beltran, 1990). The severity of anaemia observed in PC. 14, was mild to 
moderate, and it was regenerative. Schistocytes were also seen in the blood smear 
which is a frequent finding in anaemia due to neoplasia. On some occasions the dog 
was moderately anaemic with a decreased number of platelets. This finding was 
suggestive of episodes of blood loss due to the tumour.
In PC. 15, the anaemia was initially regenerative with megaplatelets and then 
non-regenerative. This was probably caused by haemorrhagic lesions. In the absence 
of a post-mortem examination the exact cause of the blood loss could not be 
established. However, it is safe to assume that the tumour may have metastasised and 
may have caused ulcerative lesions.
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5.2 Discussion
It is essential to know the history of the patient and to identify the presenting 
clinical signs in order to diagnose the cause of the anaemia. In the prospective cases 
presented in this study the history and the clinical presentation formed an important 
part in the diagnosis of anaemia. In cases where an accurate history was present, such 
as a history of certain drug treatment, it was usually easy to identify the cause of 
anaemia and to assess the prognosis of the case. Clinical presentation o f these 
anaemic dogs also revealed some common findings (Appendix E). Dogs with anaemia 
seemed to be presented with common signs of dullness, lethargy, pallor and anorexia. 
However, vomiting, pyrexia and polydipsia seemed to be less common clinical signs. 
Dogs with haemolytic anaemia in addition to the above, had more severe anaemia or 
icterus, haemoglobinuria, increased pulse rate and cardiac murmurs. It was also 
observed that anaemia could be associated with a variety of disease conditions. The 
causes of anaemia included conditions such as haematoma of the spleen, drug-induced 
chronic blood loss, immune-mediated conditions, haemangiosarcoma, lymphosarcoma 
and many others. The classification of anaemias was based upon the aetiology 
involved as discussed previously in this study. The severity of the anaemia and the 
prognosis can vary depending on the aetiology involved and the regenerative capacity 
o f the bone marrow as was seen in these cases. It can thus be concluded that anaemia 
is commonly observed in dogs and it is usually a feature of an underlying disease 
process. The cases described in this study emphasised that to a variety of disease 
conditions associated with anaemia can be anticipated in clinical practice.
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GLOSSARY
Erythrocyte Abnormalities
1. Size
Anisocytosis
Variation in size of erythrocytes which may be due to the presence of cells larger and 
smaller than normal. Can be seen in auto-immune haemolytic anaemia.
Microcytes
These are cells smaller than the normally-sized erythrocytes. These cells can be 
observed in iron deficiency anaemia and may also be the result o f spherocytosis or 
fragmentation.
Mcicrocytes
These are cells larger than the normally-sized erythrocytes. Can be seen if there is an 
increase in erythropoiesis resulting in reticulocytosis.
2. Shape
Poiki/ocytes
A non-specific term describing red cells which show deviation from the normal shape,
279
Specific Diagnostic Forms
Spherocytes
These are cells which are more spheroidal that is less disc-shaped than the normal 
erythrocytes. Their diameter is less and their thickness is greater than normal. They 
appear in a smear as small, round densely staining cells without a central pallor. They 
are formed either due to inherited membrane abnormalities as in hereditary 
spherocytosis or due to loss of membrane surface as in IgG type auto-immune 
haemolytic anaemia.
Elliptocytes
These are red cells that are oval or elliptical shaped due to primary membrane 
abnormality. They occur in hereditary elliptocytosis.
Stomatocytes
Invaginated, cup shaped cells due to membrane abnormalities They can be seen in 
hereditary stomatocytosis and are best observed in wet preparations.
Echinocytes or Crencited Cells
Red cells with numerous, small, peripheral protrusions caused by dysproteinaemia 
which may alter the cell membrane. These cells may be observed in some cases of 
uraemia, hepatobiliary or pancreatic diseases. Can also be artefactual.
Acanthocytes or Spurr Cells
These are red cells with few, irregular, asymmetrical, spine-like projections. They may 
be seen in uraemia or in cases of haemangiosarcoma. In severe cirrhosis, red cells
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accumulate excess cholesterol from abnormal cholesterol rich plasma lipoproteins 
resulting in spurr cell and target cell formation.
Burr Cells
Small red cells or cell fragments with one or a few fine spine-like protrusions 
representing damaged or fragmented cells seen particularly in uraemia.
Schistocytes
Red cell fragments of less than 3jam in diameter. Fragmentation is caused by 
excessive trauma or abnormal shear forces within the circulation due to fibrin 
deposition in small blood vessels. They may be associated with disseminated 
intravascular coagulation, haemangiosarcoma, haemangioma, myelofibrosis or may be 
due to cardiac disorders such as valvular disease.
3. Haemoglobinisation or Chromasia
A nisochromasici
This is an exaggerated variation in the colour of red cells. Can be seen in iron 
deficiency anaemia responding to iron therapy.
Hypochromasia
An increase in the central pallor of the cells which may be due to lowered 
haemoglobin concentration or abnormal thinness of the red cells. This is most 
commonly seen in iron deficiency anaemia.
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Polychromasia
Diffuse, bluish cytoplasmic tint due to the presence of RNA, indicating immaturity of 
the cells. Polychromatic cells are the reticulocytes which can only be seen when 
stained with new methylene blue.
Specific "Diagnostic " Forms
Target cells or "'Mexican Hat" cells
a. Microcytic hypochromic cells with central blob and peripheral ring of 
haemoglobinisation. These are observed in iron deficiency anaemia.
b. Macrocytic hypochromic, polychromatic target cells seen in the case of markedly 
increased erythropoeisis such as in auto immune haemolytic anaemia.
c. Normochromic, normocytic target cells. These are due to increased cell surface 
area caused by excessive cholesterol in the cell membrane. They occur mainly in 
hepatic disease.
Stomatocytes
In these cells, the normal central pallor is replaced by a slit or mouth like unstained 
area corresponding to the invagination of the membrane. Can be best seen in wet 
preparations. A few may be seen in any chronic condition.
4. Inclusions
Punctate basophilia or basophilic stippling
Numerous, fine blue dots in the erythrocytes either due to the presence o f RNA in 
young cells or iron. Seen as a normal regenerative feature in cattle. In dogs, it is seen 
associated with lead poisoning whereas in cats it is observed during active erythrocyte 
regeneration and should not be interpreted as a lead poisoning.
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Howell-Jolly Bodies
Round, small densely staining structures representing nuclear remnants and containing 
DNA. They occur usually as single but may be present as multiple remnants in the 
erythrocytes. The number of Howell-Jolly bodies increase in regenerative anaemias 
reflecting increased erythropoiesis. After corticosteroid treatment and post 
splenectomy the increase is caused by impairment or loss of the pitting function of the 
spleen.
Reticulum in reticulocytes
Cells containing ribonucleic acid precipitate into granules or filaments are called as 
punctate or aggregate reticulocytes. These are best observed by supra-vital dyes such 
as new methylene blue.
Heinz-Bodies
Large rounded refractile inclusions, usually solitary, protruding from the surface of 
the erythrocytes due to irreversibly oxidised, denatured haemoglobin attaching to the 
red cell membrane’s, reduced gluthathione groups. They stain pale blue with supra­
vital stain and may be due to oxidant drug effect.
5. Other Abnormalities
Increased Rouleaux Formation
On standing, the erythrocytes in a blood sample aggregate and lie face to face on their 
sides like a pile of coins forming a rouleau formation. This is a non-specific 
phenomenon. Increased rouleaux formation can be seen due to the increase in plasma 
high-molecular weight proteins such as high levels of fibrinogen or globulins. It may
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be associated with infections and multiple myeloma. Pseudoagglutination due to 
massive rouleaux formation should either disperse completely or transform itself into 
typical rouleaux.
A nto-aggh/tination o f erythrocytes
Red cells form large clumps which are unable to disperse after the addition of three to 
four volumes of 9g/l of sodium chloride to the blood. Can be seen in immune- 
mediated haemolytic anaemias.
Normoblastosis or normoblastaeamia
This term describes the presence of nucleated erythrocyte precursors, that is 
erythroblasts (normoblasts) in the blood. They are mainly derived from 
extramedullary foci of erythropoiesis (EMH) that is from the spleen and the liver. A 
few normoblasts may be found after corticosteroid treatment, in septicaemia or in 
cyanotic heart failure. Their number will significantly increase in regenerative 
anaemia, particularly in haemolytic anaemia, and in acute leukaemia. After 
splenectomy, if there is extramedullary haemopoiesis, their number may be very large. 
They may also be observed in myeloproliferative disorders involving the erythroid 
series.
Regenerative blood picture
This term is used to describe the changes in the blood reflecting increased rate of 
erythropoiesis and consequently increased number of young red cells (reticulocytes). 
These changes may be slight, moderate or marked and may be described as: 
“slight/moderate/marked anisocytosis, polychromasia and few/many/numerous/
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Howell-Jolly bodies and normoblasts are present”. Reticulocytes are larger in 
diameter than normal red cells, their volume is increased and if present in high enough 
numbers they increase the MCV. None of the above changes are present in a non- 
regenerative blood picture reflecting the inactivity of the bone marrow in spite of 
anaemia, so it will appear as a normal blood picture in health.
Granulocyte Abnormalities
1. Nuclear
Giant cell forms
These may be seen as metamyelocytes representing abnormal granulopoiesis in 
toxaemia associated with bacterial infection.
2. Cytoplasmic
Toxic granulation
Many purple granules appear in the cytoplasm of neutrophils representing disturbance 
of granule formation. Can be seen in bacterial infections or toxaemia.
Dohle-bodies
Round or elliptical, pale blue staining inclusions about 5nm long in the cytoplasm of 
neutrophils which develop in immature granulocytes in the bone marrow and 
represent depolymerized ribosomes. May be single or multiple. These cells are 
observed in bacterial infections.
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A regenerative left shift
The term "regenerative left shift" is used to describe neutrophilia and the appearance 
o f immature neutrophils in the blood. Depending on the degree of immaturity, the left 
shift can be slight, moderate or marked. Neutrophilia with band forms only represents 
a slight left shift while the presence of band forms and metamyelocytes will indicate 
moderate and the presence of additional myelocytes and promyelocytes a marked left 
shift. Regenerative left shift occurs in bacterial, particularly pyogenic infections and in 
auto-immune haemolytic anaemia.
A degenerative left shift
In acute septicaemic infections bacterial endotoxins may suppress granulopoiesis in 
the bone marrow and instead of neutrophilia, normal or lower than normal neutrophil 
numbers and immature neutrophils are present in the blood which represent a 
"degenerative left shift" and usually carries a poor prognosis.
Lenco-erythroblastic blood picture
This term is used to describe the presence of numerous nucleated red cells and 
immature granulocytes in the blood. It is seen in myelophthisis, auto-immune 
haemolytic anaemia, septicaemia, severe haemorrhage.
Lymphocyte Abnormalities
A typical lymphoid cells
Non specific term describing a variety of cell forms which are usually larger than 
normal lymphocytes.
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Reactive lymphoid cells or imimmocytes
These are larger than normal lymphocytes with dark nuclei and plasmacytoid 
appearance. May be seen in high numbers after vaccination. Some may appear in 
infections, particularly in viral infections.
Lymphoblasts
Large, immature cells with high nuclear cytoplasmic ratio, pale staining nuclei with 
single or multiple nucleoli and small amount of basophilic cytoplasm. High number of 
lymphoblasts are present in the blood in acute lymphoblastic leukaemia (ALL). In 
lymphosarcoma, none, occasional or numerous lymphoblasts may be found.
Lymphosarcoma-type cells
Very large, atypical cells with abnormal nuclear structure and shape, such as irregular 
nuclear outline or nuclear clefting, one or multiple large nucleoli, increased amount of 
cytoplasm which may contain vacuoles. These cells may appear in the blood in low or 
high numbers due either to direct shedding from peripheral tumour masses (overspill 
leukaemia) or to secondary involvement of the bone marrow.
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APPENDIX A 
Table A l: Normal haematological values in dogs.
Features Range Abbreviations
Red Blood Cells 5.50-8.50 x 1012/1 R .B .C .xl0l2/l
Haemoglobin 12.00-18.00 g/dl Hb g/dl
Packed Cell Volume 37.00-55.00% PCV %
Mean Corpuscular Volume 60.00-77.00 fl MCVfl
Mean Cell Haemoglobin 19.50-24.50 pg MCH pg
Mean Cell Haemoglobin Concentration 32.00-36.00 g/dl MCHC g/dl
Reticulocytes 1.00-1.50% Retie. %
Platelets 200-500 x 109/1 Pit. x 109/l
White Blood Cells 6 .00- 12.00 x 109/1 W .B.C.xl09/l
Neutrophils 3.00-11.80 x 109/1 Neutro.xl09/1
Lymphocytes 1.00-4.80 x 109/1 Lympho.xl09/1
Monocytes 0.15-1.35 x 109/1 M ono.xl09/1
Eosinophils 0.10-1.25 x 109/1 Eosino.xl09/1
Basophils Rare Baso. x l0 9/l
The normal ranges followed at the University of Glasgow, Veterinary School for 
canine red blood cell count, white blood cell count and platelet numbers were 
obtained from the literature (Schalm el al., 1975a). Zero for platelet indicates platelet 
aggregates and other cells are usually the normoblasts or any other nucleated cell.
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Table A2: Normal biochemistry values in dogs.
Assays
Urea mmol/1
Creatinine pmol/1
Sodium mmol/1
Potassium mmol/1
Chloride mmol/1
Calcium mmol/1
Phosphates mmol/1
Magnesium mmol/1
Cholesterol mmol/1
Total Bilirubin pmol/1
Alkaline Phosphatase IU/1
Alanine Aminotransferase IU/1
Aspartate Aminotransferase IU/1
Total Protein g/1
Glucose mmol/1
Mean Range
4.98 0.00-7.47
88.40 44.00-132.00
148.00 136.00-160.00
4.40 3.40-5.80
105.00 95.00-115.00
2.61 2.34-3.03
1.80 1.29-2.9
0.94 0.61-1.19
3.87 1.80-6.96
3.42 0.00-10.26
less than 233 4.00-233
22.00 0.00-35.00
23.00 0.00-35.00
62.00 50.00-78.00
3.88 2.49-4.99
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Preparation of the May-Griinwald Giemsa Stain used at the 
University of Glasgow, Department of Veterinary Pathology, 
Haematology Laboratory
Preparation o f a good stain for the examination of certain features of a blood 
smear is one o f the most essential aspects in haematology. A good smear with evenly 
spread cells and a good stain is essential to enhance certain features for identification 
of cells. A blood sample (25pil) is aspirated through the Roche ABX Minos Vet 
Automated Haematology Analyser for an automated blood cell count. Subsequently, 
a blood smear is made by a 75x 1.3-1.5 mm microcapillary tube containing blood 
from the rest of the blood in the EDTA tube. The smear is air dried and then stained 
with the May-Griinwald Giemsa stain. The method of stain preparation followed at 
the haematology laboratory is described as follows:
M aterials 
Fixative: Methanol.
Buffered distilled w ater (pH 6.8): This is prepared by dissolving one tablet of pH 
6.8 (BDH, England) in one litre of water.
May Griinwald stain (G urr®  BDH, England): The May Grunwald stain is 
prepared by freshly diluting it to 50 percent with buffered distilled water (pH 6.8 
prepared same as above) and it is then filtered with Whatman® filter paper number 
113V before use.
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Giemsa’s Stain (G urr®  BDH, England): Giemsa's stain is prepared freshly by 
diluting it to 7.5 percent with buffered distilled water (pH 6.8 prepared same as 
above) and filtering it with Whatman® filter paper number 113V before use.
M ethods
1. Fix air dried blood smears in methanol for 5 minutes.
2. The smear is then immersed in May-Griinwald stain for 6 minutes.
3. The smear is transferred for washes into clean buffered water (pH 6.8) for 1 
minute for a wash.
4. The third method is then repeated with fresh buffered water (pH 6.8).
5. It is then placed into Giemsa's stain for 8 minutes.
6. Step 4 is repeated for another 8 minutes using another fresh staining jar with 
Giemsa stain.
7. Step 3 is repeated but by using fresh buffered distilled water, for removing the 
excess stain.
8. Allow slide to stand in buffered distilled water for 1 minute to let differentiation 
take place.
9. The slide is taken out and then made to stand upright to dry.
Result
Fixation of a blood film in methanol is essential to preserve the cell structure 
and prevent disruption of morphology by the subsequent procedures. This is a 
Romanowsky stain and its properties depend on the interaction of methylene blue, 
azure and eosin components. The methylene blue, a basic dye, is absorbed by the 
acidic groupings o f the nucleic acids and proteins of the cell nuclei and primitive
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cytoplasm. Basophil granules contain heparin, which is acidic having affinity for this 
dye and stain blue in colour. Methylene blue azure stains the azurophil granules of 
leucocytes.
Eosin, which imparts red colour, is an acidic dye which reacts with basic 
groupings example haemoglobin molecule. The granules of eosinophils contain a 
spermine derivative which react strongly with eosin.
Each film is examined under the low power (x25), high power (x40) and oil 
immersion (x 100) of the microscope some blood samples follow a different procedure 
in which different staining procedures may be required.
Technique of making a blood smear:
It is essential to know the correct technique of making a blood smear for 
examination. Two clean slides and a microcapillary tube of dimensions 75x 1.3- 
1.5mm are necessary. One of the clean slides is placed on a levelled surface. Then a 
very small drop of thoroughly mixed blood, is deposited on one end but not at the 
edge of the slide with the help of a microcapillary tube. This is called as the “head” of 
the smear. The drop of blood on the slide is then spread by means of the other slide 
which has a shortened edge as is called the “spreader”. The spreader slide is placed in 
front of the drop of blood and after they make contact, the blood will spread along 
the edge of the spreader slide. Then the spreader slide is pushed forward along the far 
end of the slide in a smooth and continuous glide pulling the blood behind it. The 
feathered end is called the “tail” of the smear. The angle in which the spreader slide is 
held determines the thickness of the smear. The greater the angle the thicker the film. 
Generally, about a 30° angle is used. The slide is then dried rapidly in air either by 
holding it under a fan or waving rapidly.
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